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Abstract 
Different organs of plants and animals grow to characteristic sizes and shaped that depend 
on their identity. We still know surprisingly little about how organ identity modified patterns of 
growth within the primordium to achieve the correct final size. 
Here, I report on a novel mutant in Arabidopsis thaliana that forms smaller leaves, but 
bigger flowers. Intriguingly, the effect of the mutation strictly depends on the identity of the 
organ, marking out this mutation as a promising entry point to studying the relation between 
organ identity and growth. The phenotypes are due to a partial loss of function of one of 
three canonical nuclear poly(A) polymerases (PAP) in A. thaliana, PAPS1. By contrast, even 
complete loss of function of the other two gene-family members only causes subtle 
phenotypes, indicating functional specialization amongst the different genes. Using 
promoter-swap and chimaeric-protein constructs, this functional specificity is shown to be 
largely encoded in the C-terminal non-catalytic domains of the different proteins. Using a 
mRNA fractionation coupled with microarray, I have defined a set of mRNAs whose poly(A)-
tails and stability are changed in the mutant compared to wild type. The microarray analysis 
suggests that the reduced leaf-growth results from an ectopic upregulation of pathogen-
reponse genes. Analysis of plants that are chimaeric for the paps1-1 mutation shows that 
PAPS1 acts cell autonomously to control petal size and paps1-1 chimerism in the internal 
layer of the meristem invariably causes the meristem to split into two or more meristems. I 
propose that different pre-mRNAs are preferentially processed by different canonical PAPs 
with distinct outcomes in terms of their poly(A) tail lengths. This would open up an additional 
level of gene expression whereby cells could co-regulate large numbers of transcripts in 
response to developmental or environmental changes by modulating the balance of 
canonical PAP isoform activities. I also discuss possible reasons for the identity-
dependence of the paps1-1 mutant phenotypes. 
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1 Chapter 1: Introduction  
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1.1 Organ size control in plants: 
Plant organ size is under strong genetic control. Studies over the last 20-30 years in 
Arabidopsis have identified a number of genes that play a role in organ size control. In this 
section, I first introduce the organ grow process in plants. Secondly, I introduce the 
definition of a size regulator. I thirdly suggest a characterization pipeline that, in my opinion, 
is useful in understanding how the size regulator acts molecularly. Using these bullet points, 
I fourthly summarize the studies about the genes involved in size control in Arabidopsis. 
Fifthly, I pinpoint the general deduction from these studies that contributes to our current 
knowledge about how plant organ size is regulated. Finally, for the interest of this project, I 
emphasized what is known about how different organs can reach different sizes.  
1.1.1 The organ growth process: 
An organ is first inniated in the peripheral zone of the meristem (see further introduction in 
Chapter 5). After initiation, two basic cellular processes are tightly associated with the organ 
growth: cell proliferation and cell expansion, the patterns of which change spatially within an 
organ and also change temporally during the course of growth. Cell proliferation here 
implies the process of cell division (the forming of a new cell wall) and the growth of two 
daughter cells to reach the size of their mother cell. Cell division alone (e.g. the first few 
divisions in the early embryonic development after fertilization) does not cause growth. Our 
understanding of this pattern in leaves comes from a very thorough study by Donnelly and 
colleagues, (Donnelly et al., 1999) and reference therein, who used a cyclin promoter and a 
modified GUS (beta-glucuronidase) reporter gene (pCYC1At::CDBGUS, the CDBGUS is a 
GUS gene fused to a Cyclin Destruction Box) to specifically mark the dividing cells (Figure 
1.1). 
Initially, cell proliferation occurs evenly throughout the entire primordium (Figure 1.1A). 
Gradually, cell proliferations become restricted in a basipetal pattern. Proliferation is 
arrested first at the distal tip of the organ, and is then progressively arrested at the more 
basal parts, until all cells have stopped dividing. Cell expansion (the enlargement of cell size 
due to water uptake to vacuole) happens when a cell exits from the proliferating/cycling 
state. At high cycling rate, cells remain at a constant size of approximately 75 µm2. At exit 
from proliferating, i.e. day 12 in leaf 8, mesophyll cells are about 200 µm2 in area and 
continue to expand 4- to 5- fold. Since cell expansion starts right after the exit from the 
proliferating state, cell expansion also shows a basipetal pattern starting first at the tip and 
reaching the base of the leaf last. However, this basipetal pattern is very weak; instead, it 
seems that after day 12, there is a burst in cell expansion rate across all regions in leaves 
(Donnelly et al., 1999).  
15 
 
 
Figure 1.1. The patterns of cell division and cell expansion in Arabidopsis wild-type 
leaf 8.  
Figure is modified from Donnelly et al., 1998. 
A. Time/developmental series of cell division in the 8th leaf. The 8th Leaf is sampled at 
idicated days after emergence and stained with GUS to visualize dividing cells (blue 
staining). Numbers below the image indicate the length of the leaf blade at the 
corresponding time point. Note that the magnification of the image at day 0 is 10x 
higher than the magnification of images of later dates. The small squares indicate 
the positions where cell size is examined in panel C.  
B. Time/developmetal series of blade length (black columns) and petiole length (white 
columns) of leaf 8. Arrows point at the time when samples were taken for GUS stain 
in panel A.  
C. Palisade mesophyll cells start cell expansion after day 12.   
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3.2 mm
Day 12
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To sum up, leaves grow mainly by cell proliferation at early stages of growth; later, cell 
divisions ceases locally accompanied by a gradual increase in cell size. Cell divisions stop 
completely when a leaf reaches about half of its final size (Day 16 Figure 1.1A and B), after 
that the organ grows solely by cell expansion. Cell expansion is normally coupled with 
endoreduplication, the process in which cells undergo several rounds of DNA replication 
without entering mitosis.  
For the interest of this project, it is of note that there is a difference between leaves and 
petals in the endoreduplication during cell expansion. Cells in floral organs and especially in 
petals seldom endoreduplicate, while leaf cells undergo several rounds of 
endoreduplication. 
1.1.2 A definition: What is a size regulator? 
To be a size regulator, reduction and enhancement of the activity of the gene should show 
opposite effects on final organ size.  Changes in shapes, which are caused by local growth 
regulations that do not results in overall size change is not considered here. The enhanced 
or reduced activity of the gene can be classified into four classes (See Box 1.1).This 
criterion is denoted as the ‘size change in both directions’ criterion.  
Box 1.1. Kinds of perturbations to a gene in Arabidopsis thaliana: 
Loss-of-function mutants: mostly point mutations, T-DNA insertions, deletion mutants or 
transgenic RNAi knockdown.Gain-of-function mutants: This kind of perturbation can have 
very diverse causes e.g. point mutations that make the protein constitutively active. Over-
expressors: can be achieved by three ways: 
iiia) Constitutively expressed:  highly expressed, constitutive and spatially non-restricted 
expressors using 35S promoter (even though 35S promoter is not fully/constitutively active 
in the centre of the meristem). 
iiib)  Endogenous overexpressor: increase the mRNA level although still under control of the 
endogenous promoter such that the temporal and spatial expression patterns of the gene 
are largely unchanged. This can be achieved by supplementing the plant with extra copies 
of the genomic version of the gene or by using a two component system, e.g. LhG4/pOp, 
with the gene’s own promoter.  
Mis-expression using a different promoter than the gene’s own promoter, yet not 35S 
promoter. Mis-expression, may but does not necessarily result in an increased in mRNA 
level compared to WT.  
Care should be taken when applying this definition. Firstly, false negatives: what if the gene 
can only regulate organ size in one direction no matter how it is manipulated genetically? 
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This could be for several reasons, which are related to structure of the pathway in which the 
gene acts. Firstly, plant genes often have homologs, so if overexpression shows a 
phenotype in one direction (e.g. smaller organs), disruption of the gene, however, may not 
cause a phenotype in a reverse direction (e.g. larger organs) unless the activity from 
redundant homologs is also disrupted. Secondly, genes often act in pathways, if plants lose 
the activity of one gene, they might display a phenotype in one direction (e.g. smaller 
organs), but in order to elicit the opposite phenotype (e.g. bigger organs), the whole 
pathway needs to be upregulated. So clearly, single gene overexpression might not be 
sufficient. Even if in theory, single gene mis-regulation can create a ‘bigger size’ phenotype; 
in practice it may prove to be difficult to up-regulate the gene activity in a well co-ordinated 
way to give a well developed and bigger organ. For example, mutation in jag leads to a 
smaller organ, but over-expressing JAG by either 35S promoter or AP3 promoter failed to 
create bigger organs; rather, some strong expression lines disrupted with the organ 
development and caused an outgrowth of snake-like stumps in the place of flowers 
(Dinneny et al., 2004, Ohno et al., 2004). 
Secondly, false positives: this is because there is a strong correlation between late flowering 
phenotype and larger flowers. Also mutants that are infertile tend to have larger 
petals/flowers (SV, ML personal observation). It is questionable; whether the increased 
growth in floral organs is the indirect effect of having more photo-synthetic organs (late 
flowering mutants produced more leaves at bolting).  
Additionally, mis-regulations that increase size are much more likely to identify genes with a 
rather direct role in growth than are mis-regulations that give small organs. This is because 
growth/organ-size phenotypes have a very strong one-directional correlation with gene-
misregulation, i.e. it is very likely that a perturbation to the activity of genes results in 
unhealthy, small plants. We found a lot of ‘smaller size’ mutants in any mutagenesis 
screens. In contrast, the other consequence of gene misregulation(s), which is the creation 
of normally developed and larger plants, happens rarely.  
Taken together, it will be a clear case for a size regulator if one can show the size change 
can happen in both directions by different means of genetic mis-regulation of the gene. In 
other cases, especially, for genes whose mutants are smaller and whose over-expressors 
are not larger, other evidence needs to be gathered to demonstrate the direct role of the 
gene in organ size control. 
1.1.3 Properties to be examined for organ size mutants: 
For easier browsing through the literature of organ size regulators, I list which information I 
consider interesting for understanding the mechanism of organ size regulation (Box 1.2).  
 
18 
 
Box 1.2. Characterization pipelines for a size regulators: 
i. Cell number and cell size: Is the change in the final organ size due to cell number of cell 
size?  
ii. Growth patterns: Are there changes in the temporal and spatial patterns of cell 
proliferation and/or cell expansion?  
iii. Growth rate or growth period:  Is the rate of growth or the period of growth is changed? 
iv. Directions of the regulation: Do disruption and over-expression have opposite effects on 
organ size? 
v. Pathway: Is there a genetic interaction of the gene with other known pathway(s) involved 
in size regulation? 
vi. Organ type:  Does the gene affect the size of more than one organ type? If yes, how do 
the degree of change in different organs compare? 
vii. Expression domain: Where is the gene expressed? 
1.1.4 The players: Genes involved in organ size control in 
Arabiodopsis thaliana: 
Using the seven points above, I summarized the genes that are described as organ size 
regulators in Figure 1.2, Figure 1.4 and Table 1.1.  
1.1.5 General conclusions about the mechanism of organ size 
control in Arabiodopsis thaliana: 
First conclusion: Size control pathways are mostly genetically independent with several 
master regulators that do not converge (Figure 1.2 (Breuninger and Lenhard, 2010)) 
suggesting size control is a complex trait.  
Second conclusion: To make large organs, plants must positively regulate cell proliferation 
and cell expansion in a well co-ordinated way. Ectopically overexpressing components of 
the cell cycle alone (e.g. 35S::CYCD3;1 (Dewitte et al., 2003)) increases the cell division but 
fails to give bigger organs. In fact, 35S::CYCD3;1 transgenic plants are smaller because 
cells fail to expand properly. Similarly, ectopic upregulation of the endoreduplication 
pathway, which is necessary for cell expansion, (35S::FZR2 (Larson-Rabin et al., 2009)) 
increases the size of individual cells, but fails to give bigger organs, because cells fail to 
proliferate properly.  
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Figure 1.2. Genetic pathways that regulate organ growth in Arabidopsis. 
(from (Breuninger and Lenhard, 2010)). 
The petals are GUS (beta-glucuronidase)-stained to visualize the cell division pattern. See 
text for details on the size regulators. 
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Third conclusion: The interaction between cell division and cell expansion is very complex. 
Illustrated in Figure 1.3 are all the theorically possible combinations between changes in 
cell division and cell expansion and their outcome to final organ size. In practice, if one 
project the known size regulators to this figure, almost all the theoretical possibilities are 
backed up with experimental phenotypes (Figure 1.4). The only one theoretical possibility 
that has not yet been backed up by experimental evidence is ‘bigger’ triangle 1 possibility 
(Figure 1.4), in which bigger organs result from an increase in cell divisions surpassing a 
decrease in cell expansion.  Many size regulators change final organ size by affecting only 
cell division or by affecting only cell expansion (the genotypes that lie on line 3, 4 (cell 
expansion only) and line 5, 6 (cell division only) in Figure 1.4). This suggests that cell 
number and cell size can be regulated indendently. So co-ordination between cell division 
and cell expansion is necessary for organ size regulation, a misregulation of a gene may 
affect cell division alone or cell expansion alone or affecting both (the two squares and four 
triangles and line 1,2 in Figure 1.3). 
Fourth conclusion: Mis-regulating the timing of the transition from cell proliferation to cell 
expansion seems to be a common defect for many size-regulating mutants (klu, bb, da1, 
tcps, miR319, grf, an3, ppd1/2, argos, and arf2) see Table 1.1 for reference and more 
details.  
Fifth conclusion: changes in final organ size is mostly observed as the result of a prolong 
duration of growth rather than a change in the growth rate. This property is not well 
documented for most of the genes. However for the cases where it has been analyzed, it 
seems that most of the factors regulate the period of growth (e.g. KLUH, BB, DA1,ANT) 
rather than rate of growth (e.g. proteasomal proteins).  
Sixth conclusion: as mentioned above (in section 1.1.2. A definition: what is a size 
regulator?), a size regulator can act in one direction (size regulators that are in Blue colour 
in Figure 1.4) or in both directions (size regulators that are in Orange, Pink and Red colour 
in Figure 1.4. If in the other direction of genetic manipulation, the phenotype is 
indistinguishable from wild-type (for example ail5 single mutant) the gene might be still 
accept to be a size regulator because one can argue that phenotype in one direction was 
masked by genetic redundancy. However, for genes that showed an unexpected phenotype 
in the other direction of genetic manipulation, it is not trivial to explain and draw conclusions 
about the specific function of this gene in organ size control. For example, the jag mutant 
has smaller organs, but overexpressing JAG under the control of the 35S promoter or the 
petal specific AP3 promoter interfered with organ development and failed to give bigger 
organs. It is subjective to say how specific is the role of JAG is in controlling organ size 
compared to its role in organ development. Additionally, for genes that act in both directions, 
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Figure 1.3. All theorically possible combinations between changes in cell number and 
in the cell size and their outcomes in terms of final organ size.  
The six lines (number 1-6) divide the morphological space, generated by the combination of 
changes in cell size and cell number, into six region (number 1-6). 
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Line 1: Perfect  compensation type A : smaller cells but more cells and organ size is unchanged
Line 2: Perfect  compensation type B : Larger cells but fewer and organ size is unchanged
Line 3: Bigger organs solely caused by increased cell expansion
Line 4: Smaller organs solely caused by decreased cell expansion
Line 5: Bigger organs solely caused by increased cell division
Line 6: Smaller organs solely caused by decreased cell division
Region 4 : Bigger organs by both increased cell divisions and cell expansion 
Region 5 : Bigger organs by an increase in cell divisions surpassing  a decrease in cell expansion
Region 6 : Bigger organs by an increase in cell expansion surpassing a decrease in cell division
Region 1 : Smaller organs by both decreased cell divisions and cell expansion 
Region 2: Smaller organs by a decrease in cell expansion surpassing an  increase in cell division
Region 3 : Smaller organs by  a decrease in cell division surpassing an increase in cell expansion
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Figure 1.4. The effects of known size regulators on cell number and cell size and the 
outcomes in terms of final organ size. 
The lines and triangle annotations are adapted as for figure 1.3. OE means overexpressor. 
Font/Colour codes of the text of the name of the size regulators:  
Red and Bold  = genes that can act in both directions (increase or decrease the final organ 
size) and display  mirrored changes in cell number and cell size in opposite directions. 
Pink                  = genes that can act in both directions (increase or decrease the final organ 
size) but cell number and cell size were not determined for one direction. 
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Figure 1.4. The effects of known size regulators on cell number and cell size and the 
outcomes in terms of final organ size. 
Orange          =  genes that can act in both directions (promote or repress the final organ 
size), but exhibit partial compensation.  
Black                 = genes that were found to act in one direction but have not been examined 
in the other direction. 
Blue               = genes that change organ size in one direction but in the other direction 
affect organ development or do not have an effect on organ size 
In the black background box with white text : genes whose mis-regulation causes 
unexpected effects on organ development. 
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Table 1.1. Arabidopsis genes involved in organ size control:  
Genes are sorted using three orders: the first order is cell division vs. cell expansion: genes affecting mainly cell divisions are listed first; the second order is 
positive vs. negative regulation: the positive regulators comes first; the third order is  alphabetical order of the gene name. The phenotype of mutant and other 
kinds of mis-regulations are described (when possible) including the constructs for transgenic plants or types of mutations. The effects on cell division (+/- : 
more cells/less cells), effects on cell expansion (+/-: bigger cells/smaller cells) are shown. The known genetic/physical interactions are described. The spatial 
expression domains are described with a focus on leaves and flowers. The organs in which the effects are observed are mentioned. ND means not determined 
or no data available, EdOX: endogenous overexpressor.  
1 ant ail6 (ANTERGUMENTA LIKE 6-At5g10510) double mutant display floral organ identity defect. 2 gain of function construct: rGRF2 resistant to miR396. 3 
AP1::JAG causes malformed flowers, 35S::JAG causes bract like structure that subtend flowers and fusion cotyledons. 4 The double mutant bop1 bop2 also 
produced bract-like organs which subtended flowers. The phenotype that resembles the weakly expressed 35S::JAG plants. 5 jaw1-D mutants cause larger 
leaves with an excessive out growth of the leaf margins. 6 ppd1ppd2 double mutants mainly affect the dispersed meristematic cells like meristemoid, 
precursors of guard cells. 7 resistant form of TCP4 to miR319. 8 AP3::mTCP4 causes malformed flowers. 9 Mutants have decreased polyploidy level in leaf 
cells. 10  s6k1 s6k2/++ hemizygous mutants or the RNAiS6K plants showed high degree of phenotypic instability and size variation. All mutants however have 
smaller leaves with smaller cells and larger flowers, in which cell size were not measured. The larger flowers have almost double the DNA content, suggesting 
the defect in S6K causes chromosomal instability. 11 It is suggested that JA post-transcriptionally regulate the expression of the BPEp mRNA as pBPE::GUS 
do not response to JA, but BPEp mRNA appears to be more abundant when inducing plants with JA. 12 opr3 mutants also affect the vein patterning in petals. 
13 rot3 mutants have wider leaf blades but shorter petioles and shorter pistils and stamens. 14 rpn12a-1 and rpn10-1 mutants have larger flowers with reduced 
cell number but larger cells without changes in polyploidy. The rosette of the mutant grows more slowly and the leaves are pointed. a Cell size changes without 
change in ploidy level; b Cell size changes with changes in polidy level. pnd the ploidy was not determined. 
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Table 1.1A. Arabidopsis genes involved in organ size control: Genes that affect mainly cell division:  
 Gene name 
(Abbreviation) 
Protein 
type 
Mutant phenotype Over-expression phenotype Interaction/pa
thway 
Expression domain Organ 
affected 
Reference  
Type of 
mutant 
Cell 
divis
ion 
Cell 
expansi
on 
Final 
organ 
size 
Con
struc
t 
Cell 
divisi
on 
Cell 
expansi
on 
Final 
organ 
size 
1 AINTEGUMENTA 
LIKE 5 (AIL5)- 
At5g57390 
AP2-
domain 
TF 
single 0 0 0 35S:
:AIL
5 
+ 0 + Homologous 
to ANT 
Strong in 
developing floral 
primordia 
Leaves 
and 
flowers 
similarly 
(Nole-Wilson 
et al., 2005) 
2 AINTEGUMENTA 
(ANT)- At4g37750 
AP2-
domain 
TF 
single - + - 35S:
:ANT 
+ 0 + Up regulates 
CYCD3;1 
Synergistic 
interaction 
with AIL61 
growing domain of 
developing organs 
Petals 
(stronger 
effect) 
and 
leaves 
(Krizek, 2009, 
Mizukami and 
Fischer, 2000) 
(Nole-Wilson 
et al., 2005) 
3 AUXIN RESPONSE 
FACTOR 2 (ARF2)-
At5g62000 
ARF 
TF 
Single 
mutant 
+ + + ND ND ND ND Upregulate 
ANT, 
CYCD3;1 
expression 
in mature 
leaves 
Leaves, young  
floral organs, 
siliques, funiculus 
of ovule, embryo.  
Seeds, 
leaves, 
sepals, 
gynoeci
a, but 
not 
petals.  
 
(Schruff et 
al., 2006) 
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Table 1.1A. Arabidopsis genes involved in organ size control: Genes that affect mainly cell division (continued): 
  Gene name 
(Abbreviation) 
Protein 
type 
Mutant phenotype Over-expression phenotype Interaction/pa
thway 
Expression domain Organ 
affected 
Reference  
Type of 
mutant 
Cell 
divis
ion 
Cell 
expansi
on 
Final 
organ 
size 
Con
struc
t 
Cell 
divisi
on 
Cell 
expansi
on 
Final 
organ 
size 
4 AUXIN-
REGULATED 
GENE INVLOVED 
IN ORGAN SIZE 
(ARGOS)- 
At3g59900 
Novel-
plant 
specifi
c 
35S::a
ntisens
e 
ARGO
S 
- 0 - 35S:
:sen
se 
AR
GO
S 
+ 0 + Upregulates 
ANT and 
induced by 
auxin 
Young leaves and 
flowers.  
Leaves,  
 
ND in 
flowers  
(Hu et al., 
2003)  
5 ANGUSTIFOLIA3 
(AN3)/GRF 
INTERACTING 
FACTOR 1 (GIF1)- 
At5g28640 
SYT 
TF 
single 
mutant 
- + - ND + 0 + In teract 
with GRF5 
in Y2H 
Strong in basal 
region of young 
leaf primodia and 
floral buds 
Leaves 
and 
flowers 
similarly
. 
(Horiguchi et 
al., 2005, Kim 
and Kende, 
2004, 
Rodriguez et 
al., 2010) 
6 GROWTH 
REGULATING 
FACTOR 2(GRF2)-
At4g37740 
QLQ/
WRC 
TF 
ND ND ND ND 35S:
:rG
RF2
2 
+ 0 + Is a target 
of miR396b 
Young tissues, 
and in leaf has a 
basipetal 
expression. 
Leaves, 
ND in 
flowers 
(Kim et al., 
2003, 
Horiguchi et 
al., 2005) 
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Table 1.1A. Arabidopsis genes involved in organ size control: Genes that affect mainly cell division (continued): 
 Gene name 
(Abbreviation) 
Protein 
type 
Mutant phenotype Over-expression phenotype Interaction/pa
thway 
Expression domain Organ 
affected 
Reference  
Type of 
mutant 
Cell 
divis
ion 
Cell 
expansi
on 
Final 
orga
n 
size 
Con
struc
t 
Cell 
divisi
on 
Cell 
expansi
on 
Final 
organ 
size 
7 GROWTH 
REGULATING 
FACTOR 5(GRF5)-
At3g13960 
QLQ/
WRC 
TF 
Single 
mutant 
- 0 - Not 
men
tion
ed 
+ 0 + In teract 
with 
GIF1/AN3  
in Y2H 
Leaf primordial, 
NA in flowers.  
Leaf, 
ND in 
flowers 
(Kim et al., 
2003) 
8 JAGGED (JAG)- 
At1g68480 
Zn 
finger 
TF 
Single 
mutant 
- + - AP1
::JA
G 
and 
35S:
:JA
G 
causes bract-like  
structure that subtend 
flowers. Fusion 
cotyledon and 
Malformed floral 
organs 
NUB young primodia of 
lateral organs 
Leaf 
and 
flowers 3 
(Dinneny et 
al., 2006) 
9 KLUH/CYP78A5 
(KLU)-At1g13710 
Cytoch
rom 
P450 
Single 
mutant 
- 0 - EdO
X 
+ 0 + CYP78A7 Young organs 
primodia and 
restricted to the 
peripheral area at 
later stage of 
growth. 
Leaves 
and 
flowers 
similarly
. 
(Adamski et 
al., 2009, 
Anastasiou 
et al., 2007, 
Eriksson et 
al., 2010) 
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Table 1.1A. Arabidopsis genes involved in organ size control: Genes that affect mainly cell division (continued): 
 Gene name 
(Abbreviation) 
Protein 
type 
Mutant phenotype Over-expression phenotype Interaction/pa
thway 
Expression 
domain 
Organ 
affected 
Reference  
Type 
of 
mutant 
Cell 
divi
sio
n 
Cell 
expans
ion 
Fin
al 
org
an 
size 
Cons
truct 
Cell 
divisi
on 
Cell 
expans
ion 
Final 
orga
n 
size 
10 miR396b- 
At5g35407 
miRNA ND ND ND ND 35S::
mir3
96b 
- + - Targets 
GRF2.  
Act together 
with AN3 in 
meristem 
development,  
Is up-
regulated by 
TCP4 
Leaves, the 
mRNA level 
increases as 
leaves get older. 
Expressed more 
strongly at the 
tip compared to 
the base of the 
leaf . ND in 
flowers 
Leaves, 
ND in 
flowers.  
(Rodriguez et 
al., 2010) 
11 BIGBROTHER 
(BB)- 
At3g63530 
E3-
ubiquitin 
ligase 
Single 
mutant 
+ 0 + EdO
E 
- 0 - ND Young organs, 
expression 
decreases 
during growth. 
Flowers 
only, 
leaves 
not 
affected  
(Disch et al., 
2006) 
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Table 1.1A. Arabidopsis genes involved in organ size control: Genes that affect mainly cell division (continued): 
 Gene name 
(Abbreviation) 
Protein 
type 
Mutant phenotype Over-expression phenotype Interaction/pa
thway 
Expression 
domain 
Organ 
affected 
Reference  
Type 
of 
mutant 
Cell 
divi
sio
n 
Cell 
expans
ion 
Fin
al 
org
an 
size 
Cons
truct 
Cell 
divisi
on 
Cell 
expans
ion 
Final 
orga
n 
size 
12 BLADE ON 
PETIOLE 1 
(BOP1)-
At3g57130)  
and  
BLADE ON 
PETIOLE 2 
(BOP2-
At2g41370) 
TF bop1/b
op2 
  
double 
mutant 
ND ND +  35S::
BOP
1 
 
35S::
BOP
2 
ND ND - Upregulates 
JAG/NUB 
incipient of 
young 
leaf/flower 
primordia 
Leaves 
and 
flowers 4 
(Norberg et 
al., 2005) 
 
13 DA1 (DA1)-
At1g19270 
Ubiquitin 
interactio
n domain 
protein 
Single 
, gain 
of 
functio
n allele 
+ 0 + 35S::
DA1 
0 0 0 ND Young organs Leaves 
and 
flowers 
similarly 
(Li et al., 
2008) 
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Table 1.1A. Arabidopsis genes involved in organ size control: Genes that affect mainly cell division (continued):  
 Gene name 
(Abbreviation) 
Protein 
type 
Mutant phenotype Over-expression phenotype Interactio
n/pathway 
Expression 
domain 
Organ 
affected 
Reference  
Type 
of 
mutant 
Cell 
divi
sio
n 
Cell 
expa
nsion 
Final 
orga
n 
size 
Constr
uct 
Cell 
divis
ion 
Cell 
expans
ion 
Final 
organ 
size 
14 miRNA319a/ 
(JAW)- 
At4g23713 
 
miRNA 
Single  
miR31
9a129 
ND ND - EdOE 
: jaw1-
D  
and  
35S::m
iR319a  
+ 0 +  Targets 
TCP2,3,4,
10,24 
lowly 
expressed in 
both leaves 
and flowers  
Leaves5, ND 
on flowers. 
(Palatnik et 
al., 2003, 
Nag et al., 
2009) 
15 NGATHA 1 
(NGA1) 
(At2g46870) 
 
 B3 TF Single 
mutant 
+ ND + AP3>>
NGA1 
Weak  line caused 
reduced petal growth. 
Strong line caused 
transformation of floral 
organs in to carpeloid 
organs. 
ND At the distal 
region of 
lateral organs 
(peripherals of 
leaves and tips 
of developing 
gynoecium) 
Floral 
organs, ND 
on leaves 
(Alvarez et 
al., 2009, 
Trigueros et 
al., 2009) 
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Table 1.1A. Arabidopsis genes involved in organ size control: Genes that affect mainly cell division (continued):  
 Gene name 
(Abbreviation) 
Protein 
type 
Mutant phenotype Over-expression phenotype Interactio
n/pathway 
Expression 
domain 
Organ 
affected 
Reference  
Type 
of 
mutant 
Cell 
divi
sio
n 
Cell 
expa
nsion 
Final 
orga
n 
size 
Constr
uct 
Cell 
divis
ion 
Cell 
expans
ion 
Final 
organ 
size 
16 NGATHA2 
(NGA2)-
AT3g61970); 
NGATHA3 
(NGA3)-
AT1g01030 
NGATHA4 
(NGA4)-
At4g01500 
B3 TF Triple 
and 
quadru
ple 
mutant 
with 
NGA1 
+ ND + AP3>>
NGA3  
 
AP3>>
NGA4 
Both transgenic lines 
caused reduced petal and 
sepal growth. 
ND NGA4 
expressed 
similarly to 
NGA1 
Floral 
organs, ND 
on leaves 
(Alvarez et 
al., 2009, 
Trigueros et 
al., 2009) 
17 NUB-At1g13400 TF double 
mutant 
jag 
nub 
- NA - FIL::N
UB 
Increase number of cell 
layers in floral organs, 
however size were not 
examined. 
JAG Young 
primodia of 
Lateral organs 
Leaves and 
flowers 
similarly 
(Dinneny et 
al., 2006) 
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Table 1.1A. Arabidopsis genes involved in organ size control: Genes that affect mainly cell division (continued):  
 Gene name 
(Abbreviation) 
Protei
n type 
Mutant phenotype Over-expression phenotype Interactio
n/pathway 
Expression 
domain 
Organ 
affected 
Reference  
Type 
of 
mutant 
Cell 
divi
sio
n 
Cell 
expa
nsio
n 
Final 
orga
n 
size 
Constr
uct 
Cell 
divis
ion 
Cell 
expans
ion 
Final 
organ 
size 
18 PEAPOD1 
(PPD1)-
At4g14713 and  
PEAPOD2 
(PPD2)-
At4g14720 
Plant 
specifi
c 
putativ
e DNA 
bindin
g 
protein 
double 
mutant  
ppd1 
ppd2 
+ 0 + EdOx ND ND - ND Basipetal 
pattern in 
leaves. 
Strong in 
vascular 
tissues 
Leaves6, ND 
in flowers 
(White, 
2006) 
19 TCP4-At3g15030 TF NA NA NA NA AP3::
mTCP
4 7 
Ectopic expression 
causes malformed 
flowers 
Is a target 
of 
miR319. 
Positively 
regulates 
miR396 
expressio
n 
ND Leaves, 
flowers8. 
(Nag et al., 
2009) 
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Table 1.1A. Arabidopsis genes involved in organ size control: Genes that affect mainly cell division (continued):  
 Gene name 
(Abbreviation) 
Protein 
type 
Mutant phenotype Over-expression phenotype Interactio
n/pathway 
Expression 
domain 
Organ 
affected 
Reference  
Type 
of 
mutant 
Cell 
divi
sio
n 
Cell 
expa
nsion 
Final 
orga
n 
size 
Constr
uct 
Cell 
divis
ion 
Cell 
expans
ion 
Final 
organ 
size 
20 Other TCP 
proteins 
TCP2-At4g18390, 
TCP3-At1g53230, 
TCP10-
At2g31070 
TCP24-
At1g30210 
TF Evidence that these proteins negatively regulate growth are: they 
are all targets of miR319, and they are homology to the 
CINCINNATA (Crawford et al., 2004) protein in Anthirinum. No mis-
regulation studies have yet been reported. 
Targets of 
miR396 
ND Leaves, 
flowers 
(Palatnik et 
al., 2003, 
Nag et al., 
2009) 
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Table 1.1B. Arabidopsis genes involved in organ size control: Genes that affect mainly cell expansion :  
 Gene name 
(Abbreviation
) 
Protein 
type 
Mutant phenotype Over-expression phenotype Interaction/path
way 
Expression 
domain 
Organ 
affected 
Reference  
Type 
of 
mutant 
Cell 
divisi
on 
Cell 
expa
nsion 
Final 
orga
n 
size 
Constr
uct 
Cell 
divis
ion 
Cell 
exp
ansi
on 
Final 
orga
n 
size 
1 ARGOS-
LIKE 
ARL-
At2g44080 
Novel 
plant 
specific 
Single 
RNAi 
line 
0 - a - 35S::A
RL 
0 +a + Induced by 
Brassinosteroid 
(BR),  
rescue partially  
br1-119 mutant 
Strongly 
expressed in 
mature region 
of 
leaves/cotyled
ons, not 
observed in 
leaf primodia, 
strong in 
sepals and 
stamen.  
Leaves, ND 
in flowers.  
(Hu et al., 
2006) 
2 AtTOP6B-
At3g20780;A
tSPO11-
At3g13160;BI
N4 -
At5g24630  
Topoisom
erase VI 
compone
nts  
Single 
mutant 
in 
each 
gene.  
ND -b - ND ND ND ND All three 
mutants are BR 
insensitive 
ND Leaves9, ND 
in flowers 
(Sugimoto-
Shirasu et al., 
2005, 
Sugimoto-
Shirasu et al., 
2002) 
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Table 1.1B. Arabidopsis genes involved in organ size control: Genes that affect mainly  cell expansion (continued) :  
 Gene name 
(Abbreviation
) 
Protein 
type 
Mutant phenotype Over-expression phenotype Interaction/path
way 
Expression 
domain 
Organ 
affected 
Reference  
Type 
of 
mutant 
Cell 
divisi
on 
Cell 
expa
nsion 
Final 
orga
n 
size 
Constr
uct 
Cell 
divis
ion 
Cell 
exp
ansi
on 
Final 
orga
n 
size 
3 S6 kinases1 
 (S6K1)-
At3g08730 
and S6 
kinases2 
(S6K2)- 
 At3g08720 
Protein 
kinase 
s6k1 
s6k2/+
+  
hemizy
gous 
and 
RNAi 
line 
0 -/+b 
,10 
-/+10 ND ND ND ND TOR 
E2F/RBR, 
 
Controlling 
chromosomal 
instability 
ND Smaller 
leaves but 
larger 
flowers10.  
(Henriques et 
al., 2010) 
4 BIGPETAL 
(BPE)-
At1g59640 
TF RNAi 
and 
TDNA 
single 
0 - a - 35S::B
PEp in 
opr3 
backgr
ound 
0 + a + Upregulated by 
35S::PI and 
35S::AP3 and 
35S::SEP3 but 
downregulated 
in 
35S::AGAMOU
S, Upregulated 
by Jasmonate11 
Two forms of 
transcript:BPE
ub express 
everywhere. 
BPEp 
expresses 
specifically in 
floral organs 
Only petals 
no effect on 
leaves 
(Szecsi et al., 
2006, 
Brioudes et 
al., 2009) 
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 Table 1.1B. Arabidopsis genes involved in organ size control: Genes that affect mainly cell expansion (continued):  
 Gene name 
(Abbreviation
) 
Protein 
type 
Mutant phenotype Over-expression phenotype Interaction/path
way 
Expression 
domain 
Organ 
affected 
Reference  
Type 
of 
mutant 
Cell 
divi
sio
n 
Cell 
expan
sion 
Final 
organ 
size 
Cons
truct 
Cell 
divis
ion 
Cell 
exp
ansi
on 
Final 
orga
n 
size 
5 ORP3-
At2g06050 
12-
oxophyto
dienoate 
reductase 
Single 
mutant 
0 + a + 35S::
OPR
3 
0 0 0 JA biosynthesis 
enzyme,positivel
y regulate BPEp 
ND Petals12, ND 
in leaves 
(Brioudes et 
al., 2009)  
6 RPT2A-
At4g29040 
Proteoso
mal 
subunits 
Single 
mutant 
0 + a +
  ND ND ND ND Proteosomal 
subunits 
Expressed in 
both leaves 
and flowers. 
Affect leaves 
cotyledons 
and petals. 
(Sonoda et 
al., 2009, 
Kurepa et al., 
2009) 
7 ROTUNDIFO
LIA (ROT3)-
At4g36370 
 
oxygen 
binding / 
steroid 
hydroxyla
se  
Single 
mutant 
ND + pnd +/- 13 
 
ND ND ND ND BR biosynthesis ND Leaves and 
floral 
organs11  
(Tsuge et al., 
1996, 
Ohnishi et 
al., 2006) 
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Table 1.1C. Arabidopsis genes involved in organ size control: Genes that affect  both cell division and the cell expansion: 
 Gene name 
(Abbreviation
) 
Protein 
type 
Mutant phenotype Over-expression phenotype Interaction/path
way 
Expression 
domain 
Organ 
affected 
Reference  
Type 
of 
mutant 
Cell 
divisi
on 
Cell 
expa
nsion 
Final 
orga
n 
size 
Constr
uct 
Cell 
divis
ion 
Cell 
exp
ansi
on 
Final 
orga
n 
size 
1 ErbB-3 
epidermal 
growth factor 
receptor 
binding 
protein1  
(EBP1-
At3g51800) 
nucleolus 
dsRNA 
binding 
protein  
RNAi 
line 
- - nd - 35S::E
BP1 
+ + nd + Affect RBR 
protein level; 
positively 
regulates cyclins 
level in an auxin 
dependent 
manner 
ND Leaves. 
Flowers ND 
(Horvath et 
al., 2006) 
2 FIZZY-
RELATED 2 
(FRZ2)-
At4g22910 
 
WD40 
gene 
Single 
mutant 
+ - b 0 35S::FR
Z2 
- + b - Affect 
endoreduplicatio
n 
ND Leaves, ND on 
flowers. 
(Larson-Rabin 
et al., 2009) 
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Table 1.1C. Arabidopsis genes involved in organ size control: Genes that affect  both cell division and cell expansion (continued): 
 Gene name 
(Abbreviation
) 
Protein 
type 
Mutant phenotype Over-expression phenotype Interaction/path
way 
Expression 
domain 
Organ 
affected 
Reference  
Type 
of 
mutant 
Cell 
divisi
on 
Cell 
expa
nsion 
Final 
orga
n 
size 
Constr
uct 
Cell 
divis
ion 
Cell 
exp
ansi
on 
Final 
orga
n 
size 
3 RPN12A- 
At1g64520 
Proteaso
mal 
subunits 
Single 
mutant 
- + a + ND ND ND ND Proteasomal 
subunits 
ND Flowers and 
rosettes in 
opposite 
direction14 
(Kurepa et 
al., 2009) 
4 RPN10-
At4g38630 
Proteaso
mal 
subunits 
Single 
mutant 
- + a + ND ND ND ND Proteasomal 
subunits 
ND Flowers and 
rosettes in 
opposite 
direction14 
(Kurepa et 
al., 2009) 
5 Target of 
rapamycin 
(TOR)-
At1g50030 
 
Protein 
kinase 
RNAi - + pnd - EdOx + + + Phosphporylate 
S6 kinase 
ND Leaves, 
flowers ND 
(Menand et 
al., 2002, 
Deprost et 
al., 2007) 
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i.e. the final organ size mirrors each other in different mis-regulations, the underlying 
molecular changes to the cell number and the cell size does not always mirrors each other. 
If a gene displayed mirrored changes in the cell number and the cell size in opposite 
directions of genetic manipulations, it gets red colour in figure 1.4. Otherwise, it gets Orange 
colour: despite the final size change mirrors each other, the cell number and cell size 
changes do not. If the other direction is not yet investigated it gets the pink colour. This 
conclusion may be related to the third conclusion in part: The ability of genes to act in both 
directions in controlling size, which depends on the structure of the genetic pathways (as 
explained in section 1.1.2.), also depends on on its ability to overcome the compensation 
mechanism between cell number and cell size. Therefore, it may be hard to tell in some 
cases whether a gene is a size regulator or not. 
Seventh conclusion: The size effect on different organs, e.g., leaves vs petals, is similar in 
most of the mutants. I will further discuss this conclusion in more detail in the section below.  
1.1.6 How can different organs reach different size? What is the 
relationship between organ identity and size regulation? 
Final size of different organs within one plant is often very different. Understanding the 
mechanism of this is an important aspect in organ size regulation, yet at the moment, it is 
largely unknown what makes different organs grow to different sizes. In Arabidopsis 
thaliana, the effects of a size regulator on different organs were not always examined. Many 
studies analyzed only one type of organ (most often leaves (L)) without information about  
the effect on other organs such as petals (P), for example in the studies AIL5 (L), ARGOS 
(L), GRF5 (L), GRF2 (L), PPD1/2 (L), miR396b (L), EBP1 (L), ARL (L), TOR (L), 
Topoisomerase VI components (L), FRZ2 (L), NGA (P). I tried to extract this information and 
summarized it in Table 1.1. In many other studies, in which this aspect was examined, the 
effect of the size regulators on leaves and flowers was found to be mostly similar (KLUH, 
DA1, ANT, ARF2, AN3, JAG, JAW/miR319a, TCP4, BOP1/2, ROT3). If a mutant has 
smaller leaves, it is often found to have smaller flowers. The exceptions are i) bpep and bb 
mutants where the effect seemed to be only specific to floral organs; ii) S6 kinase mutants 
(s6k1 s6k2/++ heterozygous), proteasomal mutants (rpt2, rpn10, rpn12a) where leaves are 
smaller, but flowers are larger than WT and iii) cincinnata mutants in Anthirinum where 
leaves are bigger but flowers are smaller than WT. BPEp is expressed only in floral organs, 
so it is a floral specific size regulators (Szecsi et al., 2006). For most other cases, it seems 
that largely, the same size regulation pathways operate in different organs resulting in 
similar effect to the final organ growth. Organs like petals/sepals and leaves are 
homologous. The transformation of identity from one organ to the other requires as few 
genes as one, e.g. ap2-1 mutant (Bowman et al., 1989) and 35S::UFO::SRDX (Chae et al., 
40 
 
2008). It is therefore formally possible that organ patterning genes interact with the organ-
non-specific size regulators to fine tune the growth of the organ. 
In animals, there is one piece of evidence from a study in fly wings that supports the above 
hypothesis. In wings and halteres (similar structures, but much smaller organs than wings), 
a Decapentalegic (Dpp)-dependent growth pathway is differentially modified to achieve 
different final organ sizes. The Ultrabithorax (Ubx) identity gene is specifically expressed in 
haltere and controls both its size and identity. Ubx controls haltere size by restricting both 
the transcription and the mobility of the morphogen Decapentaplegic (Dpp), which mediates 
size control. Ubx also restricts Dpp's distribution in the haltere by increasing the amounts of 
the Dpp receptor, thickveins (Crickmore and Mann, 2006). 
Here I study a novel mutant that has bigger flowers but smaller leaves than WT. These 
reverse phenotypes in the two organs mark this mutant as a promising entry to study the 
relationship between the organ identity and size regulation. The causal gene encodes for a 
Poly(A) Polymerase, an enzyme that adds poly(A) tail to pre-mRNAs. Polyadenylation is 
part of the 3’ end formation process of pre-mRNAs. Hence, below I give introduction about 
the 3’ end processing of eukaryotic mRNAs with focus on polyadenylation.  
1.2 Pre-mRNA 3’ end formation in plants with comparison to 
yeast and human: 
1.2.1 3’ end formation in general: 
In the nucleus of all eukaryotic cells, all newly synthesized pre-mRNAs, with the exception 
of histone mRNAs, are cleaved at their 3’ end and then polyadenylated (Figure 1.5). This 
process, so called 3’ end formation happens co-transcriptionally (Proudfoot, 2004) and can 
affect all aspects of mRNA metabolism: stability, translational efficiency, export, and 
generation of mRNA variants. Because of its universal importance in basic gene regulations, 
this process has been extensively studied in yeast, animals (reviewed in (Colgan and 
Manley, 1997, Millevoi and Vagner, 2010, Wahle and Ruegsegger, 1999, Zhao et al., 1999)) 
and plants (Rothnie, 1996, Hunt, 2008). Directly involved in this process are the cis-
elements surrounding the cleavage site of the mRNAs and the trans-factors (Figure 1.6). 
1.2.2  Roles of 3’ end formation: 
3’ end formation can affect all aspects of mRNA metabolism: stability, translational 
efficiency, export, and generation of mRNA variants (see above reviews). 
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Figure 1.5. 3’ end processing of eukaryotic mRNAs.  
This figure is taken from (Zhao et al., 1999). 
PABPN1
NabII
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Figure 1.6. Schematic drawing of the eukaryotic 3′ end processing machineries. 
This figure is taken from (Millevoi and Vagner, 2010). 
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1.2.1 Components of the 3’ end formation:  
1.2.1.1 cis-elements :  
There are cis-elements at the 3’ end of a pre-mRNA to signal where the cleavage site, 
which is also the polyadenylation site, is. The function of these elements is to recruit the 3’ 
end formation complex to the pre-mRNA and to specify the polyadenylation site. Animals, 
yeast and plants possess different cis-elements. These elements are conserved to a 
different degree in each kingdom.  
cis-elements in human: 
In mammalian cells, three elements define the core polyadenylation signal:  the upstream 
AAUAAA element, the downstream sequence elements (DSE) and the cleavage site itself 
(Figure 1.6). The highly conserved AAUAAA element is found 10 to 30 nucleotides 
upstream of the cleavage site. 
Any single point mutation in this hexanucleotide (apart from A to U at the second position) 
strongly inhibits polyadenylation in vitro using HeLa nuclear extract and synthetic mRNA 
precursors (Sheets et al., 1990). The DSE is U-rich or GU-rich and is found within 30 
nucleotides downstream of the cleavage site. DSE is poorly conserved, however small 
internal deletion (10bp) and  and linker replacement mutation study on some mRNAs 
(simian virus 40 late (SV40) and adenovirus L3 pre-mRNAs, beta globin mRNAs) revealed 
that the proximity of the DSE to the poly (A) site can affect the effiency and/or the position of 
cleavage ((Mason et al., 1986), (MacDonald et al., 1994). The cleavage site, which is also 
the poly (A) addition site, is determined mainly by the distance between the USE and DSE 
(Chen et al., 1995) based on in vitro studies on SV40 pre RNA. The local sequence 
surrounding the cleavage site is not conserved.  However, the two last nucleotides at the 3’ 
end of the 5’ half of cleaved product are very often 5’-CA-3’ with C found in the penultimate 
position of 59% of 63 vertebrate mRNAs analyzed, the value for A at the last position 
(denoted position +1) is 70% (Sheets et al., 1990). Converting this A to U or C shifted the 
terminus of the 5’ half-molecule to the adjacent adenosine downstream.  
These early studies which only analyzed a small number of mRNA substrates, gave the 
conclusion that the AAUAAA elements is absolutely conserved. However, this view has 
been challenged by recent large scale studies revealing that the AAUAAA element is not so 
conserved; only 50%-70% of the analyzed mRNAs carry this elements in their 3’ end 
(Beaudoing and Gautheret, 2001, MacDonald and Redondo, 2002, Tian et al., 2005).  
In addition to the three core pA signals, other sequence elements have been found in the 
mammalian system to enhance or repress 3’ end processing efficiency. Some 
enhancer/suppressor elements have been found, mostly in virus genes, although some 
were also found in cellular genes as summarized in (Zhao et al., 1999).  
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There are also examples of cis-elements that limit the poly(A)-tail length (discussed further 
in section 1.4.1.1 
cis-elements in yeast:  
Yeast polyadenylation signals are less highly conserved compared to mammalian 
cells(Graber et al., 1999).  However, synthetic minimal yeast 3’ end signals exist (Guo and 
Sherman, 1996). The minimal yeast mRNA 3’ end region requires at least three elements: 
The efficiency element, which ensures the efficiency of the positioning elements; the 
positioning element which positions the cleavage site; and the actual cleavage site.  
cis-elements in plants: 
Plants polyadenylation signals are more complex and less well-conserved compared to 
mammalian or yeast cells. Both functional studies on a handful of cis-elements from some 
plant mRNAs (reviewed in (Rothnie, 1996)) and large scale sequence analysis of 3’ end of 
cDNAs have been carried out (see below).  
Firstly, based on functional studies some transcripts (including the Cauliflower mosaic virus 
(CaMV) 35S transcript (Rothnie et al., 1994, Sanfacon and Hohn, 1990), the pea small 
subunit of Rubisco (rbcS) gene (Mogen et al., 1992), the maize 27kDa protein gene(Wu et 
al., 1993), the rice tungro bacilliform virus (Rothnie et al., 2001),  the Agrobacterium T-DNA 
encoded octopine synthase gene (ocs)(MacDonald et al., 1991), and the nopaline synthase 
(nos) genes (Rothnie et al., 1994)), the general conclusion is that cis-elements in plants are 
not well conserved; the spacing and base composition are more important than the actual 
sequences. These studies agreed on a polyadenylation motif consisting of three 
components:  i) the near upstream element (NUE) which is located 13 to 30 nt upstream of 
the cleavage site (CS). This NUE sequence is 6-10 nt in length, its composition is A rich and 
in some cases it resembles the highly conserved hexa-sequences AAUAAA in the human 
polyadenylation signal. ii) The far upstream element (FUE) is located at least 29 nucleotides 
upstream of the CS and is 60-100 nucleotides in length. The FUE sequence is rather 
diffuse. Apart from the general property of being U rich, no conserved motifs can be 
defined.iii) the cleavage site itself is commonly after 5’-YA-3’ residues (Y is pyrimidine), 
similar to the 5’CA3’ motif in mammals.  
Mutational studies on those three elements of different genes gave different and sometimes 
contradictory conclusions about the importance/the conservatory of these cis-element 
sequences.  For example, only deletion, but  none of 18 possible base mutations in the 
AAUAAA motif, had a dramatic effect on 3’-end processing effiency of the CaMV/35S 
transcription unit (Rothnie et al., 1994). (Wu et al., 1993)reported a somewhat contrasting 
conclusion with maize 27kDa protein mRNA, where an AAUGAA motif is used as NUE. One 
kind of mutated NUE, AAUAAA, reduced the amount of mRNA polyadenylated at the normal 
pA site by half whereas other kinds, like AAUCAA or AAUUAA, decreased polyadenylation 
effiency to a very low level.   
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There is also evidence that cis-elements are also not conserved between 
monocotyledonous (monocots) and dicotyledonous (dicots) plants. When a wheat gene is 
expressed in tobacco plants, it is not well polyadenylated (Keith and Chua, 1986), and the 
poly A site was mislocated. Supporting this non-conservation in mRNA processing between 
monocots and dicots, (Keith and Chua, 1986) reported that an intron included in wheat 
rbcSgene was found to be inefficiently spliced in tobacco plants. The FUE cis-elements are 
sometimes interchangeable: CaMV FUE could partially activate an otherwise silent 
AAUAAA signal in nos mRNA (Rothnie et al., 1994). Another noteworthy result arising from 
this study is that the distance between USE and DSE is important. A 17-18 nucleotide 
increase in the distance is sufficient to alter the pre-mRNA poly adenylation profile (Rothnie 
et al., 1994). The authors suggested that the distances reflect the physical sizes of the 
trans-factors.  
In summary, based on only 5 gene annotation units, the general conclusion is that cis-
elements in plants are not well conserved; the spacing and base composition is more 
important than the actual sequences.  
Since the release of the Arabidopsis thaliana genome (2000), the poly(A) signals have been 
studied on a large scale by aligning the sequences in the 3’ end of cDNAs to the genomic 
sequences.  Based on a data set of approximately 8000 Expressed Sequence Tags (EST) 
with authenticated poly(A) sites, a new model of the poly(A) signal has been compiled 
(Figure 1.7) (Loke et al., 2005). In this study, the most highly conserved motif found in the 
examined 3’UTRs was identical to the mammalian hexanucleotide AAUAAA. Yet, this 
hexamer was found in only 10% of the 8000 3’UTRs analyzed while the figure is 
approximately 53% for a human database of 13,000 authenticated poly(A) sites (Tian et al., 
2005). The author also found some motifs in NUE and FUE (Loke et al., 2005) but with very 
low occurrences. For example, the most common motif in FUE is present in only less than 
1% of 8000 3’UTR analyzed. To summarize, a large scale sequence alignment of 8000 
3’UTRsidentified the conserved enrichment of base compositions (mainly U rich or A rich) at 
some locations in the 3’UTRs, yet no sequence motif was found to occur more than 10% of 
the transcripts analyzed. These results agree with the previous functional studies (above) 
and together they suggest that the cis-elements in plants are not very well-conserved 
compared to human and yeast.  
Another noteworthy result from this paper (Loke et al., 2005),is that the authors also 
suggested  the importance of secondary structure of 3’UTR for the choice of CS. The 
authors predicted the secondary structure of the 3’UTRs of rbcS and CaMV. They then 
mapped the published mutations in cis-elements from previous functional studies of rbcS 
and CaMV to the structures. These mutations not only change the sequence, but also 
disrupt the secondary structure. Interestingly, the resulting new choices of CS discovered in 
the previous studies (Rothnie et al., 1994, Sanfacon and Hohn, 1990, Mogen et al., 1992) 
are in agreement with their newly proposed hypothesis, that the secondary structure of 
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Figure 1.7. Proposed models of the cis-elements for 3’ end processing in plants. 
The figure and figure legend is modified from Loke et al., 2005. 
Single-nucleotide profile of 3'-UTR and a current model of plant poly(A) signals. Distinct 
profiles flanking the CS are now named CEs. A, Sequence logo generated from the actual 
percentage of each of the four nucleotide's occurrence in the 8-K dataset, indicating 
preferred nucleotides flanking the CS (–5 to +3 nt). B, A current model for Arabidopsis 
mRNA poly(A) signals. URE, U-rich regions, which are found flanking both up and 
downstream of the CS.  
  
A
B
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3’UTRs can direct CS choice. However, there is currently no evidence that this secondary 
structure alone without the actual sequences is sufficient to determine CS.  
To sum up, plant polyadenylation signals, which consist of near upstream elements (NUE), 
far upstream elements (FUE) and the cleavage site (CS), are much less well-conserved 
than mammalian polyadenylation signals. It is remains to be answer whether the less well 
conserved cis-elements have any biological functions, but it is formally possible that this 
diversity can allow 3’ end processing of pre-mRNAs in plants to be more finely regulated, 
and the regulation pathway may be very different from animals and yeast.  
1.2.1.2 Trans-factors:  
The players: 
 So far, our understanding about trans-factors in 3’ end complexes comes mostly from the in 
vitro biochemical studies on purified or recombinant individual factors or sub-complexes and 
yeast two-hybrid studies. These studies defined a polyadenylation complex as a large 
structure containing four main sub-complexes: the Cleavage Polyadenylation Specificity 
Factor complex (CPSF), the Cleavage Stimulating Factor complex (CstF), the Cleavage 
Factor (CF), and the Poly(A) Polymerase enzyme (PAP) (Figure 1.6) (Millevoi and Vagner, 
2010)). Evidence from in vitro studies in mammalian systems indicates that proteins CPSF 
is the first subunit that forms the complex; CSPF160 binds AAUAAA elements, and CPSF73 
has endonuclease activity (Mandel et al., 2006) and supposedly cleaves the RNA. CstF 
binds to the DSE and aids CPSF to bind strongly to the RNA substrates (Millevoi and 
Vagner, 2010). CFs bind to auxillary elements and increase the effiency of 3’ end 
processing. A fully processive polyadenylation complex in vitro additionally requires poly(A) 
binding proteins (PABP) (Bienroth et al., 1993). 
The assembly and interactions in the 3’ end formation complex:  
How do these individual trans-factors assemble?  (Shi et al., 2009) used 3xMS2hairpin-tag-
SV40RNA and 3xMS2hairpin–tag-adenovirus L3 pre-mRNAs as substrates to isolate the 
complexes. SV40 and adenovirus L3 pre-mRNAs are the two commonly used RNA 
substrates for in vitro 3’ end processing studies; MS2 hairpin is an RNA sequence that 
forms a hairpin secondary structure and is bound specifically by coat proteins of MS2 
bacteriophages. The authors isolated 85 proteins that are shared when using both 
substrates as bait and are not isolated using the mutated versions of substrates. The 
authors found the four main sub-complexes CPSF, CstF, CFI, CFII (though Clp1 was 
lacking), PAP, RNA polymerase II (RNA pol II) subunits, PAF (transcription enlongation 
complexes), components of splicesosomes, intergrators (that is involved in the 3’ end 
processing of small RNAs), translational enlongation factors, DNA–damage repair proteins, 
and some novel components that had not been known to be associated with 3’ end 
complexes before. The biological function of this interaction remains to be investigated, but 
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the data suggest that the interactions between 3’ end process and other cellular processes 
are more complicated than anticipated.  
Trans-factors in plants:  
Factors: Homologs of yeast and human trans-factors exist in plants (summarized in Table 
1.2). Some of the factors have been studied biochemically; mutations have been isolated for 
some factors, and most of them are essential genes. However there are a handful of 
weak/hypomorphic mutations in some factors, for which strong mutants are lethal. These 
weak mutants surprisingly displayed specific phenotypes: late flowering and defects gene 
silencing or oxidative stress repsonse. The cpsf100/esp5 mutation suppresses gene 
silencing (Herr et al., 2006); cstf64-1 and esp1 are two mutation alleles in CstF64 gene, 
both of which results in late flowering and also suppress gene  silencing (Liu et al., 2010), 
Symplekin/esp4 is also a suppressor of gene silencing(Herr et al., 2006);pfs2/fy-2 is late 
flowering (Simpson et al., 2003); cstf77-1 is late  flowering.  
Assembly:  
Using cell suspension cultures, CPSF components in Arabidopsis were identified by a 
proteomic approach (Zhao et al., 2009) using TAP-tagged version of CPSF100, CPSF73-I 
and II, CPSF30, AtFY and AtCLPS3. Note that antibodies against AtCPSF30, 73-I, -100, -
160 (Xu et al., 2006); AtFY (Simpsons et al., 2003) and AtCLPS3 (Xing et al., 2008a) exists. 
In a different studies,(Herr et al., 2006) reported that FLAG-tagged AtCPSF100 co-purified 
with AtCPSF160, AtCPSF73-I, AtFY. (Delaney et al., 2006). Hunt et al., 2008 used yeast 
two-hybrid assays to investigate all possible pairwise interactions among trans-factors (Hunt 
et al., 2008), summarized in Figure 1.8. Using TAP-AtFY constructs, Manzano et al., 2009 
pulled down FY complexes (using FY-C terminal TAP tag construct) and reported two 
distinct complexes at different sizes (Manzano et al., 2009). Over-expressing FCA promotes 
the formation of the high molecular weight complex. AtCPSF160 is more abundantly found 
in the low molecular weight complex. However, the composition of these two complexes 
was not analyzed by mass-spectrometry. FY interacts physically with AtCPSF100 and 
AtCPSF160. The authors showed that in the late flowering fy-2 hypomorphic mutant, the 
complex where AtCPSF160 resides changes, but the complex where FCA resides does not 
change. The fact that Arabidopsis thaliana has several homologs for some singular trans-
factors in human  and yeast, and the results from in vivo pull down and yeast two hybrids 
experiments, suggest that Arabidopsis thaliana may have several distinct 3’ end processing 
complexes.   
It is concluded that plants have a more diverse trans-factors and cis-elements involved in 3’ 
end processing and there are different 3’ end processing complexes with perhaps different 
functions.  
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Table 1.2. The Arabdiopsis homologs/orthorlogs of yeast/human core 3’ end processing factors: 
The blank cells in the table indicates the information is not available.  
Factors Human/yeast 
counterpart  
At code Overexpression Mutants phenotype Available 
material 
Enzymatic 
activity 
Reference 
CPSF160 CPSF160/Yhh1 At5g51660 NA NA Peptide 
antibody 
 (Xu et al., 
2006) 
CPSF100 CPSF100/Ydh1 At5g23880  + some alleles are 
lethal 
+ esp5 enhances 
silencing and affects 
flowering time.    
Peptide 
antibody 
 (Elliott et al., 
2003, Tzafrir 
et al., 2004, 
Herr et al., 
2006, Xu et 
al., 2006) 
CPSF73 CPSF73/Ysh1 At1g61010  
(CPSF73-I) 
+ 35S::cDNA all 
transformations failed to 
give transformants 
+pCPSF73::cDNA 
transgenic plants  are 
male sterile and have 
big flowers 
+ Plants carrying 
inducible RNAi 
constructs  are dead 
after induction,   
  
Peptide 
antibody 
 (Xu et al., 
2006) 
At2g01730 
(CPSF73-II) 
 Embryonic lethal,  Peptide 
antibody 
 (Xu et al., 
2006, Xu et 
al., 2004) 
Table 1.2.  The Arabdiopsis homologs of yeast/human core 3’ end processing factors (continued): 
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Factors Human/yeast 
counterpart  
At code Overexpression Mutants phenotype Available 
material 
Enzymatic 
activity 
Reference 
CPSF30 CPSF30/Yth1 At1g30460  oxt6 mutants show 
enhanced sensitive to 
oxidative stress (a T-
DNA allele) 
 Endonuclease, 
interacts with 
calmodulin 
(Addepalli and 
Hunt, 2007, Xu 
et al., 2006, 
Delaney et al., 
2006) 
FY hPfs2/Pfs2 At5g13480  fy-1 and fy-2  are late 
flowering. 
  (Simpson et 
al., 2003) 
CstF77 CstF77/Rna14 At1g17760  hypomorphic cstf77-1 is 
late flowering; 
cstf77-2 causes female 
gametophytic lethality.  
 Bind RNA (Yao et al., 
2002, Bell and 
Hunt, 2010, 
Liu et al., 
2010) 
CstF64 CstF64/Rna15 At1g71800  cstf64-1 reduced fertility, 
flowering time delayed; 
cstf64-2  small, sterile; 
esp1  enhances gene 
silencing  
  (Liu et al., 
2010) 
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Table 1.2.  The Arabdiopsis homologs of yeast/human core 3’ end processing factors (continued): 
Factors Human/yeast 
counterpart  
At code Overexpression Mutants phenotype Available 
material 
Enzymatic 
activity 
Reference 
CstF50 CstF50 At5g60940  ?   No study 
Fip1 hFip1/Fip1 At3g66652(FIPS3)      
At5g58040(FIPS5)  a T-DNA insertion allele 
is  lethal 
  (Forbes et al., 
2006) 
CFIm25 hCFIm25 At4g25550 (CFIS2)     No study 
At4g29820 (CFIS1)     No study 
CFIIm hClp1/Clp1 At3g04680 (CLPS3) CLPS3::TAP Small 
deformed flowers, 
other morphological 
changes, 
a T-DNA insertion allele  
is lethal 
CLPS3-
TAP 
RNA kinase (Xing et al., 
2008a) 
  At5g39930 (CLPS5)  T-DNA no phenotype   (Xing et al., 
2008a) 
Symplekin Symplekin/Pta1 At1g27590 (SYM1)      
At1g27595 (SYM2)      
At5g01400 ( SYM5)  esp4  enhances gene 
silencing 
  (Herr et al., 
2006) 
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Table 1.2.  The Arabdiopsis homologs of yeast/human core 3’ end processing factors (continued): 
Factors Human/yeast 
counterpart  
At code Overexpression Mutants phenotype Available 
material 
Enzymatic 
activity 
Reference 
CFIIm hPcf11p/Pcf11 At1g66500 (PCFS1)     (Xing et al., 
2008b) 
 
At4g04885 (PCFS4)  pcfs4 is late flowering   
At5g43620 (PCFS5)     
Cytoplasmic 
Poly(A) 
Binding 
protein 
(PAB) 
Pab1(yeast) At1g34140 (PAB1)     (Belostotsky, 
2003, 
Belostotsky 
and Meagher, 
1993, Bravo et 
al., 2005, 
Chekanova 
and 
Belostotsky, 
2003, 
Belostotsky 
and Meagher, 
1996, 
Chekanova et 
al., 2001, 
Palanivelu et 
al., 2000) 
At4g34110 (PAB2)*   
At1g22760 (PAB3)*   
At2g23350 (PAB4)   
At1g71770 (PAB5)*   
At3g16380 (PAB6)   
At2g36660 (PAB7)   
At1g49760 (PAB8)   
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Table 1.2.  The Arabdiopsis homologs of yeast/human core 3’ end processing factors (continued): 
Factors Human/yeast 
counterpart  
At code Overexpression Mutants phenotype Available 
material 
Enzymatic 
activity 
Reference 
Nuclear  
Poly(A) 
Binding 
protein (PAB) 
Nab2/PABPN1 At5g65260 (PABN1)     No study 
At5g51120 (PABN2) 
At5g10350 (PABN3) 
* The PAB that can rescue pab1 yeast mutant.   
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Figure 1.8. Interactions between 3’ end processing factors  identified by yeast two 
hybrid. 
This figure is taken from (Hunt, 2008). 
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1.3  Poly (A) polymerase: 
1.3.1 General properties of canonical PAPs in yeast and animals:  
A PAP is classified as canonical PAP (cPAP) if it shares a high amino acid sequence 
identity 30-40% with, and are the most similar proteins in that organism genome to, the 
human PAP alpha or the yeast PAP1. cPAPs have a steady-state localization in the 
nucleus. cPAPs add adenosine to the 3’ end of cleaved mRNAs to form poly(A) tails of 
mRNAs.  
The number of cPAPs varies with species: human has three, Drosophila melanogaster(fruit 
fly) has one, Saccharomyces cerevisiae (budding yeast) has one, chicken has one, 
mammals has three, Caenorhabditis elegans(worm) has three, Daniorerio (fish) has two, 
Amoeba has one. Plants have more: Physcomitrella patens (moss) has two, 
Chlamydomonas (algae) has one, Selaginella moellendorffii has two, Oryza sativa (rice) has 
six, Sorghum has six, Populus has three, grapevine has four, and Arabidopsis thaliana has 
four. Canonical PAPs that have been studied includes bovine, human, mouse, yeast, fly, 
and Arabidopsis. In species whose genome has not been fully sequenced, there could be 
more canonical PAPs. The phylogenetic tree of 45 cPAPs, the alignment file of amino acid 
sequence and the % ID table are attached as an electronic version. A canonical PAP has 
two domains, the N-terminal catalytic domain and the C-terminal domain. A phylogenetic 
trees of cPAPs was published Meeks et al., 2009 (Figure 1.9). The N-terminal catalytic 
domain is highly conserved in eukaryotes but the C-terminal domain is not conserved 
between plants and animals. Yeast PAP does not have a C-terminal domain.  
In vitro biochemical studies on mammalian cPAPs revealed that cPAP on its own does not 
have any preference to RNA substrates in vitro (Bienroth et al., 1993). The cPAP itself is a 
distributive enzyme in vitro, that is it only adds one or very few adenosines at one binding 
event (the Km is quite high). Also on its own, in vitro, the cPAP does not give a specific 
poly(A)-tail length, i.e. the tail length in the final product depends on the amount of the 
enzyme and the time of the reaction (Wahle, 1995). With the help of the other components 
of the 3’ end processing complex including CPSF and PABP, cPAP becomes a processive 
enzyme, and this three-component complex also regulates poly(A) tail length, such that 
inone binding event of the fully assembled complex to a pre-mRNA can lead to the 
formation of the final product of a default 200 to 250 A’s (in mammalian systems) (Wahle, 
1995).  
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Figure 1.9. Phylogenetic tree of plant and mammalian cPAP proteins based on the 
proteins’ enzymatic core. 
Arrows indicate position of Arabidopsis proteins. This figure is from (Meeks et al., 2009) 
  
57 
 
1.3.2 Detailed properties of canonical PAPs in yeast and animals: 
1.3.2.1 X-ray crystal structure: 
Several structures of PAP have been solved, yet for only the N-terminal domain and not for 
the C-terminal domain. The Bohm group published the structure of the yeast PAP with 3’ 
dATP, 3’ deoxy adenosine ribonucleotide (also called cordycepin, which is an analog of 
ATP, and it is also a chain terminator) (Bard et al., 2000). In 2007, a structure of yeast PAP 
was published also by this group with the other three components that are required and 
sufficient for in vitro non-specific polyadenylation: RNA substrates, ATP and Mg2+ (Balbo 
and Bohm, 2007). Additionally, using other structures and steady state fluorescence studies 
(Balbo et al., 2007) revealed the protein domain movements during catalytic cycles. The 
structure of bovine PAP was published in 2000 by a different group (Martin et al., 2000) 
showing similar structure to yeast PAP. (Meinke et al., 2008) revealed the structure of yeast 
PAP in the complex with a peptide of Fip1.  
These structures shed light on the molecular mechanism of how PAP acts, providing an 
explanation of specificity towards ATP but not other nucleotides and the reason why PAP is 
distributive Balbo et al., 2007. The N-terminal and C-terminal domains of the yeast PAP 
move independently as rigid bodies along two well defined axes of rotation during the 
catalytic cycle. This C-terminal domain of yeast PAP is not to be mistaken with the C-
terminal domain of bovine canonical PAP, as yeast PAP lacks the similar domain to the 
bovine C-terminal domain; the whole yeast PAP, which is equivalent to the N-terminal 
catalytic domain of bovine PAP, can be subdivided into three parts the N-terminal, middle 
and C-terminal domains).  (Balbo et al., 2007) proposed a model of the catalytic cycle of 
PAP (Figure 1.10). 
In this model, a cycle begins with an open conformation allowing sampling of nucleotide 
substrates; only a correct nucleotide (ATP) can induce the closed enzyme conformation, 
thereby enabling efficient catalysis. After catalysis, i.e. addition of one AMP, the enzyme 
opens again to release the product which then must bind again for the next round of 
adenylyl transfer. The fact that the product (the poly(A) tail)  is released after every cycle 
explains why the enzyme on its own is distributive.  
1.3.2.2 Biochemical properties as revealed by site-directed mutagenesis: 
By site-directed mutagenesis, many single amino acid (aa) substitutions have been made to 
the PAP protein to study the contribution of these aa to the kinetic of the enzyme (Km, 
substrate specificity, Vmax). (Martin et al., 1999, Balbo and Bohm, 2007, Martin et al., 2004, 
Zhelkovsky et al., 2004). These studies identified the three critical catalytic Asp residues 
(D113A, D115A, D157A in bovine PAP), mutations in any of which inactivate the enzyme. 
Also, residues affecting the substrate binding of: pre-mRNA, ATP Mg, were identified.   
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Figure 1.10. A Model for the catalytic cycle of a poly(A) polymerase. 
The free enzyme exists in an open form. Upon binding both substrates (in random order), 
the enzyme undergoes a conformational change to the closed form, where catalysis occurs. 
After catalysis, the enzyme returns to the open form to release the products. The two metal 
ions (Mg2+ or Mn2+) in the active site are shown as gray spheres. 
The figure and figure legend are taken from (Mandel and Tong, 2007). 
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Finally there are residues that when changed can drive the specificity of the enzyme 
towards GTP/CTP rather than ATP.  
1.3.2.3 Known physical and genetic interactions 
A mutant that can partially suppress yeast pap1-1 defect is the RNA polymerase III pds1 
mutant (Briggs and Butler, 1996). Other mutants in the RNA processing machinery also 
showed genetic interaction with pap1-1, e.g. the exosome mutants rrp6 (van Hoof et al., 
2000). Synthetic lethal mutants with pap1-1 at permissive temperature are lcp5 mutants, 
affecting a protein that is involved in maturation of 18S rRNA (Wiederkehr et al., 1998). 
1.3.2.4 Post-translational modification at the C-terminal domain (CTD): 
The mammalian cPAP protein can be inactivated by phosphorylation in the C-terminal 
domain during the M-phase of the cell cycle (Colgan et al., 1998). Mammalian Poly(A) 
polymerase alpha (PAPOLA) is also subject to other protein modifications at its C-terminal 
domain such as sumoylation (Vethantham et al., 2008) (Figure 1.11). PAPOLA protein was 
also shown to be acetylated at the nuclear localization signal (Shimazu et al., 2007). This 
modification promotes the cytoplasmic localization of PAPOLA and reduces the interaction 
between PAPOLA and CF.Im. 
1.3.3 The genes encoding cPAPs and their mutant phenotypes in 
yeast and mammalians cPAPs:  
1.3.3.1 Human cPAPs: 
In human, three canonical PAPs that are encoded by three different genes have been 
discovered. They are named: PAPOLA (also called PAP alpha or hsPAPII), PAPOLB (also 
called PAP beta or testis PAP) and PAPOLG (also called PAP gama or neo-PAP).  
PAPOLA (Swissprot P51003) and PAPOLG (Swissprot Q9BWT3) 
Identification of PAPOLA and PAPOLG were identified in the early experiment by using 
antibodies and Western blot. In HeLa cell nuclear extracts, a monoclonal antibody NN2 
(raised against a purified recombinant PAP protein from E.coli expressing a human cDNA of 
PAP (Thuresson et al., 1994)) detected three proteins of 90kDa, 100 kDa and 106kDa. 
There is a different antibody, anti-PAPIIex22 (Kyriakopoulou et al., 2001) that only 
recognizes only two larger forms.  
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Figure 1.11. Modification of mamalian PAP C-terminal domain.  
Figure is taken from (Vethantham et al., 2008) 
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PAPOLA The 100kDa and 106kDa forms are proteins encoded by human PAPOLA (or also 
called humanPAPII) (Thuresson et al., 1994, Kyriakopoulou et al., 2001). The protein 
PAPOLA (Swissprot P51003)has 745 amino acids. The 106kDa is most likely to be the 
phosphorylated form of PAPOLA (Thuresson et al., 1994). Both the 100kDa and 106kDa 
proteins are present in both nuclear and cytoplasmic fractions of HeLa cells. The gene 
encoding PAPOLA in mouse has been demonstrated to produce five different alternative 
spliced/alternative polyadenylated transcripts falling into two classes, the long forms and the 
short forms, which lack the C-terminal half of the gene (Zhao and Manley, 1996). Only the 
long transcripts seem to be translated as deducted from the western blot experiment using 
yet another antibody that is raised against purified bovine PAP I. The relative abundance of 
these spliced forms is tissue specific (Hela cells, mouse brain tissues, intestine tissues and 
liver tissues were examined). One of the long forms, PAPII, is expressed most strongly 
amongst PAPOLA transcript isoforms and is found in all tissues tested. In in vitro assay 
using purified recombinant proteins, the short forms were found to be inactive. It seems that 
the spliced form II (PAPII) of PAPOLA is the main PAP in human.  
PAPOLG The 90kDa protein is the product of a different gene, called PAPOLG or also neo-
PAP (Kyriakopoulou et al., 2001, Topalian et al., 2001).PAPOLG shared 76% identity in 
amino acid sequence with PAPOLA. PAPOLG seemed to be exclusively localized in the 
nucleus as demonstrated by transfection experiment (Topalian et al., 2001) and by western 
blot comparing the nuclear vs. cytoplasmic fractionations of HeLa cells (Thuresson et al., 
1994).The protein is 736 amino acid long, has a calculated molecular weight of 82.8kDa. 
PAPOLG is an authentic canonical PAP (Topalian et al., 2001). PAPOLG has non-specific 
polyadenylation activitiy in vitro (when assayed on pre-cleaved synthetic RNA substrates 
and without CPSF addition), and this activity is comparable to bovine PAPI. PAPOLG also 
has specific polyadenylation and cleavage activity in vitro (assayed with pre-cleaved 
synthetic RNA substrates with added purified CPSF). In contrast to PAPOLA, PAPOLG 
seems not to be phosphorylated, as it is not sensitive to phosphatase treatment. The 
expression of PAPOLG varies in different tissues.  
PAPOLB or testis PAP, is specifically expressed in mouse testis (Kashiwabara et al., 
2002)..PAPOLB is shared 86% identity in amino acid sequence with PAPOLA. It is the 
shortest of the three cPAPs with a molecular weight of 70kDa. PAPOLB only contains 636 
aa, it lacks the 100 aa at the C-terminal domain. The other unique properties of PAPOLB 
compared to the PAPOLA and PAPOLG is that it is cytoplasmic. Mice deficient in PAPOLB 
are male sterile, but otherwise have normal growth and behaviour. Female mice deficient for 
PAPOLB are fertile. Specific substrates of PAPOLB are RNAs from that are the haploid-
specific genes that are important for the morphogenesis of the sperm cells. Poly(A)-tail tests 
showed that disruption of PAPOLB shortens the poly(A) tails of these mRNAs. Interestingly, 
poly(A)-tail shortening did not destabilize these mRNAs or repress translation of many of 
these genes as judged from Western blot results. The only one transcript that the authors 
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found to have shortened poly(A) tails and reduced protein levels in the nuclear, but not the 
cytoplasmic fraction in tpap mutant compared to WT is the TAF10 transcript. The author 
argued that as TAF10 is a component of the TFIID complex, which is dispensable for 
general RNA polymerase II–mediated transcription yet essential for selective expression of 
specific genes, disruption of TAF10 protein level in the nucleus is likely to contribute in part 
to the mutant phenotype.  
1.3.3.2 Yeast cPAP and fly cPAP: 
Yeast has only one canonical PAP, PAP1.Yeast PAP1 is nuclear. Yeast PAP1 protein is 
lacks C-terminal domain. pap1-1 yeast mutant is temperature sensitive, and growth is 
inhibited at high temperatures(Patel and Butler, 1992). 
Drosophila has only one canonical PAP, it is 659 amino acids long, has both N and C 
terminal domains, and is 56% identical in amino acid sequence to bovine PAP. The null 
mutant is lethal. A weak mutant allele, hiiragi, causes a very specific phenotype of defects in 
morphology of the wing margins (Murata et al., 2001). The molecular mechanism of this 
defect is unknown. Interestingly, HIIRAGI protein resides in both the nucleus and the 
cytoplasm and is essential for the polyadenylation of certain mRNAs in both compartments 
(Juge et al., 2002). Overexpression of hiiragi protein in female germ line causes 
hyperadenylation of mRNAs that are (bicoid mRNAs) and are not (sop mRNAs) normally 
regulated by cytoplasmic polyadenylation, and causes embryonic lethality. Yet, 
overexpressing HIIRAGI in somatic tissues did not cause any changes to the poly(A) tail 
length of the ubiquitously expressed sop mRNAs. The authors suggested that 
overexpressing HIIRAGI protein in germlines causes increased levels of cytoplasmic protein 
hence can cause non-specific hyperadenylation via increasing the interaction between PAP 
and mRNAs in the cytoplasm.  
1.3.4 Plant canonical poly(A) polymerases: 
1.3.4.1 Phylogenetics of cPAPs across kingdoms: 
(Meeks et al., 2009) shows the phylogenetics of PAPs across kingdoms (Figure 1.9) (a 
more complete comparision with more species is attached as an electronic version). Plant 
species other than Arabidopsis possess several canonical PAPs, functional studies of which 
have not yet been reported. 
1.3.4.2 Arabidopsis thaliana cPAPs: 
The studies on canonical and non canonical PAPs in Arabidopsis are (Addepalli et al., 2004, 
Lange et al., 2009, Meeks et al., 2009) and reference therein.  
Identity. Arabidopsis has four genes that encode highly similar proteins to human/yeast 
canonical PAPs (The % of identity and the alignment of the protein sequences are included 
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as electronic version). They are on four different chromosomes hence are named PAPS1 
(At1g17980), PAPS2 (At2g25850), PAPS3 (At3g06560) and PAPS4 (At4g32850).  
Domain structure. The exon and intron patterns of the four genes are similar (Figure 
1.12A) (Addepalli et al., 2004). Amongst the four, PAPS3 is the most divergent because it 
encodes a smaller protein of 506 amino acid (aa). PAPS3 protein lacks the C-terminal 
domain and lacks the nuclear localization signal. This property of PAPS3 resembles human 
PAPOLB(Kashiwabara et al., 2002). The other three proteins PAPS1, PAPS2 and PAPS4 
are larger in size (713, 800 and 738 amino acids, respectively) and contain both the highly 
conserved N-terminal domain and the variable C-terminal domain. The C-terminal domains 
of PAPS1, PAPS2 and PAPS4 do not align to each other and neither do they align to any 
known proteins either within or outside of the plant kingdom. The C-terminal domain of 
human PAP has been proposed to be the regulatory domain of PAP, and is subjected to 
extensive post translational modification (Colgan et al., 1998, Vethantham et al., 2008), yet 
whether this is also true for Arabidopsis cPAPS is not known.  
Mutants. Meeks et al., 2009 reported the failure to obtain homozygous single mutants for all 
four cPAPS from the heterozygous plants carrying T-DNAs inserted in each locus. The 
authors suggested that a disruption to any single cPAPS causes lethality and hence every 
cPAPS is essential.  
In vitro activity. All four recombinant cPAPS proteins have been shown to possess non-
specific polyadenylation in vitro (Hunt et al., 2000, Addepalli et al., 2004). The activity of 
three proteins in vitro are not equal with PAPS1 = PAPS3 > PAPS4 (Addepalli et al., 2004). 
However, the differences in activity among them are not large, less than two fold. The 
activity of PAPS2 has been demonstrated in a different study (Hunt et al., 2000) and 
therefore is not suitable for comparisons with those of PAPS1, PAPS3 and PAPS4.  
Protein localization. By bombardment of onion cells with construct over-expressing a 
translational fusion of AtPAPS and GFP (C-terminal fusion: 35S::PAPS-CGFP), (Meeks et 
al., 2009) showed that PAPS1, PAPS2 and PAPS4 are exclusively localized in the nuclei 
while PAPS3 is exclusively localized in the cytoplasm (Figure 1.12B). 
Expression domain. Using promoter: GUS constructs (Meeks et al., 2009) and Northern 
blots (Addepalli et al., 2004), three cPAPSs were shown to be widely expressed in largely 
overlapping domains (Figure 1.13). PAPS3 is highly expressed in pollen. Again this 
resembles PAPOLB in mammals (Kashiwabara et al., 2002).  
Alternative splicing pattern. It has been known in animals that PAPOLA produce at least 
six different spliced forms (Zhao and Manley, 1996). (Addepalli et al., 2004) reported that 
Arabidopsis cPAPSs also share this property with human PAPOLA. For PAPS1, there are 
two spliced forms published (Addepalli et al., 2004). Spliced form ‘b’ is caused by an 
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Figure 1.12. Gene structure and intracellular localization of PAPSs in Arabidopsis.  
Figures were modified from the reference  indicated underneath the figures.  
A. The organization of the four cPAP genomic loci.  
B. The cellular localization of cPAPs. Onion cells were bombarded with  constructs  
encoding GFP fused to the C-terminal domains of cPAPs. 
  
Addepalli et al., 2004
A
B
Meeks et al., 2009
65 
 
 
Figure 1.13. Expresssion patterns of PAPSs  
A. Expression domains visualized by pPAPS::GUS  constructs. From (Meeks et al., 2009) 
B.  Absolute expression levels of PAPS1, PAPS2, PAPS3 and PAPS4 in different 
Arabidopsis tissues. Data are from AtGenExpress . 
(http://jsp.weigelworld.org/expviz/expviz.jsp). Arrow indicates stamen and pollen samples 
(Sample 56). The 63 sample types are as follow: 
Sample  
Tissue 
cluster Tissue Age 
AtGenexpress 
sample ID 
1 root roots 7 days ATGE_3 
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2 root roots 17 days ATGE_9 
3 root root 15 days ATGE_93 
4 root root 8 days ATGE_94 
5 root root 8 days ATGE_95 
6 root root 21 days ATGE_98 
7 root root 21 days ATGE_99 
8 stem hypocotyl 7 days ATGE_2 
9 stem 1st node 21+ days ATGE_28 
10 stem stem, 2nd internode 21+ days ATGE_27 
11 leaf cotyledons 7 days ATGE_1 
12 leaf leaves 1 + 2 7 days ATGE_5 
13 leaf rosette leaf #4, 1 cm long 10 days ATGE_10 
14 leaf rosette leaf # 2 17 days ATGE_12 
15 leaf rosette leaf # 4 17 days ATGE_13 
16 leaf rosette leaf # 6 17 days ATGE_14 
17 leaf rosette leaf # 8 17 days ATGE_15 
18 leaf rosette leaf # 10 17 days ATGE_16 
19 leaf rosette leaf # 12 17 days ATGE_17 
20 leaf leaf 7, petiole 17 days ATGE_19 
21 leaf leaf 7, proximal half 17 days ATGE_20 
22 leaf leaf 7, distal half 17 days ATGE_21 
23 leaf leaf 15 days ATGE_91 
24 leaf senescing leaves 35 days ATGE_25 
25 leaf cauline leaves 21+ days ATGE_26 
26 whole plant seedling, green parts 7 days ATGE_7 
27 whole plant seedling, green parts 8 days ATGE_96 
28 whole plant seedling, green parts 8 days ATGE_97 
29 whole plant seedling, green parts 21 days ATGE_100 
30 whole plant seedling, green parts 21 days ATGE_101 
31 whole plant 
developmental drift, entire rosette after 
transition to flowering, but before 
bolting 21 days ATGE_22 
32 whole plant as above 22 days ATGE_23 
33 whole plant as above 23 days ATGE_24 
34 whole plant vegetative rosette 7 days ATGE_87 
35 whole plant vegetative rosette 14 days ATGE_89 
36 whole plant vegetative rosette 21 days ATGE_90 
37 apex shoot apex, vegetative + young leaves 7 days ATGE_4 
38 apex shoot apex, vegetative 7 days ATGE_6 
39 apex shoot apex, transition (before bolting) 14 days ATGE_8 
40 apex 
shoot apex, inflorescence (after 
bolting) 21 days ATGE_29 
41 flowers flowers stage 9 21+ days ATGE_31 
42 flowers flowers stage 10/11 21+ days ATGE_32 
43 flowers flowers stage 12 21+ days ATGE_33 
44 flowers flowers stage 15 21+ days ATGE_39 
45 flowers flower 28 days ATGE_92 
46 floral organs flowers stage 15, pedicels 21+ days ATGE_40 
47 floral organs flowers stage 12, sepals 21+ days ATGE_34 
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48 floral organs flowers stage 15, sepals 21+ days ATGE_41 
49 floral organs flowers stage 12, petals 21+ days ATGE_35 
50 floral organs flowers stage 15, petals 21+ days ATGE_42 
51 floral organs flowers stage 12, stamens 21+ days ATGE_36 
52 floral organs flowers stage 15, stamen 21+ days ATGE_43 
53 floral organs mature pollen 6 wk ATGE_73 
54 floral organs flowers stage 12, carpels 21+ days ATGE_37 
55 floral organs flowers stage 15, carpels 21+ days ATGE_45 
56 seeds 
siliques, w/ seeds stage 3; mid globular 
to early heart embryos 8 wk ATGE_76 
57 seeds 
siliques, w/ seeds stage 4; early to late 
heart embryos 8 wk ATGE_77 
58 seeds 
siliques, w/ seeds stage 5; late heart to 
mid torpedo embryos 8 wk ATGE_78 
59 seeds 
seeds, stage 6, w/o siliques; mid to late 
torpedo embryos 8 wk ATGE_79 
60 seeds 
seeds, stage 7, w/o siliques; late 
torpedo to early walking-stick embryos 8 wk ATGE_81 
61 seeds 
seeds, stage 8, w/o siliques; walking-
stick to early curled cotyledons 
embryos 8 wk ATGE_82 
62 seeds 
seeds, stage 9, w/o siliques; curled 
cotyledons to early green cotyledons 
embryos 8 wk ATGE_83 
63 seeds 
seeds, stage 10, w/o siliques; green 
cotyledons embryos 8 wk ATGE_84 
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inclusion of intron 6 which is predicted to result in truncated non-functional protein (Figure 
1.14). In flowers, this spliced form ‘b’ is predominantly detected. The longer spliced form ‘a’ 
should produce a functional protein. This spliced form is predominantly detected in leaves. 
Based on the prediction that ‘b’ produces a non-functional protein, flowers may not require 
as much catalytically functional PAPS1 (protein produced from spliced form ‘a’) compared to 
PAPS2/PAPS4 proteins. PAPS2, PAPS4 and PAPS3 genes also produce alternative 
spliced forms (Figure 1.14). 
1.4 Regulation of canonical polyadenylation: 
In this section, I summarize what is known about the regulation of polyadenylation with two 
main aspects: the poly(A)-tail length and the poly(A) site. 
1.4.1 Poly(A)-tail length regulation 
It is apparent that at the steady state level, cellular mRNAs have very different tail lengths 
that range from a few adenosines (A’s) to ca. 90 A’s in yeast (Brown and Sachs, 1998), ca. 
250 A’s in mammals (Sawicki et al., 1977, Wahle, 1995), ca. 150-200 A’s in fly (Benoit et al., 
2005) and ca. 150 A’s in plants (this study). Measurement of the steady-state tail lengths on 
a genome-wide scale (Meijer et al., 2007, Beilharz and Preiss, 2007) showed that mRNAs 
can have very different averaged poly(A)-tail length. Theoretically, tail lengths can be 
controlled by three processes: i) the synthesis in the nuclei (de novo polyadenylation); ii) the 
shortening of poly(A) tail (deadenylation) in the cytoplasm or nuclei and iii) the extension of 
poly(A) tail, that is distinct from i) as this is not a de novo synthesis of the entire poly(A) tail, 
it is only addition of adenosines to a pre-existing poly(A) tail.  
In practice, it is widely believed that the deadenylation generates most of the heterogeneity 
of the steady-state tail lengths. Deadenylation is mostly a cytoplasmic event.  It is also 
widely believed that during de novo polyadenylation, most of mRNAs are synthesized with 
the same default tail length, which depends on species. Cytoplasmic extension of the 
poly(A) tail only applies to certain mRNAs, whose tails are deadenylated in the unfertilized 
oocytes but then re-adenylated in the cytoplasm after fertilization (Huarte et al., 1992). 
Below, I summarize the key experimental evidence that this generally accepted view is 
based on. As will be seen, much of the important evidence is based mainly on in vitro 
systems using a few mRNA substrates, and even in vivo, only a few cell types were tested. 
These experimental set up must be taken into account when extrapolating this generally 
accepted view to all cellular mRNAs and to mRNAs from different tissues.  
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Figure 1.14. The alternative spliced patterns of PAPSs. 
Figures were modified from the reference indicated.  
A. The alternative spliced patterns, two forms of transcripts a and b were shown. 
B. The expression level differences between the two forms of transcripts a and b analyzed 
by RT-PCR. L: leaves, L—leaf, S—stem, R—root, F—flower.  
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1.4.1.1 de novo poly(A)-tail length control: 
Mammals de novo poly(A)-tail length control 
PABP1N ensures that polyadenylation reaches but does not exceed 250 A’s (with few 
exceptions):  
In mammals, it has been widely accepted that most mRNAs, after de novo synthesis, are 
homogeneous in poly(A)-tail length, which is approximately 250 adenosines. This 
conclusion is based on in vitro and in vivo evidence.  
In vivo, (Sawicki et al., 1977) performed pulse chase experiments in HeLa cells using 
radioactively labeled adenosine. They analyzed the tail length of newly synthesized mRNAs 
in the nuclei and in the cytoplasm separately, examining the A tail length after various 
labeling times (from 1 minute to several hours and up to 3 days). The results indicated that 
in the nuclei, within one minute of labeling, most of the newly synthesized poly(A) tails have 
a homogenous length of 200 to 280 nucleotides. This pattern did not change over time even 
after 3 days of labeling, especially no incomplete “nascent” poly(A) could be detected. In 
contrast, in the cytoplasm the pattern changes over time such that the poly(A)-tail length 
rapidly becomes homogeneous at 200 to 280 nucleotides in length during the initial 40 
minutes but these became heterogeneous in size after labeling periods of longer than two 
hours. The data strongly suggested that both newly synthesized and steady state mRNAs 
from the nucleus reach a tail of approximately 230 A’s. The results however do not exclude 
the possibility that some pre-mRNAs with a shorter or longer than 230 A’ could have 
escaped the detection due to their low abundance. In fact, poly(A) tails of such pre-mRNAs 
with less than 20 nucleotides have been discovered ((Rao et al., 1996) and see below). 
Also, the results do not exclude that in a different cell type, the nascent poly(A) tail can be 
different.  
In vitro, using proteins from mammals, (Wahle, 1995) could faithfully reconstituted the same 
de novo A tail regulation using purified Cleavage Polyadenylation Specificity Factor (CPSF), 
and Poly(A) binding proteins (PAB II) and Poly(A) Polymerase (PAP). Precleaved L3-
preRNA substrates, which carried poly(A) tails of different length, was used. In the presence 
of all the three proteins, a homogeneous poly(A) tails of 200-250 A’s were found in the final 
products regardless of how many A’s the substrates had before the reaction. PAP alone 
was not sufficient for this tail-length regulation and PABII and CPSF were necessary for the 
regulation. Bovine/yeast PAP alone, or yeast PAP combined with the non-compatible bovine 
CPSF and PABII, failed to synthesize a fixed tail length of 250 nucleotides in vitro. In latter 
in vitro study by the same research group using a modified substrate (Kuhn et al., 2009), the 
authors showed that only As residues were counted as part of the tail. The authors 
suggested a model for the role of PABII  in controlling the poly(A) tail length. In this model, 
PABII, (or renamed as PABPN1 for poly(A) binding protein nuclear 1) binds poly(A) and 
forms a folded back structure within the 3’ end complex. Once the poly(A) tails goes beyond 
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250 nucleotides, the poly(A)-PABPN1 structure no longer supports the interaction between 
PAP and  CPSF. So it seems that during de novo synthesis of the poly(A) tail, the PABPN1, 
by binding directly to adenosine residues (one PABPN1 per 15 A’s), served as a ruler to 
measure the poly (A) tail length. 
Disruption of the nuclear PABPN1 in mammals and flies causes reduced level of the very 
long poly(A) species (Apponi et al., 2010, Benoit et al., 2005). However, the effect is quite 
subtle in the bulk poly(A)-tail analysis. Probably this is because of the mild disruption to the 
PABPN1 gene. The homolog of mammalian PABPN1 in fly is PABP2. Homozygous null 
pabp2 mutants are lethal (Benoit et al., 2005). It is intriguing that PABP2 acts to promote 
polyadenylation of ubiquitously expressed genes including sop and rp49 mRNA, but 
contrastingly PABP2 acts to restrict the polyadenylation of cycB and osk mRNA, which 
undergo cytoplasmic polyadenylation (Benoit et al., 2005). 
Exceptions to the “250 A’s” rule have been reported. (Rao et al., 1996) discovered that 
albumin mRNA in liver has a very short poly(A) tail ranging from 12 to 17 residues. The 
author showed that both intron-containing pre-mRNA and mature steady-state mRNA of 
albumin have the same short poly (A) tail. Later, a cis element, namely Poly(A) limiting 
element (PLE), was identified as being responsible for this regulation(Das Gupta et al., 
1998). PLEs have been mapped to the terminal exons (Das Gupta et al., 1998, Gupta et al., 
2001). Splicing factor U2FA binds to this element (Gu and Schoenberg, 2003). Surprisingly, 
the presence of this PLE in the 3’ end of reporter genes stimulates faster 3’ end processing, 
resulting in increased accumulation of mRNA compared to controls without PLE elements 
(Peng et al., 2005). These PLE-containing short-tail reporter mRNAs are efficiently recruited 
to polyribosome, and the final protein levels are comparable to those translated from the 
control PLE-lacking, long-tail mRNAs (Peng and Schoenberg, 2005).  The group also found 
conserved motifs of PLEs in many mRNAs that have short (<20 A) tails suggesting that 
nuclear regulation of poly (A) tail length is a feature of many mRNAs (Gu et al., 1999). 
In sum, the in vitro and in vivo evidence here strongly support the default de novo poly (A) 
tail length of 250 nucleotides for most pre-mRNAs in mammals. However, the discoveries of 
extremely short oligo(A) tail, PLE containing pre-mRNAs suggest that, in different cell types 
or with different pre-mRNA substrates, the de novo poly(A) tail can deviate from this rule. 
Apart from PLE, there is little evidence for regulation of the length of poly(A) tail added 
during pre-mRNA processing.  
Yeast de novo poly(A)-tail length control 
In yeast, in vivo evidence using conditional lethal mutants that disrupt core components of 3’ 
end processing machinery  such as pap (Proweller and Butler, 1994), hrp1(Kessler et al., 
1997), rna15 (Kessler et al., 1997), fip1 (Preker et al., 1995), supported the roles of these 
factor in poly(A) tail length control. However, in my opinion, it is questionable whether the 
reduction in poly(A)-tail length reflects the direct effect of de novo polyadenylation or the 
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indirect effects of inhibiting transcription and other cellular processes. In all of the studies, 
the authors did not uncouple the detrimental effect of disrupting these components to 
general transcription and cell growth. Apart from fip1 and pap in which the effect on bulk 
poly(A) was found shortly after switching to the non-permissive temperature (after 5 minutes 
and 30 minutes, respectively), for other mutants, the poly(A) tail was already found to be 
different before the temperature switch and was examined again 3 or 6 hour after the 
switch. During this long period of time, transcription could have been inhibited hence the 
general reduction in poly(A) tail could reflect the reduction in newly synthesized nascent 
poly(A) tails  and compared to the steady-state of deadenylated poly(A) tails.  
Yeast lacks a homolog of human nuclear PABPN1, so the PABPN1-dependent poly(A)-tail 
regulation is not present in yeast. Instead, two other poly(A) binding proteins were shown to 
regulate poly(A) tail length. Both proteins function to suppress polyadenylation rather than to 
promote polyadenylation like in mammals. They are the cytoplasmic poly A binding protein 
Pab1p (Sachs and Davis, 1989)and the nuclear poly(A) binding protein Nab2p (Hector et al., 
2002). 
pab1 deletion is lethal. Pab1p was found to interact with cleavage factor IA (CFIA) and 
suppress polyadenylation in vitro (Minvielle-Sebastia et al., 1997). Despite the steady-state 
cytoplasmic location, Pab1p can also be present in the nucleus. Later experiments 
confirmed that Pab1p can shuffle between nucleus and cytoplasm and suggest that the N 
terminal domain carries the nuclear targeting signal (Dunn et al., 2005, Brune et al., 2005). 
Based on bulk poly(A)-tail analysis of mutants and studies on physical and genetic 
interactions of Pab1p, the following model was proposed. In the nucleus, Pab1p binds to 
poly(A) tails and recruits PAN (Poly(A) ribonuclease) complexes to trim off the poly(A) tail of 
newly synthesize mRNAs, which are 70-90 A’s by default, to messenger specific poly(A) 
tails ranging from 55-70 nucleotides (Brown and Sachs, 1998). The model is based on in 
vivo poly(A)-tail length measurements, however, only three pre-mRNAs were analyzed 
(RPL46, PGK1 and MFA2). By using a GAL-inducible promoter to analyze only newly 
synthesize mRNAs, the authors also showed that the poly(A) tails were trimmed very rapidly 
(4 to 12 minute after induction) and the trimming could not be uncoupled from the de novo 3’ 
end processing of the pre-mRNAs. Later experiments identified other positive and negative 
regulators of the Pab1p-PAN pathway in controlling poly (A) tail length (Mangus et al., 
2004). I summarized these findings in Figure 1.15. The exosome mutant rrp6 can suppress 
pab1 lethality ( Dunn et al., 2005, Brune et al., 2005).  
PAN is one of the two deadenylation complexes in S.cerevisae (reviewed in (Parker and 
Song, 2004)). Its activity is stimulated by Pab1p. PAN contains 2 subunits, PAN2 and PAN3. 
PAN2 is a member of the RNaseD family and therefore is the catalytic subunit of PAN 
complex (Boeck et al., 1996). PAN3 interacts with and is thought to enhance and regulate 
PAN2 (Brown et al., 1996).  
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Figure 1.15. The model of poly(A)-tail length regulation in yeast. 
Figure is modified from Brown and Sachs,1998 and Mangus et al., 2004. Proteins that 
interact physically with each other are connected with dash line.  
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PAN3 also interacts with Pab1p and with Mex67p(Ito et al., 2001), a shuttling protein 
involved in mRNA export. pan2 and pan3 single mutants and pan2 pan3 double mutant 
show hyperpolyadenylation but in contrast to pab1, these mutants survive and display no 
growth defects (Brown et al., 1996, Boeck et al., 1996).  
Nab2p is another poly(A) binding protein in yeast. Unlike Pab1p, Nab2p is constitutively 
nuclear. Nab2p is an essential nuclear poly(A) binding protein that plays a role in both 
poly(A) tail length control and nuclear export (Hector et al., 2002). Disruption of NAB2 
causes hyperadenylation of poly(A) tail and accumulation of poly(A)+ mRNA in the nucleus. 
The effect on mRNA export could cause synthesis-independent hyperadenylation, because 
the export defect keeps mRNAs in the nucleus hence protects them from the deadenylase 
enzyme in the cytoplasm, potentially increasing the average length ofpoly(A) tails.To rule 
out this possibility, the authors grew a cold sensitive mutant nab2-21 at 30⁰C to uncouple 
export defects and the poly(A)-tail length regulation. The experiments confirmed the direct 
role of Nab2p in the poly(A)-tail length regulation. The authors suggested that Nab2p 
functions to terminate polyadenylation. Also in this study, overexpressing Pab1p or targeting 
Pab1p to the nucleus rescued the lethality of nab2 mutant, suggesting their function is 
interchangeable. Yet intriguingly, at the molecular level, the PAB1 overexpression strain 
actually enhances the hyperadenylation defect in nab2 mutants. However, the export defect 
in the nab2 mutant was partially rescued in the transgenic yeast, suggesting this is the 
explanation for the rescue of the lethal phenotype. In my interpretation, alternative 
explanations, for example, Pab1p can alleviate the hyperadenylation defects on only a few 
mRNAs that is essential for growth, can not be ruled out. 
To sum up, in yeast de novo poly(A) tail of 70-90 nucleotides is subjected to two pathways 
for controlling tail length in the nucleus during synthesis. They are the Pab1p-PAN pathway, 
which trims off the A-tail to 55-70 nucleotides depending on transcripts, and the Nab2p, 
which terminates polyadenylation.  
Finally, more mutants affect poly(A) tail length in yeast, but their molecular basis is not clear 
as reveal in a study on cordycepin sensitive mutants(Holbein et al., 2009). 
Plants de novo poly(A)-tail length control 
It is not known how plants regulate poly(A) tail length during synthesis. It is not known 
whether newly synthesized poly(A) tails have a fixed tail length. As shown in Table 1.2, 
homologs of human and yeast core 3’ end processing factors exist in Arabiodopsis. 
Arabidopsis also has eight cytoplasmic poly(A) binding proteins and three nuclear poly(A) 
binding proteins (Table 1.2) expressed in an organ-specific manner (Belostotsky and 
Meagher, 1993). One of them, PAB3 can rescue the lethality of both pab1, and nab2 mutant 
when expressed in yeast. However, similar to yeast Pab1p overexpression, overexpressing 
PAB3 did not rescue the hyperadenylation in yeast nab2 mutants (Chekanova and 
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Belostotsky, 2003). It is formally possible that plants use similar de novo poly(A)-tail length 
regulation as mammals.  
1.4.1.2 Deadenylation: 
Once the mRNAs are exported from the nucleus to the cytoplasm, the homogenously long 
poly(A) tails are subjected to deadenylation. Deadenylation is the first step in the 3’ to 5’ 
degradation of eukaryotic mRNA (Figure 1.16 reviewed in (Parker and Song, 2004, 
Goldstrohm and Wickens, 2008) and reference here on. A factor that can influence the 
steady-state average poly(A)-tail length is the variation in deadenylation rate during  a 
mRNA life span and how short the poly(A) tails need to get in order to trigger rapid 
degradation. For example, mRNA X, which is rapidly degraded when its poly(A) tail reaches 
10-15 nucleotide in length, will have shorter steady-state poly(A) tail length compared to 
mRNA Y, which is rapidly degraded when its poly(A) tail reaches 40-50 nucleotide in length. 
The transcript-specific poly(A)-tail-length threshold that primes the degradation of the mRNA 
is not well explored in the literature.  
There are three deadenylation complexes: CCR4/POP2/NOT, PAN and PARN. PAN has 
been introduced above and its activity is dependent on PAB1P and it deadenylates pre-
mRNA in the nucleus in yeast. PAN also acts in mammals (Yamashita et al., 2005). In the 
cytoplasm, CCR4 is the predominant deadenylase complex. 
Again, it is not clear how important the role of cytoplasmic/nuclear deadenylation is to 
poly(A)-tail length control in plants. Plants have homologs to proteins of all three 
deadenylation complexes. Functional studies exist for only AtPARN and AtCCR4. 
AtCCR4 is transiently upregulated by three plant hormones (jasmonic acid JA, salicyclic 
acid SA and abscisic acid ABA) and pathogen (Liang et al., 2009). Mutants and 
overexpression of AtCCR4 reduced and enhance PR1/2 (PATHOGEN RELATED 1/2)-
mediated pathogen responses respectively, resulting more or less susceptible to 
Pseudomonas syringae. 
The strong AtPARN mutant allele is embryo lethal (Reverdatto et al., 2004), the weaker 
allele ahg2-1 (acid abscisic (ABA) hypersensitive germination 2) displays a specific 
phenotype: ABA hypersensitive (Nishimura et al., 2009, Nishimura et al., 2005). However, 
poly(A)-tail lengths were not analyzed, and no PARN-sensitive targets were identified.  
1.4.2 Regulation of cleavage and the site of polyadenylation 
(Alternative polyadenylation) 
For some genes, there can be more than one poly(A) sites, which are also the cleavage 
sites of pre-mRNAs. Alternative polyadenylation (APA), and the preference of which poly(A) 
site(s) to use are under regulation and have diverse roles in gene regulation (reviewed  
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Figure 1.16. Deadenylation and mRNA degradation pathways in eukaryotes. 
A. From Goldstrohm and Wickens, 2008 
B. From Parker and Song, 2004. 
  
A. mRNA degradation pathways in eukaryotes 
B. Deadenylase complexes in eukaryotes.
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extensively in (Lutz and Moreira, 2011, Lutz, 2008, Xing et al., 2010, Wang et al., 2008). I 
summarize the kinds of APA and highlight the functions of APA from recent studies. 
Kinds of alternative polyadenylations: 
For coding genes, alternative polyadenylation can be classified into three types depending 
on where the poly(A) sites are (Figure 1.17). If the gene has only one poly (A) site, no 
alternative polyadenylation happens.  
In type I, the different poly(A) sites lie in the 3’UTRs, hence the coding sequences amongst 
the alternatively polyadenylated mRNAs are not changed, but the 3’UTR sequences are 
changed. Many RNA cis-acting elements that are present in 3’ UTRs can regulate mRNA 
polyadenylation (via cytoplasmic polyadenylation elements), mRNA stability and 
translational effiency (via binding sites for miRNAs, translation factor etc…). In type II, the 
different poly(A) sites lie within exons. If the exon is the last exon, the pre-mRNA is not 
differently spliced; but if the exon is the middle exon, alternative polyadenylation can be 
coupled to alternative splicing. In type III, the different poly(A) sites lie within introns. In this 
type, the splicing patterns of pre-mRNAs change.  
In plants, studies on a dataset of 55,000 rice authentic poly(A) sites revealed 50% of the 
genes have more than one poly(A) site, excluding microheterogeneity of 30 nucleotides 
(Shen et al., 2008). A recent study using a method for sequencing only the poly(A) site 
suggested that  alternative polyadenylation is even more wide-spread and occurs  not only 
in sense mRNAs but also in antisense RNA and intergenic cryptic transcripts (Wu et al., 
2011). The authors identified 57,000 poly(A)-site clusters (PAC) (sites that are within 30 
nucleotides away from each other are clustered as one PAC) that mapped to the sense 
strand of annotated transcripts, 24,000 PAC that mapped to the antisense strand of the 
annotated transcripts and 14,000 PAC that mapped to intergenic regions. The 57,000 PACs 
in sense orientation mapped to 18,000 genes, over 70% of which possess more than one 
poly(A) sites.  
Recent discoveries give a hint about the biological role of alternative polyadenylations of 
antisense transcripts. For example, it was suggested that two proteins in the autonomous 
pathway that control flowering time in Arabidopsis, FCA, an RNA binding proteins and FPA, 
a Spen family protein, promote the selection of the proximal poly(A) site in the antisense 
transcript  of the FLOWERING LOCUS C (FLC) gene, which is a key repressor of flowering 
(Liu et al., 2010, Hornyik et al., 2010). FCA does that by targeting three components of 3’ 
end processing, FY, CstF64 and CstF77, to the distal poly(A) site of FLC antisense mRNAs. 
Interestingly, this regulation of the 3’ end processing of antisense transcripts helps down 
regulate the FLC sense transcript, hence promoting flowering (Liu et al., 2010).  
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Figure 1.17. Types of alternative polyadenylation. 
Figure is modified from Lutz and Moreira, 2011.  
Type I. The alternative poly(A) sites lie within the 3’UTR. 
Type II. The alternative poly(A) sites lie within exons. 
 Type III. The alternative poly(A) sites lie within introns. 
  
Type I
Type III
Type II
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1.5 Non-canonical PAPs: 
Eukaryotes possess several other PAP-like proteins but with very low identity to the human 
PAPOLA, or yeast PAP1. These proteins are non-canonical PAPs (extensive reviewed in 
Schmidt and Norbury, 2010). Their roles are diverse. The most well studied is the TRAMP 
complex that adds short poly(A)tails (adenylation activity is suppressed after 3-4 adenosine 
(Jia et al., 2011)) to mRNAs, which mark them for degradation. ncPAPs often only target 
specific mRNAs like mis-folded and other short-lived nuclear RNAs, centromeric siRNAs 
and their precursors, rRNAs, miRNAs, U6 snRNAs, histone mRNAs, , miRNAs, HO-1 
mRNAs (reviewed in Schmidt and Norbury, 2010). Some ncPAPs (star-PAP) can even add 
oligo(U) tail to mRNAs.  
Non canonical PAPS (ncPAP): Arabidopsis possesses nine non-canonical PAPs (Figure 
1.18 (Lange et al., 2009)). These non-canonical PAPs are indentified insilico by the 
sequence similarity to the charaterized ncPAPs in yeast. The function of these geneshave 
not yet been reported, apart from one, which is At4g00060 (or MEE44) whose disruption 
causes embryonic lethality (Pagnussat et al., 2005). In addition, Arabidopsis also 
prossesses five bacterial-type PAPs that are targeted to organelles like mitochondria and 
chloroplasts (Zimmer et al., 2009). 
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Figure 1.18. Canonical and non-canonical PAPs in Arabidopsis.  
This figure is taken from (Lange et al., 2009) 
Domain architecture of PAPs in Arabidopsis thaliana. Boxes represent conserved structural 
domains identified using the structural classification of proteins (SCOP) according to the 
superfamily database. Non-conserved regions are drawn as lines. AGI (Arabidopsis 
Genome Initiative) gene numbers are also given. The number of predicted gene models is 
indicated in parentheses. Protein length is indicated by the number of amino acids on the 
right.(a) cPAPs contain a characteristic combination of three well-conserved domains and 
are involved in mRNA 3′ end formation in the nucleus.(b) Nine ncPAPs are encoded in the 
Arabidopsis genome. Compared with cPAPs, the domains of the ncPAPs are more 
heterogeneous and do not belong to a corporate domain family. Members of the ncPAP 
family, such as the protein encoded by At2g45620, probably function as PUPs rather than 
PAPs.(c) Bacterial-type PAPs and tRNA-nucleotidyltransferases are characterized by the 
poly(A) polymerase C terminal region-like fold (yellow boxes), which is distinct from the 
PAP/OAS domain (poly(A) polymerase and/or oligo adenylate synthase substrate binding 
domain, red boxes) found in eukaryotic cPAPs and ncPAPs. Bacterial-type PAPs and tRNA-
nucleotidyltransferases have the same basic structure but can be distinguished by a 10-
amino acid motif (white boxes) that is present in the nucleotidyltransferase domain of 
bacterial PAPs, but absent in bacterial tRNA-nucleotidyltransferases. In fact, only one tRNA-
nucleotidyltransferase is annotated in A. thaliana and, whereas the other four members of 
the family are putative PAPs.       
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1.6 Project Aims and Objectives: 
1.6.1 Preliminary results: 
From an Ethyl Methane Sulfonate (EMS)–mutagenized population, D.S noticed a mutant 
which has reduced leaf size but enlarged flower size. Because of the Lenhard group’s 
interest in size control, the mutant was given to us, initially called ds39. The opposite size 
effects of this mutation on leaves and flowers are particularly exciting. As explained in 
section 1.1.6 most size regulators affect the size of leaves and flowers in similar ways. 
There are a few mutants (proteasomal mutants, cincinnata mutants and s6 kinase mutants) 
that regulates size of leaves and flowers in opposite directions. The basis of these reverse 
effects is not yet known. ds39 therefore provides opportunities to tackle this elusive and 
important problem: how organ identity modifies the general growth patterns. 
In this project, I identified the causal gene by map-based cloning and found that the gene is 
At1g17980, which encodes for one of the four canonical Poly(A) Polymerases in 
Arabidopsis. 
1.6.2 Aims and objectives: 
The project has three aims and several objectives are drawn for each aim: 
For the first aim, to understand molecularly how ds39 affects organ size in general, the 
objectives are:  
 To identify the causal gene underlying the ds39 phenotype.  
 To characterize the growth phenotype in detail, including measuring growth 
parameters: organ size, cell number, cell size of both leaves and petals in a final 
stage of the organ and also during organ development 
 To determine when the gene is required for growth control. 
 To determine whether the gene acts autonomously or non-autonomously.  
 To study the genetic interactions between the gene and other genetic pathways that 
control organ size. 
 To identify targets of PAPS1 that cause the growth phenotype in leaves and flowers 
(also for the second aim and third aim).  
 
For the second aim, to clarify why the sizes of leaves and flowers are regulated in the 
reverse directions in this mutant, the objectives are: 
 To clarify whether the reverse growth defect is dependent on organ identity or organ 
position. 
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 To identify direct mRNA targets of PAPS1 that cause the growth phenotype in 
leaves and also the mRNAs that causes the phenotype in flowers (this is also an 
objectives in the third aim).  
For the third aim, to understand why a mutation in such a house keeping gene like canonical 
Poly(A) Polymerases can have such a specific phenotype, the objectives are:   
 To analyze different mutant alleles of PAPS1. 
 To analyze mutants in other canonical PAPs and also mutant combinations with 
PAPS1. 
 To identify the specificity in the protein factors (i.e. domains of PAPS) that is 
responsible for the functional specification amongst PAPS. 
 To identify the cis-elements (i.e. RNA motifs) that make mRNAs sensitive to PAPS1 
defects.  
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2 .Chapter 2. ds39 is a peculiar 
mutant with smaller leaves and 
larger flowers than wild-type. 
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In this chapter, I show the detailed phenotypic characterization of ds39 looking at final organ 
size, final cell size, growth rate, growth period, cell division vs. time were compared between 
ds39 and wild-type (WT) Ler.  
2.1 ds39 mutant plants have larger floral organs, but smaller 
leaves: 
ds39 mutants make larger flowers and smaller leaves than WT (Figure 2.1 and Figure 2.2). 
Not only petals are larger (89% increase) but also the other floral organs: sepals (62% 
increase) anthers (27% increase) and gynoecium (20% increase) are larger, though to a 
lesser extent. In contrast, leaves of ds39 are only a third of the size of WT leaves. The 
height of ds39 mutant plants is also reduced (Figure 2.1A).  
To compare, the increase of 89% in petal size is a large effect compared to the effect of the 
other known negative regulators of size: the petal increase in bpe-1 is 24%, (Szecsi et al., 
2006); in the da1-1 mutant it is 60% (Li et al., 2008) , and in the bb-1 mutant it is 60% (Disch 
et al., 2006).  
2.2 Final cell size is increased in petals, but decreased in leaves 
of ds39 mutants: 
I next compared the cell size of petals and leaves of the mutant with wild-type plants. 
Epidermal cells on the adaxial face of mature petals at a position a third of the petal towards 
the tip were measured using the low melt agarose method (see section 9.2.4.8 for 
description). Using this experimental setting, the cells size in mutant petals are 21% larger 
than wild-type petals Figure 2.2A Compared to the overall increase of 86% in area of 
mutant petals, it is likely that the mutant petals are larger because of both more cells and 
larger cells. Although no difference in the spatial pattern of the change in cell-size between 
mutant and WT petals was observed, in the future, more measurements at various positions 
in the petals should be examined to statistically confirm this. 
Mesophyll cells in the mature forth and fifth leaves were measured by using the chloral 
hydrate method (see section 9.2.4.8 for description). Cells were sampled at three positions: 
one third of the leaf towards the tip, the middle of the leaf and one third of the leaf towards 
the base; all of the positions are the middle point between the midvein and the outer border 
of the leaf. These measurements at the three positions were averaged for each genotype 
and the data is presented in Figure 2.2A. Using this experimental setting, in leaves of ds39 
mutants, the cell size reduces more than 2 fold compared to WT leaves. Representative 
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images of the cells at position a third of the leaf towards the tip, away from the midvein are 
shown in Figure 2.2C.  
In sum, petals of the mutant are larger because of more cells and larger cells, while the 
leaves of the mutant are smaller mainly because of smaller cells, with little change in cell 
number. This suggests that DS39 wild-type gene function restricts both cell division and cell 
expansion in petals, and promotes cell expansion in leaves.  
Compared to other negative size regulator mutants, the effects of the ds39 mutation in 
promoting both cell size and cell number in petals is unique. da1-1 and bb-1 mutations only 
increase cell number; cell size remains unchanged (Disch et al., 2006, Li et al., 2008). The 
bpe-1 mutation increases cell size and reduces cell division in petals (Szecsi et al., 2006). 
This suggests that the DS39 size regulator is probably a novel regulator.  
2.3 ds39 petals grow at the same rate but for longer period: 
The enhanced petal growth in the mutant can be caused by either an increased growth rate 
or an extended growth period or both. To answer this question, a developmental series on 
growing petals was analyzed. Petals were dissected from the flowers/buds in the 
inflorescences and areas were measured then plotted against their growth periods. The 
growth period of the youngest bud, which contained the smallest dissectible petals 
(approximately 50.000 µm2 in area) was set to be 0. The growth period of the next bud was 
calculated by adding the plastochron to the growth period of the previous bud. The 
plastochron (the time difference between two sequential buds) was estimated by counting 
how many flowers that were made in six days. The plastochron of the wild-type flower is 
9.86 hours (SEM= 0.37 hours, n=18 plants); of the ds39 mutant flower is 19.80 hours 
(SEM=0.75 hours, n=19 plants). The resulting growth curve is shown in Figure 2.3A. In the 
petals of the mutant, growth rate is the same as WT but the growth period is extended 
resulting in an overall increase in final petal size. This growth curve is better analyzed when 
the petal area is transformed to log2 value Figure 2.3B. Using log2 petal area vs time data, 
a straight line can be fitted with a high correlation (r2>=0.9 for all six lines from six 
inflorescences analyzed) suggesing that the petal growth is exponential for both mutant and 
wild-type. The average slope caculated from three WT inflorescences is 0.034 (SEM=0.002, 
n=3)) and from three ds39 inflorescences is 0.031 (SEM=0.001, n=3). ttest showed the 
difference between these two average slopes from mutant and WT is not significant. It is 
therefore concluded that the mutant and WT petals grow at the same rate but the mutant 
petals grow for a longer period of time resulting in a final increase in size compared to WT 
petals. This characteristic, i.e. having the same growth rate, but an extended growth period 
in ds39 is shared with da1-1 and bb petals.  
86 
 
 
Figure 2.1. ds39 mutant plants have smaller leaves but bigger flowers than wild-type. 
Plants were grown at 21⁰C.  
A.  Plants at 40 days after germination.  
B.  Mature flowers.  
C.  Inflorescences.  
D.  Plants at 30 days after germination.  
1cm
1mm1cm
1cm
Wild-type (Ler)
ds39
ds39Ler
Ler
Ler ds39
ds39
87 
 
 
Figure 2.2. Final organ size and organ cell size of ds39 mutants and WT.  
Plants were grown at 21⁰C.  
A.  Organs from mature flowers (petals, sepals, anthers, gynoecium) and mature leaves (the 
4th and 5th leaves) of plants when they have produced 5 to 10 flowers (approximately 5 
week old) were used for measurements. Numbers above the red bar showed the ratio (in %) 
of mutant/wt for that measurement. Value is mean ± s.e.m; for measurement on petals, 
sepals and anthers n ≥ 20; for gynoecium  n = 7; for leaves n≥5; for seeds n ≥ 55; for petal 
cell size, at least 20 petals were examined (n ≥ 20); for leaf cell size, at least four leaves 
were measured (n≥4). All measurements are significantly different between WT and mutant 
(unpaired t-test  p-value <0.01), except the seed size (not significantly different).   
B.  Cells from petals. They are images of conical epidermal cells on the adaxial face of 
mature petals at a position a third of the petal towards the tip.Scale bar 100 µm. 
C.  Mesophyll cells in leaves. Mature fourth and fifth leaves were cleared by chloral hydrate 
for 2 days, and then images were taken at a position a third of the leaf towards the tip, away 
from the midvein. Scale bar 50 µm 
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Figure 2.3. The DS39 gene regulates the duration and not the rate of petal growth.  
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Figure 2.3. The DS39 gene regulates the duration and not the rate of petal growth. 
(continued): 
Developmental series of petal growth : Petals were dissected from the flowers/buds in the 
inflorescences and areas were measured then plotted against their growth periods. The 
growth period of the youngest bud, which contained the smallest dissectible petals 
(approximately 50.000 µm2 in area) was set to be 0. The growth period of the next bud was 
calculated by adding the plastochron to the growth period of the previous bud.  The 
plastochron (the time difference between two sequential buds) was estimated by counting 
how many flowers that were made in six days. Two to four petals per bud and three 
inflorescences per genotype were measured.  
 
A. Petal area vs time.  
B. Log2(Petal area) vs time. The petal area data in A. was transformed in to log2 scale. 
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2.4 Cell division is enhanced in ds39: 
The increase in cell number in mature petals of the mutant suggests that cell division is 
enhanced. To understand how this enhancement occurs temporally and spatially, we 
directly visualized and traced the dividing cell using the mitotic reporter construct 
pAtCycB1;1::CDBGUS. This construct when transformed into plants allows only dividing 
cells to be stained blue after GUS staining. GUS only accumulates during the G2/M phases 
of the cell cycle because of the combined transcriptional restriction due to the  pAtCycB1;1 
promoter, which is only active around the G2/M transition, and protein degradation at the 
end of mitosis that results from translationally fusing GUS to the Cyclin Destruction Box of 
CycB1;1(de Almeida Engler et al., 1999).  
As shown in Figure 2.4A, cell division in petals is enhanced in the mutant compared to WT. 
Cell division is also arrested later in mutant compared to wild-type (arrest happens when 
ds39 petals reach a size of 0.4 mm2, while the number for Ler is 0.25 mm2). This result 
suggests that the cell division arrest in ds39 petals is delayed, then resulting in a longer 
period of growth which contributes to the increase in final size. Additionally, this 60% 
difference in the area, at which cell division is arrested (0.4 mm2 for WT vs 0.25 mm2 for 
mutant), combined with a 20% increase in cell size predict the total difference in final petal 
area of 92% (i.e.160% x 120% = 192%). This number is very close to the measured 
difference in final petal size i.e. 89%.  
Spatially, the cell division pattern is not affect in the ds39 mutant petals (Figure 2.5). Similar 
to wild-type, cell division is arrested first at the very tip and base of the petals and last at the 
central of the petals.  
In leaves, the cell division activity is arrested later in the mutant, similar to what happened in 
petals of the mutant (Figure 2.4B) but to a lesser degree. This increased cell division is not 
able to compensate for the defect in cell expansion. However, quantitatively, the data does 
not fully match, cell size of mutant is 43% of cell size of WT, given the same number of 
cells, the over all size of mutant should be 43% of WT. In fact, the overall leaf size of the 
mutant is 30% of the WT, meaning that the cell number must also decrease in the mutant. 
This contradicts with the CDBGUS results. The resolution of GUS staining in this experiment 
is not at single cell level. So perhaps, in the ‘blue’ area marked by CDBGUS of the ds39 
mutant, a fewer number of cells divide.  
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Figure 2.4. Cell division is enhanced in ds39 mutants compared to WT. 
Cell division area was visualized by GUS staining the organs from plants harbouring the 
mitotic marker construct pAtCycB1;1::CDBGUS. Dividing area is the area that showed blue 
GUS staining. 
A.  Developmental series of cell division in petals.  
B.  Developmental series of cell division in leaves.  
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Figure 2.5. Cell division pattern does not change spatially between ds39 mutants and 
WT 
The positions of red square (ds39) and blue dots (WT) represent the petal size. The dashed 
lines connect the corresponding GUS stained images of the petals to their areas. All images 
are at the same magnification. 
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2.5 Other phenotype of ds39:  
ds39 plants grow more slowly, form fewer leaves, fewer flowers and fewer side shoots ( 
Figure 2.1C and D). Siliques of ds39 mutants are shorter. Seed size is not changed (Figure 
2.2A). Total seed number is much reduced. The seeds also have a reduced germination 
rate. 
2.6 The opposite phenotypes of ds39 on flower size and leaf size 
are dependent on the organ identity rather than organ 
position: 
I ask whether the opposite phenotype of ds39 on flower size and leaf size are dependent on 
the organ identity rather than organ position. The organ position scenario can happen for 
example: there could be a mobile growth inhibitor that travels from roots to leaves and 
flowers to control size; in ds39 mutant, the mobility may be blocked so that the inhibitors 
may not be able to reach the flowers. In such case, leaves accumulate the inhibitors and 
grow less well but flowers are free of the inhibitors and enlarge.  
To test this possibility, I combine ds39 with a mutant background that changes an organ 
identity but keeping its position intact. ap2-1 (Bowman et al., 1989) mutant transform sepals 
in to leaf-like organs. Sepals of ds39 mutants are larger than Ler WT but ‘leaf-like’ organs in 
the second whorles of the flower s of ds39 ap2-1 double mutants are smaller than the ‘leaf-
like’ organs in the second whorles of the flowers of single ap2-1 single mutants (Figure 2.6). 
Therefore, the effect of ds39 on petal enlargement is identity dependent rather than position 
dependent. 
 
The conclusions in this chapter are: i) in petals, the ds39 mutation enhances growth by 
delaying cell division arrest and also by increase cell expansion; ii) By contrast, in leaves, 
the ds39 mutation represses growth by inhibiting cell expansion. iii) the opposite size effects 
of paps1-1 mutations on leaves and sepals are dependent on organ identity. 
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Figure 2.6. The opposite effect of ds39 on sepals and leaves is dependent on the 
organ identity rather than the position.  
A. Floral organs of different genotypes were shown. Note that ap2-1 mutant transforms the 
sepals (second whorl) in to leaf-like organs.  
B. Size of the organs at the second whorl were measured for different genotype, error bars 
are S.E.M, n≥10.  
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3 .Chapter 3.The identification of 
the ds39 mutation as paps1-1 
and the phenotypes and 
interactions among four paps1 
mutant alleles. 
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3.1 Mapping of the ds39 mutation: 
The gene causing the ds39 phenotype was identified by map-based cloning (Lukowitz et al., 
2000). The mutation is fully recessive as the petal size of F1 plant from a cross between WT 
and ds39 is indistinguishable from WT (Figure 2.2). In the F2 population from the selfed F1 
plants, the phenotypic segregation ratio is 33 mutant:232 wild-type (i.e. mutant ratio is 0.14).  
This ratio is much higher and statistically different from a ratio of one in 16 (the p-value is 
less than 0.001 in a χ2 –test), so it rules out the possibility that the phenotype is caused by 
two mutations. This ratio is also lower and statistically different from a 1:3 ratio (pvalue is 
less than 0.001 in χ2 –test). However, homozygous mutant seeds showed a low germination 
rate, so the simplest explanation is that the phenotype is caused by one mutation, with the 
distortion due to reduced germination of the homozygous mutant class. 
After PCR-genotyping about 1000 phenotypically mutant individuals from F2 mapping 
population, the mutation is found to be tightly linked to two markers flanking an interval of 
80kb (Figure 3.1A). 19 candidate genes (Figure 3.1B) in this interval were sequenced. T-
DNA insertion lines which disrupt genes in this region were ordered. In the end, sequencing 
identified a C to A point mutation in At1g17980 (Figure 3.1C). Additionally, plants that are 
homozyogous for a T-DNA insertion that disrupts this gene were found to have smaller and 
pointed leaves. This suggests At1g17980 is the causal gene.  
3.2 3.2. The causal gene is At1g17980, which encodes a 
canonical poly(A) polymerase 1 (PAPS1): 
We have three lines of evidence to support that the ds39 mutant is in At1g17980, which 
encodes for PAPS1. First evidence is from the mapping of ds39 and the identification of a 
point mutation in At1g17980 gene in ds39 mutant. Secondly, transforming ds39 mutant with 
a genomic version of wild-type PAPS1 fully rescued the ds39 phenotype in both leaves and 
flowers (Figure 3.2A). Thirdly, two independent T-DNA insertion lines which have the T-
DNA inserted in PAPS1 locus are allelic to ds39 (Figure 3.2B and C).F1 of a cross between 
ds39 and these TDNA lines did not show a rescued phenotype as judged from their petal 
sizes (Figure 3.2A). One of them called pap1-4 also showed similar phenotype to ds39, i.e. 
smaller leaves but larger flowers (Figure 3.2B and Figure 3.3A). Taken together, these 
three lines of evidence confirm that the mutation in PAPS1 is responsible for the ds39 
phenotype. From now on the ds39 mutant allele is called paps1-1.  
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Figure 3.1. Fine mapping of the ds39 mutation. 
A.  The ds39 mutation was mapped to the interval of 60 kb between two markers indicated. 
Dashed lines represent the chromosome, horizontal thick arrows represent the two Bacterial 
Artificial Chromosome s (BACs) spanning the chromosomal region, vertical arrows 
represent the marker position.  
B.  Genes within the mapping interval (the annotation is from TAIR website). Arrow head 
points at the gene from which a mutation is found in ds39 plants.  
C.  Part of the wild-type nucleotide sequence in exon 8 of At1g17980, where a C to T 
mutation is found in the ds39 mutant. Above is the coding strand, below is the 
complementary strand. The translation of the coding strand is shown on top of the 
nucleotide sequence. One letter amino-acid code is used.  
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Figure 3.2. The causal mutation in ds39 affects PAPS1 locus. 
Plants are grown at 21⁰ C.  
A.  Full length wild-type PAPS1 genomic fragment (gPAPS1) rescues ds39 mutant. From 
here, ds39 is called paps1-1. Plants are 5 week-old. 
B.  Whole plants and flower pictures of WT and mutants carrying different paps1 alleles. 
Note that paps1-1 is in Ler background; paps1-2, paps1-3 and paps1-4 are in Col-0 
background.  
C.  Genomic PAPS1 locus showing gene structure, protein domains and positions of the 
paps1 allele polymorphisms.  
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Figure 3.3 Allelic interactions between paps1 alleles. 
Petal size of plants with different genotype, which is shown below the bar, e.g., paps1-1 x 
paps1-2 means F1 plants between paps1-1 and paps1-2 homozyogous mutant. Note that 
here paps1-1 is in Ler background and other alleles paps1-2 and paps1-4 is in Col-0 
background hence control crosses (Col-0 x Ler ) were also measured.  paps1-2 petals were 
deformed and much smaller than WT so were not measured (ND).  
All plants in A were grown and measured together; all plants in B were grown and measured 
together in a different experiment from A.  
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3.3 The different paps1 alleles show a range of different 
phenotypes:  
Because of the peculiar phenotype of paps1-1 mutant, more paps1 mutant alleles were 
isolated. In addition to paps1-1, more alleles were isolated, all of which are T-DNA insertion 
alleles (Figure 3.2B and C). In the next sections, the phenotypes of these four mutant 
alleles and the defects in their PAPS1 transcripts were examined in detail.  
3.3.1 The paps1-1 mutation probably changes the conformation of 
the protein. 
The point mutation in paps1-1 causes an amino acid change from proline at the amino acid 
(aa) number 313 to Serine (P313S). This point mutation lies in the N-terminal catalytic 
domain of PAPS1, which is highly conserved across kingdoms (Figure 3.4).The only PAPS-
like protein that does not have proline at this position is Arabidopsis PAPS3 and 
Sorghum_Sb02g043400. PAPS3 is quite divergent amongst plants (see Figure 1.9 and 
Figure 1.12). By alignment, Sorghum_Sb02g043400 was found to to have a large deletion 
at this region of the protein (Figure 3.4). 
To know where exactly the amino acid is in the protein, the structure of the N-terminal 
catalytic domain of bovine PAP (Martin et al., 2000), which shares 43% identity with PAPS1 
N-terminal catalytic domain, was examined (Figure 3.5). This structure only contains the 
first 513 aa of bovine PAP, which is the N-terminal catalytic part of the protein and lacks the 
C-terminal domain (residues 514 to 739). The N-terminal catalytic part is further subdivided 
in to three domains: the catalytic domain (residues 60-173), the middle domain (residues 
20-59 and 174 to 352) and the C-terminal RNA binding domain (residues 353-498) (Martin 
et al., 2000). By sequence alignment, the position of the Arabiodopsis PAPS1-P313 is 
equivalent to bovine PAP-P321. As seen in Figure 3.4, P321 is at the loop between helix K 
and helix L in the middle domain. So P321 is neither in the catalytic nor RNA binding 
domain. It is very far away from the active site, i.e. the position of the 3’ATP, the analog of 
the substrate used in this crystallization. Therefore, the P321S mutated amin oacid should 
not make any direct contact with either the ATP substrate or pre-mRNA substrate. A closer 
look at position P321 reveals its potential structural role. In bovine PAP, P321 together with 
the other close by and highly conserved P318 form a bend in the linking peptide (Figure 
3.5B). P321S mutation perhaps affects the movement of N-terminal and C-terminal domain 
during the catalytic cycle of PAP as suggested by (Balbo et al., 2007). This is also likely to 
be the reason why the paps1-1 mutation is temperature-sensitive while the other paps1 
mutant alleles are not (see below). Probably, high temperature further enhanced the 
incorrect folding/conformation of the mutant protein. 
101 
 
 
Figure 3.4. Position of the mutated proline residue (P313) in paps1-1 mutant. 
Apart from Arabidopsis PAPS3 (At3g06560) and Sorghum_Sb02g043400, this proline is 
conserved in all examined model organisms. The FASTA sequences used for the alignment  
and the full alignment are supplemented in electronic version. Alignment was carried out 
using alignX-vector NTI. The colour code of amino acid: Weakly similar: Dark green text on 
a white background ; Block of Similar:   Black on a light green background; Conservative: 
Dark blue on a light blue background; Non-similar : Black on a white background .  
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Figure 3.5 Position of the proline 321 (P321) in bovine PAPs 
A.  The whole structure of the N terminal catalytic domain of bovinPAP (structure 1F5A-
protein data bank). Helices are in magenta ribbon, short helices are in purple ribbons, beta 
strands are in yellow ribbon, linker peptides are in white threads, P321 are in yellow ball and 
stick, d3’ATP, the substrate analog has its sugar and base colored in blue and gray, its 
phosphate group in red ball and sticks. 
B.  Simplified structure where parts of the protein, notably of the middle domain, are 
removed. Note the curve where P321 lies in the linker peptide of the middle domain. 
Distance from P321 to the base of d3’ ATP is measured to be 14.04 Å.  
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To sum up, the position of the mutated proline in the protein structure suggests that the 
PAPS1-P313S mutated protein probably has a reduced function because of impaired 
conformation. 
3.3.2 paps1-1 mutants are temperature sensitive and this is not due 
to the higher requirement for PAPS1 at higher temperature.  
Another property of paps1-1 is that the mutation is temperature sensitive. While WT plants 
grow faster at 28⁰ C than at 23⁰ C (Figure 3.6A), the paps1-1 seedlings did not grow at 
28⁰C as well as they grows at 23⁰ C. paps1-1 seeds did germinated at 28⁰ C; however, the 
seedlings produced very tiny leaves.  
This growth depression behavior at high temperature is only found in paps1-1 but not found 
in either of the other paps1 alleles paps1-2 or paps1-4 (Figure 3.6A and B). This 
observation weakens the possibility that the growth deteriorates at high temperature 
because plants require more PAPS1 activity to cope with increasing temperature.  
Strikingly, while the growth inhibition is exaggerated in paps1-1 leaves by high temperature, 
the growth promotion in petals is not. Instead, at 25⁰C, the paps1-1 petals become 
narrower. They deform mildly (Figure 3.7A- compare paps1-1 flowers at 23⁰C and 25⁰C). 
Moreover, when plants are moved from 23⁰C , at the stage when they already produce 
some normal-large flowers,  to even higher temperature (28⁰C), the newly made flowers 
(examined one week after the switch) becomes severely deformed and infertile like pap1-2 
flowers (Figure 3.7B). 
Taken together, the data suggests that the paps1-1 mutation interferes with the normal 
conformation of the protein, and this structural defect is further enhanced by high 
temperature.  
3.3.3 paps1-4 mutants share the phenotype, but showed weaker 
phenotype compared to  paps1-1 
paps1-4 is a T-DNA insertion allele. The T-DNA inserted at an exon that ecodes for part of 
the C terminal domain of PAPS1 protein (Figure 3.8). 
Similar to paps1-1 phenotype, paps1-4 also has smaller and pointed leaves, and bigger 
flowers, although both the petal size increase and leaf size decrease is to a lesser degree 
compared to paps1-1 (Figure 3.2B and Figure 3.3A) 
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Figure 3.6. paps1-1 is temperature sensitive but the requirement for PAPS1 activity is 
not higher at higher temperature 
A.  15 day-old seedlings of paps1-1 (in Ler background) and paps1-2 (in Col-0 background) 
grown at 23⁰C and 28⁰C.  
B.  25 day-old seedlings of paps1-1, WT Ler, WT Col-0, paps1-2 and paps1-4 grown at 
28⁰C.   
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Figure 3.7. Petals of paps1-1 plants grown at high temperature (25-28⁰C) but not at 
23⁰C resemble paps1-2 petals. 
A.  Flowers of plants grown at different temperature: paps1-1 at 23⁰C and 25⁰C; paps1-2 at 
23⁰C; WT (Col-0) at 25⁰C; paps1-4 at 25⁰C. Compare paps1-1 flowers at 23⁰C  and 25 ⁰C 
and paps1-2 at 23⁰C.  
B.  Inflorescenes of paps1-1 and WT (Ler) plants one week after being switched from 23⁰C 
to 28⁰C. Note that flowers become deformed and sterile.  
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Figure 3.8 Defects of PAPS1 transcripts in paps1-2 and paps1-4 mutant alleles 
A.  Schematic diagram of PAPS1 locus showing position of the point mutation or T-DNA 
insertions for each alleles. The annotation is similar to Figure 3.2. The positions of primers 
for qPCR and RT-PCR in B are shown as blue arrows. 
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Figure 3.8 Defects of PAPS1 transcripts in paps1-2 and paps1-4 mutant alleles 
(continued) 
B. qPCR comparing abundance of PAPS1 mRNAs (using primers oSV187 and oSV188) in 
Wt (Col-0), paps1-2 and paps1-4 with two house keeping genes PDF2 and UBC. 
Comparisions are based on the Ct values.  
C.  RT-PCR with different primers, positions of which relate to the insertion site of the T-
DNA in indicated the mutant alleles. 
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RT-PCR analysis using primers flanking the paps1-4 insertion site gave no PCR products, 
suggesting there is no intact PAPS1 transcript in paps1-4 (Figure 3.8C). RT-PCR analysis 
with primers downstream of the paps1-4 insertion site showed a slight reduction in the 
abundance of transcript from this region of the gene (Figure 3.8C). However, both qPCR 
and RT-PCR analysis using primers upstream of the paps1-4 insertion site suggest equal 
abundance of transcripts transcribed in this region of the gene in paps1-4 compared to WT 
(Figure 3.8B and C). In the best scenario, this truncated transcript is able to give rise to a 
truncated protein. Since the insertion is after the catalytic domain, the hypothetical truncated 
protein is expected to retain some activity.  
Based on these analysis of PAPS1 mRNA, in paps1-4, the PAPS1 protein is probably 
truncated hence activity of PAPS1 is probably reduced slightly resulting in a phenotype that 
resembles but is less strong than in paps1-1.  
3.3.4 paps1-2 mutants are allelic to paps1-1 and paps1-4 but cause 
petals to be deformed:  
paps1-2 mutant plants has a T-DNA inserted in the 5’ UTR of the PAPS1 locus. Similar to 
paps1-1 and paps1-4, the paps1-2 mutant plants also have smaller leaves (Figure 3.2B); 
however in contrast with the other alleles, the petals of the paps1-2 mutant are not bigger 
(Figure 3.2B and Figure 3.7A). By contrast, the petals are all smaller and narrower than 
WT. There are usually only one or two petals per flowers in the paps1-2 flowers instead of 
four petals per flowers in WT plants. The paps1-2 flowers are female sterile, which is 
caused by the deformed gynecium. Pollen of paps1-2 mutants has very reduced fertility but 
some were viable because F1 plant between homozygous paps1-4  (female) plants and  
homozygous paps1-2 (male) plants were obtainable. Contrastingly, the reciprocal crosses to 
this cross yeilded no seeds.  
PAPS1 transcript was checked in paps1-2 mutants. qPCR and RT-PCR analysis using 
primers upstream and downstream of the T-DNA insertion site showed that these two 
regions of the transcript is as abundant as WT (Figure 3.8B and C). However, RT-PCR 
analysis using the primers flanking the insertion site suggests a served reduction of the 
transcript in the mutant compared to WT. It is unexpected to have a PCR product, length of 
which is approximately the same WT (Figure 3.8C), using the primers flanking the T-DNA 
insertion site in paps1-2 mutants. The presence of this PCR product are either due to PCR 
contamination, which I consider unlikely because the PCR experiments have been repeated 
twice with similar results, using two independent RNA samples. A second explanation for 
the presence of this PCR product is that somehow a small fraction of the transcript manages 
to splice out perfectly the T-DNA. The PCR product thefore should be sequenced in future 
experiment. Nevertheless, the important deduction from this RT-PCR analysis is that the full 
length coding region of the mRNA of PAPS1 is likely to be intact and equally abundant in 
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paps1-2 compared to WT (based on the qPCR and RT-PCR with primers downstream of the 
insertion site). Because of the insertion in 5’UTR, this potentially intact coding region of 
PAPS1 can still be mis-translated for example: T-DNA insertion can results in a chimeric 
fusion of ‘T-DNA-PAPS1’ transcripts that is translated in to a protein with a different reading 
frame. Therefore, it is not exactly clear about what could go wrong to the PAPS1 protein in 
paps1-2 mutants. We are now generating antibody against PAPS1 in order to check the 
PAPS1 protein in paps1-2.  
To sum up, paps1-2 has T-DNA inserted in the 5’ UTR, which causes the petal to deform, a 
unique phenotype that is not shared by paps1-1 and paps1-4. RT-PCR and qPCR suggest 
that the coding of region of PAPS1 mRNA is likely to be intact and the transcript is as 
abundant as wild-type, however as the insertion is in 5’UTR, the protein may not be 
translated normally. Notably, because of the phenotypic similarity between paps1-2 flowers 
and paps1-1 flowers at high temperature (28⁰C), it is likely that the remaining PAPS1 activity 
in paps1-2 plants is lowest amongst paps1-1 (at 23⁰C), paps1-2 and paps1-4 plants.  
3.3.5 paps1-3 mutants are probably embryonic lethal or 
gametophytic lethal. 
paps1-3 mutants has a T-DNA inserted in the intron 5 of the PAPS1 gene (Figure 3.2). 
Genotyping 90 F2 plants from a heterozygous paps1-3/+ plant found 51 wild-type plants and 
39 heterozygous plants and no homozygous plant. The segregation ratio (close to 1:1) 
suggests paps1-3 is probably gametophytic lethal. Reciprocal crosses with Col-0 will have 
to be carried out to prove this. 
3.3.6  The allelic relationship between paps1 mutant alleles: 
Figure 3.3 shows the petal size of homozygous paps1 mutants and trans-heterozygous 
plants (i.e. F1 plants between two different paps1 homozygous mutants, alleles of which are 
different). Both paps1-2 and paps1-4 are allelic to paps1-1 because their trans-
heterozyogous with paps1-1 plants still have large petals (Figure 3.3A). The different in 
background (F1 of Ler x Col-0) did cause hybrid vigor, i.e. bigger petals than either of 
parent, however this effect is very small compared to the increase (over the wild-type) in the 
petal size of the paps1-1/paps1-4 and paps1-1/paps1-2 trans-heterozygous. 
In the same ecotype Col-0, the combination of paps1-2 allele, which causes smaller petals 
than WT and paps1-4 allele, which causes bigger petal than WT, resulted in trans-
heterozygous plants with even larger petals than paps1-4 homozygous mutant plants 
(Figure 3.3A). Using normal dominant/recessive relationship can not explain this further 
increase in petal size. I explain this in the general discussion in chapter 8.  
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In conclusion, the ds39 mutation is in At1g17980, which encodes for poly(A) polymerase 1 
(PAPS1), ds39 is renamed paps1-1. In total, four paps1 mutant alleles were isolated. paps1-
1 and paps1-4 similarly have smaller leaves and bigger flowers than WT whereas paps1-2 
have smaller leaves but deformed and smaller petals than WT. One other allele, paps1-3, is 
embryonic or gametophytic lethal. 
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4 .Chapter 4. Properties of 
PAPS1 and the functional 
specialization among four 
PAPSs in Arabidopsis. 
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In this chapter, I show that in vitro PAPS1 WT protein possesses polyadenylation activity but 
the mutated protein in paps1-1 (the PAPS1P313S) is almost completely inactive. I showed 
however, in vivo; the bulk poly(A) tails of all the mRNAs in cells does not change 
dramatically in the paps1-1 mutant. Later, I looked at the properties of all canonical PAPS in 
Arabidopsis with respect to: their knock out mutant phenotypes, the expression domains by 
using promoter:GUS constructs, their alternative splicing patterns and finally, the conditions 
where the balance amongst PAPSs changes. Lastly, I show evidence from transgenic plants 
to support that the functional specificity of different PAPSs lies with the C-terminal domains.  
Together, these results suggest a novel layer of gene regulation whereby cell controls large 
group of genes in response to stimulus by adjusting the balance of different canonical PAPs. 
4.1 In vitro poly(A) polymerase activity: 
To explore the biochemical properties of PAPS1, the His-tag PAPS1 and His-tag 
PAPS1P313S protein were expressed in E.coli, purified and assayed for activity in vitro. This 
experiment is done in collaboration with NishtaRao in James Manley’s lab. My contribution 
is generating the two constructs ready for expression in E.coli.  
The activity was determined in a non-specific polyadenylation assay, which measure the 
ability of the enzyme to add adenosines to radioactively-labelled precleaved mRNAs from 
SV40 virus. As shown in Figure 4.1A, the WT PAPS1 protein has activity, while the mutated 
PAPS1P313S has almost no activity at 26°C, but may retain a very low level of activity at 
16°C. This suggests that the mutated protein is not functional and the activity decreases at 
26°C compared to 16°C.  
To conclude, based on in vitro activity paps1-1 seems to be a hypoactive/loss of function 
mutation rather than a hyperactive mutation. 
4.2 In vivo bulk poly(A)-tail analysis: 
To assess the effect of paps1-1 in vivo, the bulk poly(A) tail length was measured in mutant 
and in WT plants. Knowing the mutation is temperature sensitive, I analyzed RNA from 
seedlings grown at 28°C. Figure 4.1B shows that despite the dramatic effect on growth of 
seedlings at high temperature, the overall poly(A)-tail composition and patterns are almost 
unchanged in paps1-1 compared to WT (Figure 4.1B). There could be a subtle reduction in 
the proportion of the longest (A) tails, but the results were not reproducible in other 
replicates in flowers (not shown).  
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Figure 4.1.PAPS1P313S protein is not functional in vitro but its effect in vivo on bulk 
mRNAs tail-length is subtle.  
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Figure 4.1. PAPS1P313S protein is not functional in vitro but its effect in vivo on  overall  
mRNAs tail-length is subtle (continued).  
A.  In vitro non-specific PAP assay Left: SDS-PAGE  showing purified wt and mutated 
PAPS1 (PAPS1-P313S)  protein from E.coli, Right: Radiograph of RNA products resolved on 
agarose gel after mixing different concentration of purified PAPS1 proteins with the 
precleaved substrate.  
B.  In vivo bulk poly(A)-tail analysis. Total cellular RNAs were end-labelled with 32P 
cordycepin then treated with  RNaseT1 and RNaseA to degrade all RNAs but the poly(A) 
tails, which are then resolved in 8M urea 10% polyacrylamide gel.  
The righter most picture is a magnified picture of  the upper part of  the gel (i.e., the square 
marked on the gel). 
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A yeast temperature sensitive pap mutant (pap1-1) showed a very strong reduction in 
poly(A) tail length after being shifted from permissive to non-permissive temperature 
(Proweller and Butler, 1994) . Compared to this result, clearly the effect in the Arabidopsis 
paps1-1 mutant is very subtle.  
Bulk poly(A)-tail analysis using RNA from inflorescences of Col-0, paps1-2 and paps1-4 
showed similar results, i.e. the difference between mutant and WT was not detected (not 
shown).  
4.3 Phenotypes of other paps single and double mutants: 
To answer whether the phenotype of paps1-1 is specific to PAPS1 compared to other 
PAPSs, the knock out mutants, which are all T-DNA insertion lines, for the other three 
PAPSs were ordered from the seed stock centre and analyzed. There are several T-DNA 
insertion lines (shown in Figure 4.2) for PAPS2 and PAPS4 and PAPS3. The plan was first 
try to find null mutants for each PAPS. If this is not possible because some are essential, I 
would look for T-DNA insertions that inserted in the C-terminal domain or UTRs etc., 
hopefully to be able to obtain weak but surviving homozygous mutant plants.  
Therefore, initially, for each PAPS, one line, T-DNA in which inserted in the exon of the 
gene and preferably in the N-terminal catalytic domain, was chosen for genotyping and 
phenotyping. With these criteria, three T-DNA insertion lines were chosen paps2-3, paps4-3 
and paps3-1, the insertions sites of which are shown in Figure 4.2.  In the end, I was able to 
get plants that are homozygous for the T-DNA insertion in all three lines.  
4.3.1 paps3 single mutants: 
Three paps3 mutant alleles were isolated (Figure 4.2). paps3-1 homozygous plants 
(confirmed by genomic DNA genotyping) did not show a phenotype. However, paps3-3 and 
paps3-4 homozygous mutant (confirmed by genomic DNA genotyping) clearly showed a 
phenotype. The overall stature, the leaves and flowers of paps3-3 and paps3-4 
homozyogous mutant plants are smaller (Figure 4.3). The homozygous plants are also 
sterile.  
The linkage of the phenotype to the homozygous state the T-DNA insertion was confirmed 
by analyzing approximately twenty T2 plants that were seggregating for the T-DNA. 
Because paps3-3 and paps3-4 are two independent T-DNA lines which share similar 
phenotype, it is unlikely that the phenotype is caused by an additional T-DNA that is 
unlinked to the PAPS3 locus. In the future, allelic test and transformation with PAPS3 
genomic rescue construct can be carried out to further confirm this linkage.  
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Figure 4.2. Mutant alleles and positions of T-DNA insertion in four PAPS genes. 
The numbers in brackets indicate the nucleotide position from the 5’ A (in the first ATG 
codon) of the gene genomic sequence. 
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Figure 4.3. paps3-3 and paps3-4 mutant showed deleterious phenotype. 
Pictures of plants three weeks after germination that are segregating for the indicated paps3 
T-DNA insertion alleles. The homozygous mutants, which were confirmed by PCR-
genotyping, are marked with red arrows. Other plants are either WT or heterozygous for the 
T-DNA insertion.  
  
paps3-4
paps3-3
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paps3-1 has T-DNA inserted in exon while paps3-3 and paps3-4 has T-DNA inserted in the 
intron (Figure 4.2), paps3-1 did not show a phenotype while paps3-3 and paps3-4 did. This 
is quite unexpected. The insertion position is based on the published sequence of the 
insertion positions in these lines, may be paps3-1 mutant has a T-DNA inserted in an intron 
instead of an exon. RT-PCR needs to be done to check for mRNA of PAPS3 in these three 
homozygous mutant alleles.  
4.3.2 paps2 and paps4 single mutants: 
The more interesting PAPS to us are PAPS2 and especially PAPS4 because they are more 
similar to PAPS1. I focused on paps2-3 and paps4-3 alleles. Molecularly, there is no full 
length/intact mRNA of the PAPS in its corresponding mutant (Figure 4.4A). Because the 
insertion is in the middle exon of the gene, it is very unlikely that the hypothetical fusion 
protein(s), which is created by translational fusion of T-DNA sequence to PAPS sequence 
upstream or downstream of the insertion site, are active. Therefore, paps4-3 and paps2-3 
are probably null mutants. 
Surprisingly, homozygous paps2-3 and paps4-3 plants are indistinguishable from wild-type 
in our standard growing condition. Their petals are not larger. A closer examination showed 
that paps4-3 is late flowering (Figure 4.4C and D). I also checked the phenotype of the 
segregating families for other alleles of PAPS2 and PAPS4 (Figure 4.2). At least twenty 
plants were sown out per family, 25% of which should be homozyogous for the T-DNA 
insertion. However, all of these plants were, morphologically indistinguishable from WT.   
4.3.1 paps2 paps4 double mutants:  
Since PAPS2 and PAPS4 are probably redundant, the double mutants were generated to 
reveal the phenotype. Double mutants were found but apart from being late flowering (even 
later than paps4-3), they showed no additional phenotype at our standard growing condition 
(Figure 4.4C and D). This data indicates indeed PAPS2 and PAPS4 are partially redundant 
at least to the flowering time phenotype. However, the petal size and leave size and overall 
growth of the double mutant are normal.  
This suggests the role among PAPS2, PAPS4 and PAPS1 such that at our standard growth 
condition, PAPS1 appears to be the only essential PAPS. When PAPS1 is wild-type, PAPS2 
and PAPS4 are both dispensable.  
119 
 
 
Figure 4.4. Phenotype of paps2-3 and paps4-3 single mutants and paps2-3 paps4-3 
double mutant 
A.  RT-PCR on cDNA made from WT (Col-0), paps2-3 and paps4-3  single mutant. Primers 
are indicated. PDF2 is a house keeping gene used for control.  
B.  Petal size of WT (Col-0), paps1-1 and paps2-3/paps4-3 double mutants . paps1-1 in Col-
0 is the paps1-1 mutant, originally in Ler background, which was backcrossed three times to 
Col-0.  
C.  Flowering time (the number of leaves the plants have made at the time the 
inflorescences stem is 5cm long) of WT and mutants. These measurements were done by 
H.C.  
D.  Picture of WT and the paps2-3/paps4-3 double  mutant. Both genotypes were sown out 
on at the same time, and picture was taken 43 days after sowing.  
  
Flank paps2-3 
insertion site
Flank paps4-3
insertion site
PDF2
Primers
Flowering time analysis
16
21
24
11
0
5
10
15
20
25
30
17
Le
af
 n
um
be
r a
t b
ol
tin
g 
(5
cm
 st
em
)
0
20
40
60
80
100
120
140
160
Pe
ta
l s
iz
e 
(%
 o
f W
T)
Petal size  analysis
paps2-3/paps4-3 Col-0
A B
C D
120 
 
4.4 Spatial expression pattern of PAPSs: 
To visualize PAPS expression domains, the promoters of the four PAPSs were fused 
upstream of the GUS reporter gene. At least 10 independent transgenic lines for each 
constructs were analyzed to account for the variation in the insertion positions of the 
transgene. Figure 4.5 showed the representing GUS-stained image of transgenic plants 
carrying the reporter constructs in WT background. In inflorescences, pPAPS2::GUS  and 
PAPS4::GUS express strongly and overlappingly, pPAPS1::GUS did not show any 
detectable GUS staining, pPAPS3::GUS showed a weak staining. pPAPS3::GUS showed 
strong expression in in the trichome. In seedlings, the expressions are being analyzed on T2 
plants as this thesis is being written so the results are not yet available. 
4.5 Functional specializations of PAPSs: 
4.5.1 Promoter is not likely to account for the functional differences 
between PAPS1 and PAPS4 gene.  
As in section 4.4, the spatial PAPS1 expression is different from PAPS4, but the temporal 
and dynamic of this regulation is difficult to determine by the promoter::GUS analysis. To 
directly test the role of promoters, we ask if PAPS4 can rescue paps1-1 if expressed by 
PAPS1 promoter. Figure 4.7 and Figure 4.8 shows that phenotype of neither leaves nor 
flower of paps1-1 mutant was rescued in any of the T2 transgenic lines carrying the 
pPAPS1::genomicPAPS4 transgene (the construct is illustrated in Figure 4.6) . This result 
suggests promoter is not likely to account for the functional differences between PAPS1 and 
PAPS4 gene.  
4.5.2 The C-terminal domains are likely to be the specificity 
determinants between PAPS1 and PAPS4: 
As pPAP1::genomicPAPS4 did not rescue, the protein sequence and especially the very 
divergent C terminal domains sequence may encodes specificity amongst PAPS. To test 
this possibility, I modified the pPAP1::genomicPAPS4 construct, replacing PAPS4 C 
terminal domain with PAPS1 C-terminal domain (pPAP1::gNPAPS4::gCPAPS1_construct 
shown in Figure 4.6 and transformed this construct to paps1-1 mutants. Interestingly, in 
contrast to pPAP1::genomicPAPS4, some of the T2 transgenic lines carrying 
pPAP1::gNPAPS4::gCPAPS1 did rescue, though partially, the petal size phenotype (Figure 
4.5). More over, all of the lines have bigger leaves than paps1-1 (Figure 4.6). These results 
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Figure 4.5. PAPS expression domain overlaps each other. 
GUS stain pictures of transgenic plants expressing different PAPS promoter driving GUS. 
Each row are from one transgenic line indicated in the outer left pannel. From left to right of 
each row are pictures showing inflorescences with siliques, younger buds and zoomed in 
floral structures respectively.  
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Figure 4.6. Constructs used to transform paps1-1 to check for rescued phenotype.  
35S is a constitutive promoter from Cauliflower mosaic virus 35S gene.  
  
pPAP1
pPAP1
pPAP1
pPAP1
exon PAPS1 
exon PAPS4 
Intron PAPS1
Intron PAPS4
UTR PAPS1
UTR PAPS4
Last codon of the catalytic domain
35S
promoter
A. genomic rescue PAPS1
B. pPAPS1::genomicPAPS4
C. pPAP1::gNPAPS4::gCPAPS1
E. 35S::PAPS1cDNA
D. pPAP1::PAPS1cDNA
3’ UTR 35S 
123 
 
 
Figure 4.7. Petal size of different transgenic plants compared to paps1-1 and WT. 
In case of transgenic plants, bars that are grouped by a underneath bracket represent 
measurements from plants carrying the same construct indicated. Each bar represent an 
independent T2 transgenic family. At least 4 plants, which contain the transgene, were 
measured per family. This gives an average value for that family. Descriptions of the 
constructs are shown in Figure 4.6. 
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Figure 4.8 Leaf phenotype of WT, paps1-1 and different transgenic lines. 
A.  Ler (WT) 
B.  paps1-1 
From C-G: Basta selected T2 family plants, which are paps1-1 mutant carrying one of the 
following transgene: (Details information about the constructs are described in Figure 4.6) 
C.  pPAP1::PAPS1cDNA 
D.  35S::PAPS1cDNA 
E.  pPAPS1::genomic PAPS4 
F.  pPAP1::gNPAPS4::gCPAPS1 
G.  genomic rescue PAPS1 
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showed that swaping the both the C-terminal domain and the promoter can largely (but not 
completely) make PAPS4 equivalent to PAPS1. 
4.6 Conditions that change the balance among PAPS transcripts.  
We hypothesize that mRNAs has different preference for different PAPSs, which perhaps 
give different A-tail length to its substrate. If this is used as an active mechanism to adjust 
the poly(A) tails of some transcripts, cell must actively control these preferences. The 
mechanism of this fine tune can be at multiple levels. 
For example, control the abundance of a PAPS through transcription and translation control 
or through controlling its activity (e.g. phosphorylation inhibits the yeast PAP during the cell 
cycle (Colgan et al., 1998) or through controlling its recruitment to mRNA substrates. 
One possibility, which we can easily check, is whether cells can change the balance in the 
mRNA abundance of different PAPSs. We therefore used bio-informatics to find which 
physiology conditions/genotypes/treatments change the balance of the mRNA abundance 
among PAPS1, PAPS2 and PAPS4. Using GeneInvestigator, a public database of 
microarray experiments in many different conditions, we discovered that PAPS1, but not 
other two PAPS, is up-regulated when treating plants with FLG22 peptide (Figure 4.9). 
FLG22 is a 22 aa synthetic peptide derived from flagellin; the FLG22 treamentmimics a 
bacterial attack to plants. On the opposite direction of regulation, PAPS1, but not other two 
PAPSs, is down-regulated in plants that are treated with cold.  
4.7 Overexpressing PAPS1 did not results in any morphological 
changes: 
paps1-1 mutants carrying the overexpression 35S::PAPS1cDNA construct are 
indistinguishable from wild-type with respects to plant statures, leaf size and petal size 
(Figure 4.7 and Figure 4.8). The transgenic plants showed no other visible morphological 
changes.  
4.8 Discussion: 
The bulk poly(A) tail analysis results indicate that in paps1-1 mutants and other paps1 
mutants carrying paps1-4 and paps1-2 alleles, only a small number of transcripts were 
affected. This result again lends credit to the hypothesis that there is only a small proportion 
of the transcriptome that appears to be sensitive to the paps1-1 defect. 
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Figure 4.9 Conditions where PAPS1 is up/down regulated while other PAPSs remains 
largely unchanged, or change in the reverse direction. 
Interesting conditions are highlighted with arrow. 
blue dot is PAPS1,  
gray dot is PAPS2,  
red dot is PAPS4  
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The fact that PAPS3 is pollen specific explains the fertility problem in homozygous paps3-3 
and paps3-4. Mammals also have a canonical PAP that lacks C-terminal domain, which is 
testis specific (PAPLOB). Arabidopsis PAPS3 may be the PAPLOB equivalent in plants. 
Because the petals of paps3-3 and paps3-4 are not bigger, this mutant is of little immediate 
interest to us. Nevertheless, the important conclusion from this results is that  it suggests 
that PAPS3 and PAPS1 are functionally non-redundant. 
Judged by the expression domains, which are based on the pPAPS::GUS experiements, 
PAPS1 is not the mainly expressed PAPS in inflorescences. However, some consideration 
must be taken in to account when analyzing the expression domains using promoter::GUS 
reporter gene. For examples, in contrast to the results from promoter::GUS experiments, 
microarray data from AtGenExpress, and previous study (Addepalli et al., 2004) using 
Northern blot indicates that PAPS1, PAPS2 and PAPS4 expression levels are similar in 
floral organs (Figure 1.13). This indicates that the staining patterns may not truly reflect the 
expression dynamic of PAPSs (including spatial, temporal and mRNA stability).It is also 
possible that there are other transcriptional regulatory elements outside of the promoter 
fragments that was used in driving GUS expression in these constructs. Did I capture the full 
upstream regulatory sequence of PAPS1? Probably, yes because: The pPAPS1 promoter 
sequence used in pPAPS1::GUS construct is as long as the fragment that is present 
upstream of the ATG in the genomic rescue construct, which fully rescued the paps1-1 
phenotype. This suggests that the missing elements lie downstream of the ATG in PAPS1 
genomic locus. One can test this by either making translational fusion of PAPS1 genomic to 
a reporter protein or directly carry out in situ hybridization probing for PAPS1 mRNA.  
Nevertheless, results on Northern blot (Addepalli et al., 2004) and AtGeneExpress clearly 
indicates that PAPS1/2/4 transcripts are equally abundant in inflorescences. This suggests 
that expression patterns alone can not be the reason for the differences in phenotypes in 
flowers of different paps mutants.  
Knowing about the complication with pPAPS1 promoter explained above, I reconsider the 
interpretation of the promoter swap pPAPS1::genomicPAPS4 result. The question is: did 
pPAPS1::genomicPAPS4 not rescue because of the PAPS4 protein could not replace 
PAPS1 protein or because I failed to reconstitute PAPS1 expression dynamic in this 
construct. I believe the later is unlikely because of the results of the followed construct 
pPAP1::gNPAPS4::gCPAPS1. The very same promoter in pPAPS1:: genomicPAPS4 was 
used in the  pPAP1::gNPAPS4::gCPAPS1 construct, which did show rescued phenotype, 
meaning that the promoter combined with genomic construct did work well. In the future 
experiments, one should check the expression of the PAPS4 transgene in 
pPAP1::genomicPAPS4. 
One thing, though unlikely, that I reserve for the interpretation of the 
pPAP1::gNPAPS4::gCPAPS1 construct is whether the protein sequence of C-terminal 
domain (CTD) of PAPS1 protein or the 3’UTR of the PAPS1 gene, or both are responsible 
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for the rescue? Both CTD and 3’ UTR were changed in creating 
pPAP1::gNPAPS4::gCPAPS1 derived from pPAP1::genomicPAPS4 (Figure 4.6). 
Nevertheless, what I can be sure from this experiment is the promoter plus the sequence 
starting from C terminal domain to the end of the gene are sufficient to rescue the paps1-1 
phenotype in petals.  
For future experiments, a way to avoid the complications about pPAPS1 promoters and 
PAPS1-3’ UTR and focusing only on protein domain is to use 35S promoter and 35S 
terminator. This is because 35S::cDNAPAPS1::35S terminator fully rescued the paps1-1 
without any additional morphological phenotype (Figure 4.7, Figure 4.8). Next step would 
be to create 35S::genomicPAPS4 or 35S::cDNAPAP4 and transform paps1-1 to check for 
rescued petal size.This construct will also answer whether supplying paps1-1 with ample 
polyadenylation activity from a different PAPS, PAPS4 is able to rescue the phenotype of 
the mutants. This experiment will clarify whether the total activity of PAPS in general or the 
specific activity of individual PAPS underlies paps1-1 phenotype.  
The identified conditions, where the balance of PAPSs expression changes, are fascinating 
because it shows that each PAPS is under active gene regulations. Hence, I speculate that 
there will be more conditions that cells can finetune PAPS expression to regulate poly(A) tail 
length of specific pools of transcripts in order to response to those conditions. It will even be 
more interesting if we can find some target genes that are changed in paps1-1 and are also 
changed in WT which is treated with these conditions. Additionally, we can check whether 
subjecting WT plants to these conditions can induce the change in poly(A) tail lengths of the 
target genes. Several PAPS1 regulated genes were identified and described in chapter 7.  
Taken together, the data suggests the functional specializations of canonical PAPSs and 
the C-terminal domain of the protein is likely to be the specificity determinant. 
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5 Chapter 5. Analysis of the cell 
autonomy of PAPS1 
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5.1  The idea:  
5.1.1 The concept of non-autonomous/autonomous effect:  
An important question to be clarified in studying the function of a developmental regulatory 
gene is whether the gene acts autonomously or non-autonomously. This basic question can 
be answered by studying chimeric plants with genetically mutant and wild-type parts. If the 
cellular or organ-wide phenotype solely depends on the genotype of the cells or the organ, 
the effect is autonomous. Conversely, if the wild-type parts can rescue the phenotype of the 
neighboring mutant parts, or the mutant parts influence the phenotype of the wild-type parts, 
the effect is non-autonomous.  
There are several examples of non-autonomous effects in developmental processes such 
as: florigen FT (Corbesier et al., 2007) in flowering time regulation, WUS/CLV3 in stem-cell 
maintenance. (Schoof et al., 2000). 
In the case of growth, this question is highly pertinent because growth must be co-ordinated 
amongst different parts of the organ and different organs in the organism in order to form 
the correct shape and size. Growth co-ordination can happen  over  a range of distance: for 
example between ‘source’ organs (photosynthetically active leaves) and ‘sink ‘organs 
(flowers), amongst petals in a flower to ensure species-specific floral symmetry or between 
anthers and gynoecium to ensure the physical architecture that allows self-pollination.  
Several studies have shown that growth is under the control of both autonomously or non-
autonomously acting factors (Galloni and Edgar, 1999). In plants, a growth promoting factor 
KLUH acts non-autonomously to co-ordinate growth of different organs in one flower, or 
different flowers within an individual inflorescence (Eriksson et al., 2010).  
Another question involving growth co-ordination regards the  contribution of the epidermal 
layer and internal layer in driving/restricting organ growth in plants (Savaldi-Goldstein et al., 
2007). What happens if the growth of two layers is uncoupled: Can the growth of one layer 
drive the growth of the other layer (a cell non-autonomous effect)?  
The specific question: non-autonomous/autonomous effect across a range of 
distance. 
Here, I want to address the question of a possible non-autonomous aspect of PAPS1 
function across several scales. There are six levels that I will consider (Figure 5.1):  
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Figure 5.1 Sectored plants allow the analysis of growth co-ordination across different 
distances 
Level 1: Two different organs in individual plants: leaves and flowers.                                                                                     
Level 2: Petals from different side inflorescences in individual plants.                                                                                       
Level 3: Petals from different flowers in one individual inflorescence.                                                                                     
Level 4: Petals within individual flowers.                                                                                                                                        
Level 5: Two halves of individual petals or of leaves.                                                                                         
Level 6: Layers of individual petals: epidermis (L1), illustrated as the border of the circle, 
and internal (L2) layers.  
Yellow color represents wild-type tissues. Blue color represents mutant tissues. 
  
a
Level 2
Level 3
Level 1
Level 4
Level 5
Level 6
Level 5Level 1
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In each case, the specific question when examining the levels 2-6 is: In case of petals, is the 
size of the genotypically paps1-1 mutant part increased compared to its wild-type 
counterpart? The logic would be reversed for leaves. 
5.2 The method 
5.2.1 A system for generating predictable chimeras:  
The investigation of non-autonomous effects requires the generation of chimeric plants. To 
make sure that any non-autonomous effects on growth will be captured, one needs to 
consider at least two issues. The first issue is temporal. In my case, the phenotype of 
interest is growth, which is a continuous process starting from organ initiation until the fully 
mature organ reaches its final size. The non-autonomous effect may influence growth at any 
moment during this process. Therefore, if the chimeric situation is not established during the 
particular time window of gene action, the non-autonomous effect can be missed. The 
second issue is spatial, i.e. the range of communication that determines how close the two 
sectors of different genotype need to be in order for the non-autonomous effect to take 
place. These two issues combined require a temporal and spatial control over the induction 
of chimeras.  
A method has been developed in the Lenhard lab to generate predictable chimeras 
(Adamski et al., 2009, Eriksson et al., 2010). The method has four components (illustrated in 
Figure 5.2). The first is a Cre/loxP system that ensures a non-reversible switch in genotype. 
Cre is an enzyme that specifically recognizes and recombines two directly repeated loxP 
sequences in such a way that after recombination, the sequence between the two loxP sites 
is circularized and excised from the original DNA molecule. This is used to excise a loxP-
flanked genomic rescue fragment for the gene of interest from the genome of a 
corresponding homozygous mutant, thus uncovering the mutation. As the circularized 
fragment is not replicated or regularly distributed during mitosis anymore, essentially all 
daughters of a recombined cell will have the homozygous mutant genotype. The second 
component of the system is the ethanol inducible AlcR-AlcA system that allows the temporal 
induction of Cre, and hence allows the timing of induction of the chimera to be controlled 
(Roslan et al., 2001). In the set-up outlined above, plants will form wild-type organs in the 
absence of ethanol-induction, and only after induction will recombination occur and mutant 
organs will be formed. In the AlcR-AlcA system, the fungal transcription factor AlcR is 
activated only in the presence of ethanol; it then binds to the cis-element AlcA and 
transcribes the gene downstream of AlcA, in my case Cre. Another advantageous property 
of the ethanol inducible system is that it can be induced incompletely. Hence, after a mild 
induction some cells will express Cre, some others will not. The third component is a 
promoter of choice to control the expression of AlcR. These promoters add additional layers   
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Figure 5.2 The system to generate predictable chimeras. See text for description.   
term stands  for  terminator. 
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of control over the recombination including spatial and developmental control (see below). 
Fourthly, a dual-colour fluorescence system is used: Cyan Fluorescent Protein (CFP) and 
Yellow Fluorescent Protein (YFP) label the cells of the opposite genotypes as specified by 
the design of the loxP construct (Figure 5.2). The recombined/mutant sectors will be 
marked with CFP (blue) and the non-recombined/wild-type sectors will be marked with YFP 
(yellow). The net result of these four components is a temporally and spatially controllable 
induction of chimeras, the genotypes of which are tractable using a fluorescent microscope. 
The third component of the system provides flexible controls over recombination. By using a 
different promoter driving AlcR, we can choose when and where chimerism is induced. For 
example, to produce chimerism long before organs initiate, pCLV3::AlcR-AlcA::Cre (from 
now on abbreviated as CLV3>>Cre), which restricts the Cre expression domain to stem 
cells, can be used. CLV3 is specifically expressed in the stem cells and immediate 
daughters of stem cells (Fletcher et al., 1999). To produce chimerism at or after organ 
initiation of petals and sepals, a petal/sepal-specific promoter AP3 or AP1 (Weigel and 
Meyerowitz, 1994).can be used (abbreviated as AP1>>Cre or AP3>>Cre) For the specific 
purposes of this project, two other promoter sources can be used to spatially regulate Cre 
expression. The first is pKLU>>Cre, in which Cre should be expressed only in the peripheral 
cells and not the meristem (Zondlo and Irish, 1999) (pKLU>>Cre), therefore, should give 
rise to mutant rosettes and wild-type inflorescences, which is the reverse effect of 
pCLV3>>Cre. The other promoter is pAtML1, in which Cre should only be expressed in the 
epidermis L1 layer (Sessions et al., 1999). 
5.2.2 How to analyze of growth of different sectors:  
One of the aims I set out to investigate was to analyzethe co-ordination between different 
parts of petals or of leaves (level 5), and for this one needs to compare the size of different 
sectors of an organ. Chimeric organs can have sectors of different sizes, depending on the 
number of precursor cells that had one or the other genotype. This is true even when the 
sectors do not differ in their growth behaviour. How then do we know which sectors to 
compare with one another to be able to learn about the effect of the paps1-1 mutation? To 
answer this, we need to understand how the sectors within individual organs are formed. To 
understand how sectors are formed, we need to consider the process of organ initiation in 
the Arabidopsis shoot meristem, and the concept of organ anlagen and of clonal analysis.  
5.2.2.1 Arabidopsis shoot meristem structure 
An Arabidopsis shoot meristem has three clonally distinct layers, L1, L2 and L3 (Figure 
5.3A). In the L1, cells divide anticlinally to make the entire epidermis.The L2 layer, in which 
cells also divide anticlinally, and L3, in which cells divide in both anti- and periclinally, 
together form internal tissues, including the vasculature. Because of the strictly anticlinal 
divisions, cells in the L1 layer and L2 layer do not mix with each other or mix with cells from 
L3 layers. Therefore, three sets of stem cells are required.     
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Figure 5.3 Arabidopsis meristem structure and the formation of chimeric organs 
A.  Structure of the Arabidopsis shoot meristem. CZ: central zone, PZ: peripheral zone. The 
image is modified from raweb.inria.fr/  
B.  Two ways to form chimeric organs (see text for more details).  
Shoot apical meristem view from the top. Only the L1 layer is illustrated. There are three 
stem cells in the L1. Organ anlagen containing two founder cells in the L1 are illustrated. 
The two possible scenarios to form chimeric organs, stream A and stream B, are shown.  
Stream A: chimeric organs are formed at the boundary of the two sectors that are derived 
from two stem cells; stream B: chimeric organs are formed when the boundary between 
recent stem-cell daughter cells formed after recombination and the older daughters formed 
before recombination is displaced into the organ formation zone. When the meristem grows 
further, only stream A can create chimeric organs.   
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It is estimated that there are about three stem cells in each layer (Steward and Dermen, 
1970). Each stem cell divides slowly and asymmetrically to give rise to two immediate 
daughters of stem cells. Depending on their position within the meristem, the daughters will 
either retain the stem-cell fate and take the mother cell’s place, or they will enter 
differentiation. Ongoing cell division by the centrally located stem cells will push earlier 
stem-cell daughters towards the peripheral zone, where they will be incorporated into organ 
anlagen to make up organs. 
5.2.2.2 Organ anlagen 
The very early organ primordium at the time of its specification is called the organ anlage. 
The cells that make up the organ anlage are referred to as founder cells. Different organs 
have different number of founder cells. Each founder cell in one layer forms a sector in the 
mature organ. Thus, by determining how many “fractions” an organ can be subdivided by 
sectors, one can estimate the number of founder cells as the inverse of this fraction. If for 
example marked sectors can make up either ¼, ½, or ¾ of an organ’s epidermis, the most 
likely number of epidermal founder cells for the organ is four. For this to be valid, however, 
the sectors must originate outside of the organ, so that one can be sure that one captured 
the founder cells at the earliest point when they are committing their fate. 
5.2.2.3 Clonal sectors 
If some of these founder cells are mutant, the resulting sectors in the mature organs will 
also be mutant. Depending on the number and the arrangement of the mutant founder cells 
in the organ anlage, the sector sizes and patterns can vary. The more mutant founder cells 
there are, the larger will be the mutant sector. 
Now, we can answer the question of which sectors need to be compared to assess the 
effect of the paps1-1 mutation. We must compare sectors that are derived from the same 
number of founder cells. Generally, it is not possible to trace back the number of founder 
cells that gave rise to a sector, when its size can be affected by the number of founder cells 
and a potential difference in the growth of cells of the two genotypes (wild-type or paps1-1). 
There are fortunately two exceptions. One case is when the organ anlage has only two 
founder cells in one layer. There can then be only one kind of chimeric organ: it consists of 
only two sectors, each derived from one founder cell. In the other case, the organ anlage 
has more than two founder cells, but there are also two sectors, the boundary of which 
coincides with the midvein. The midvein is assumed to always divide an organ into two 
halves with equal number of founder cells. From the studies (Bossinger and Smyth, 1996), 
the number of founder cells in one layer is estimated to be eight for leaves, eight for sepals, 
eight for gynoecium, four for anthers and two for petals.  
Therefore, to analyze the growth co-ordination between sectors within one organ, I aimed to 
analyze chimeric petals and leaves with the sector boundary running along the midvein. 
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5.2.2.4 How to generate chimeric petals and leaves with a sector boundary along 
the midvein?  
Having considered the structure and the dynamics of the stem cell population and the 
formation of the organ in the meristem, it is inferred that there are two ways to form chimeric 
organs using theCLV3>>Cre system. Firstly, if one uses a mild ethanol treatment, 
sometimes only one of the stem cells recombines. As the stem cells divide, they eventually 
give rise to two distinct clonal populations, one of which contains all mutant cells and the 
other contains all wild-type cells. If at the border of these two populations an organ is 
formed, it will be chimeric. This is the main stream from which chimeric organs arise 
(denoted as stream A in Figure 5.3B). However this is not the only possibility. Another 
way(denoted as stream B) to create a chimeric organ is when the boundary between the 
stem cells daughters that were formed after the focal stem cell underwent recombination 
and the daughters that were formed before comes to lie within the region of organ initiation 
in the meristem periphery, giving rise to a chimeric organ (Figure 5.3.B). Unlike the stream 
A type, which can operate during the life time of the chimeric meristem, the stream B-type 
formation of chimeric organs happens in a very restricted time window. This is because after 
recombination, the organ initiation zone will soon be filled with only the newly made 
descendants of stem cells. In contrast to stream A, stream B can also happen even if all 
three stem cells are recombined i.e. a homogenous stem cell population.  
In the approach presented here I  therefore applied only mild ethanol induction on the 
paps1-1 mutants carrying the CLV3>>Cre and one copy of the loxP::genomic rescue 
PAPS1::loxP (termed floxPAPS1)construct in order to obtain sectored meristems, and as a 
result sectored petals. 
5.3 The results 
In total, 13 F1 plants from a cross of a paps1-1 mutant that is homozygous for the 
CLV3>>Cre transgene and a paps1-1 that is homozygous for the floxPAPS1 transgene 
were induced with ethanol at 7 days after sowing and then analyzed. Figure 5.4 shows a 
typical sectored rosette. Most of the rosette is wild-type, though some younger leaves have 
recombined sectors. These chimeric rosettes later produced several kinds of inflorescences. 
These inflorescences can be classified by two criteria: firstly, whether they are sectored or 
non-sectored and secondly, whether the recombination happens in the epidermis, in the 
internal layers or in all layers. All possible classes of inflorescences are listed in Box 5.1. 
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Figure 5.4 A sectored rosette 
paps1-1 homozygous mutant carrying one copy each of the CLV3>>Cre and the floxPAPS1 
transgenes were induced with ethanol vapour 7 days after germination and imaged 13 days 
later.  Scale bar 0.5 cm.  
A.  Overlay of CFP and YFP fluorescence micrographs. YFP (yellow) signal indicates non-
recombined, i.e. rescued wild-type tissues, CFP (blue) signal indicates recombined, i.e. 
paps1-1 mutant tissues. This is true for all following fluorescence images in this chapter.   
B.  YFP fluorescence micrograph of the marked square in A.  
C.  CFP fluorescence micrograph of the marked square in A 
  
B. YFP C. CFP
A. overlay
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Box 5.1 The nine possible classes of inflorescences that can be observed when using 
the CLV3>>Cre system. 
The border of the square represents the L1 layer, the inside of the square represent the L2 
and L3 layers. Note that for the split inflorescences, the proportion of the two sectors can 
varies from a third to two third of the inflorescences. Chimeras that have the L1 and L2 of 
one genotype, but the L3 of the opposite genotype are possible, but difficult to detect using 
a fluorescence stereomicroscope (see text), so are not considered here. 
  
Class 1. Whole inflorescences are recombined in all layers
Class 2. Whole inflorescences  are non-recombined in all layers
Class 3. Whole inflorescences  are recombined in L1 layer only 
Class 4. Whole inflorescences  are recombined in L2 and L3 layers only
Class 5. Split/Sectored inflorescences in both layers
Class 6. Split/Sectored inflorescences in L1 layer plus the internal layer L2 is wholly non-recombined.
Class 7. Split/Sectored inflorescences in L1 layer plus the internal layer L2 is wholly recombined.
Class 8. Split/Sectored inflorescences in internal layer L2. The L1 layer is wholly non-recombined. 
Class 9. Split/Sectored inflorescences in internal layer L2. The L1 layer is wholly recombined. 
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5.3.1 Level 1 and Level 2: The interaction between two different 
organs in individual plants: leaves and flowers and the 
interaction between petals from different side inflorescences in 
individual plants.  
The analysis of growth co-ordination at the first two levels (level 1: leaves versus flowers, 
and level 2: between flowers from different inflorescences) requires only analysis of non-
sectored inflorescences. Petals were compared from two different kinds of inflorescences, 
as shown in Figure 5.5 (inflorescence 1: fully mutant and inflorescence 2: fully wild-type). 
Most rosette leaves of these plants are wild-type (Figure 5.4). The fully recombined, i.e. 
mutant, petals are 50% larger than the fully non-recombined, i.e. wild-type petals (Figure 
5.6-Level 1 and 2-Whole flower-Both). These results indicate that the petal enlargement 
caused by the paps1-1 mutation does not require the whole rosette to be mutant and is 
neither influenced by, nor does it influence the growth of wild-type organs from a different 
side shoot. Hence, over different inflorescences PAPS1 acts autonomously.  
With regards to the contribution of cell layers, the results indicate that the genotype of the 
epidermis largely determines the growth behaviour of the organ; petals with a mutant 
epidermis were 44% larger than wild-type petals (Figure 5.6-Level 1 and 2-Whole flower-
Epi), while loss of PAPS1 function in the internal tissue did not lead to a significant size 
increase (Figure 5.6-Level 1 and 2-Whole flower-Int). Therefore, across cell layers, the 
paps1-1 effect seems to be non cell-autonomous.  
Levels 3 to 5 require the analysis of sectored inflorescences. 
5.3.2 Level 3: the interaction between petals from different flowers in 
individual inflorescences.  
Only one epidermally sectored inflorescence was obtained in this experiment (Figure 5.7). 
The flowers with a mutant epidermis had 37% bigger petals than the wild-type flowers that 
are derived from this very same sectored inflorescence (Figure 5.6-Level 3-Whole flower-
Epi). The results again support a cell-autonomous effect of the paps1-1 mutation at the level 
of different flowers in one inflorescence; however I did not have data to conclude about the 
effect of a chimera in the internal layer at this level.  
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Figure 5.5 Chimeric inflorescences generated by CLV3>>Cre. 
paps1-1 homozygous mutant carrying one copy each of the CLV3>>Cre and the floxPAPS1 
transgenes were induced with ethanol vapour 7 days after germination and imaged 30 days 
later. Scale bar 5 mm. 
Inflorescence 1:  a non-sectored inflorescence that was recombined in all cell layers. 
Inflorescence 2:  part of the  sectored and fasciated inflorescence that was non-recombined 
in all cell layers.  
Inflorescence 3 : part of the  sectored and fasciated inflorescence that was internally 
recombined, but non-recombined in the L1.  
1
2
3
Over lay CFP
YFP
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Figure 5.6 The paps1-1 mutation act autonomously to promote the growth of petals. 
paps1-1 homozygous mutant carrying one copy each of the CLV3>>Cre and the floxPAPS1 
transgenes were induced with ethanol vapour 7 days after germination and analysed 30 
days later.  Refer to Figure 5.1. for a definition of the five levels. Level 1 to level 4, each data 
point represents the mean ratio ± s.e.m, and the number of petals (n) that were used to 
calculate the mean is indicated by the number beneath. For level 5, each data point 
represents the measurement for one petal; in total only 5 split petals were obtained in this 
experiment.  
Level 1 and 2. Petals were dissected from flowers from different inflorescences. These 
inflorescences were non-sectored and recombined in both layers (Whole flower - Both), in 
the epidermal layer only (Whole flower - Epi) or in internal layers only (Whole flower - Int). 
The size of the petals in each category was normalized to non-recombined petals from other 
inflorescences on the same plants. 
Level 3. Petals were dissected from different flowers from within one inflorescence. This 
inflorescence was sectored. Only epidermal recombination was obtained for this level. Petal 
size was normalized to the non-recombined petals from flowers within that inflorescence.  
Level 4. Petals were dissected from split flowers and normalized to the other petals in the 
same flower. The petals with least mutated tissue were set to be 100%. Refer to Figure 5.8 
and Figure 5.9 (below) and text for the definitions of the split-flower classes.  
  
80
100
120
140
160
180
200
220
Level 1 and 2 . 
Different 
inflorescences
Level 3. Same 
inflorescences
Level 4. Same flowers Level 5. Same petals
Both layer effect Epidermis effect Internal effect
17
39
12
11
2
6
4 9
Ch
an
ge
s i
n 
siz
e 
( %
 c
om
pa
re
d 
to
 W
T 
or
 o
f a
 le
ss
 m
ut
at
ed
 t
iss
ue
)
143 
 
Figure 5.6 The paps1-1 mutation act autonomously to promote the growth of petals 
(continued). 
Level 5. Split petals. Both halves of split petals were measured, and the size of the half with 
least mutant tissue was set to 100%. Refer to Figure 5.10 and Figure 5.11 (below) and text 
for the definitions of the split-petal classes.   
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Figure 5.7 The inflorescence with a sector boundary in the epidermis overlying wild-
type internal tissue. 
paps1-1 homozygous mutant carrying one copy each of the CLV3>>Cre and the floxPAPS1 
transgenes were induced with ethanol vapour 7 days after germination and and imaged 30 
days later. Scale bar 1mm.  
  
Over lay CFP
YFP
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5.3.3 Level 4: the interaction between petals within individual 
flowers.                                                                                                                                         
At level 4 of this analysis, split or sectored flowers can be classified to five classes using two 
criteria. The first criterion is which layer(s) was recombined: L1, L2 or both (the genotype of 
the L3 layer in flowers is difficult to ascertain using only a stereomicroscope, as the L3 only 
contributes a relatively small amount of the final tissue to floral organs; for example, it only 
contributes to the internal tissue in a small region at the base of sepals, and not at all to 
petals). The second criterion is the genotype of the remaining parts of the flowers (wild type 
or mutant). Using these two criteria, all five theoretically possible split flowers are illustrated 
in Figure 5.8 and Figure 5.9. In Class E, no flower was found in this experiment. The size 
comparisons of petals from each class of split flowers are shown in Figure 5.6-Level 4. The 
percentages were calculated as the ratio of the petals with more mutant tissues over the 
petals with the least mutant tissues from the same sectored flower. Clearly, in all classes, 
there is an increase in the size of the petals with more mutant tissue relative to the control 
petals, albeit only a moderate one of about 20% in some of the cases. This is again 
consistent with an autonomous effect of the mutation on growth. Regarding the contribution 
of each layer, loss of PAPS1 function in either the epidermis or the internal tissue of the 
petal led to a comparable increase in petal size (Figure 5.6) 
5.3.4 Level 5: the interaction between different parts of individual 
petals. 
Split petals can also be classified into five classes using the two criteria similar to split 
flowers (i.e., recombination happened in which layer (L1 or L2) and the genotype of the 
remaining parts of the petals) as illustrated in Figure 5.10. Petals have four founder cells, 
two of which form the epidermis and the other two form the internal tissue including the 
vasculature. The size comparisons of these five classes of petals are shown in Figure 5.6-
level 5 and Figure 5.11. Note that for two classes (split in both layers [class A] and split 
internally, but fully mutant in the epidermis [class E] no petals were found in this experiment. 
In total, five split petals were found, all of which, regardless of the particular combination of 
mutant and wild-type tissue, showed increased growth of the petal half with more mutant 
tissue relative to the other half, again supporting a cell-autonomous effect of the paps1-1 
mutation. 
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Figure 5.8 Five different theorically possible classes of split flowers and the four 
classes found in this experiment.   
Class A. Fully split flowers in both layers. Two petals are fully WT and two petals are fully 
mutant. 
Class B. Split in the epidermal layer. Two petals are fully WT and two petals are mutant in 
the epidermis, WT in the internal layer. 
Class C. Split in the internal layer. Two petals are fully WT and two petals are mutant in the 
internal layer, WT in the epidermis. 
Class D. Split in the epidermal layer. Two petals are fully mutant and two petals are mutant 
in the internal layer, WT in the epidermis. 
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Figure 5.8. Five different theorically possible classes of split flowers and the four 
classes found in this experiment (continued).  
Class E. Split in the internal layer. Two petals are  fully mutant and two petals are mutant in 
the epidermis, WT in the internal layer.  
Number in % indicates the increase in size of the petals with more mutated tissues over the 
other petals with less mutated tissued from the same flowers. Values are average ± s.e.m, 
and the number of petals (n) that were used to calculate the mean is indicated. 
 
 
 
  
148 
 
                                CFP            YFP          Overlay 
 
Figure 5.9 Petals from sectored flowers. 
Each panel shows the four petals from a split flower in Figure 5.8. Refer to Figure 5.8  for 
the class definitions. Scale bar 1mm. 
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Figure 5.10 paps1-1 mutation is autonomous within different parts of a petal.   
Eight classes of theoretically possible recombined petals generated by ethanol inducing 
paps1-1 homozygous mutants carrying one copy each of the CLV3>>Cre and the 
floxPAPS1 transgenes are shown. The four squares represent the organ anlage of a petal 
consisting of clonally distinct cells arranged in two rows of two cells each. The two upper 
cells form the epidermis (L1), while the two lower ones form inner tissue (L2). The genotype 
of the inner tissue is recognized in the chimeric petals by the presence of fluorescence 
signal from vasculature.  The number above the squares indicates the number of 
recombined petals found in this experiment for the corresponding class. 
 
Upper pannel : From left to right: WT petals and the three classes of non-split petals: Fully 
recombined in both layers, fully recombined in L1 only, fully recombined in L2  only.  
Below pannel: The five classes of split petals (Class A to E) were illustrated.  
Class A: split in both layers, Class B: split in L1; the other half is fully WT; Class C: split in 
L2, the other half is fully WT; Class D Split in L1, the other half is fully mutant; Class E: split 
in L2, the other half is fully mutant.  
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Figure 5.11 Split petals show asymmetric growth. 
Magnified pictures of petals shown in Figure 5.10. The genotype of the inner tissue is 
recognized in the chimeric petals by the presence of fluorescence signal from vasculature.  
The percentage shown under the pictures is the size of the mutant half normalized to the 
size of the control half with less mutant tissue.  
Scale bar is 1mm.  
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5.3.1 The effect of having paps1-1 and wild-type tissues in the the 
internal layer: the internal chimera induces inflorescences 
meristem to split:  
From the analysis of chimeric plants, out of at least 20 inflorescences observed, no 
inflorescence was found to be split in both layers.  I found one inflorescence that contained 
sectors in the epidermal layer only, while the internal tissue was fully wild-type (Figure 5.7); 
one inflorescence that contained sectors in the epidermis only, while the internal tissue was 
mutant. However, I did not find inflorescences that were split in both layers or were split in 
the internal layer only. All plants analyzed contained internally-sectored stems, which in 
theory should give internally split inflorescences. However, invariably all of these internally 
split stems later fasciated and split into two or more stems (Figure 5.12, Figure 5.13, 
Figure 5.14, Figure 5.15). Some of these derived stems that still contained mutant and 
wild-type tissue internally, split again and again, until eventually the two split stems were 
homogeneous in the internal tissue (either mutant or wild-type).  Therefore, no 
inflorescences with a sector boundary running through the internal tissue or through both 
epidermis and internal tissue were obtained except one inflorescence shown in Figure 5.16. 
This inflorescence produced a flower with a sector boundary in both layers, but the flowers 
that are made later in the fully CFP/mutant sector were wild-type (Figure 5.16 B).This 
suggested that the sector was terminated, possibly because it arose not in the long-term 
stem cells themselves, but in the immediate daughters of stem cells fated to differentiate 
that also express the CLV3>>Cre construct. Taken together, these results suggest that the 
presence of paps1-1 mutant and wild-type tissues in the internal layer of a 
shoot/inflorescence meristem induces the meristem to split in to two or more meristems.  
5.4 Discussion: 
The growth effect of the paps1-1 mutation is cell-autonomous, and a mutant 
epidermis is sufficient to drive excess growth in petals. 
The results showed that the growth effect of the paps1-1 mutation is autonomous at the 
level of different organs within one plant and within one flower, and also at the level of the 
two halves of one petal. When mutant and wild-type tissues were juxt aposed within one 
petal, the mutant half grew larger than the wild-type half. However, within one half of the 
petal, the paps1-1 mutation seemed to act in a non cell-autonomous manner between the 
epidermis and the internal layer. The results here suggest that the epidermis plays a 
dominant role, as a mutant epidermis can promote growth of a wild-type L2 layer 
underneath. This non cell-autonomous effect on growth between layers is  
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Figure 5.12 The fasciated meristem phenotype was caused by chimerism in 
meristems, not by ethanol induction of CLV3>>Cre. 
All plants were treated with ethanol vapour for 1 hour at when 7 days old. Pictures were 
taken at 31 days after induction. Scale bar 1cm.  
Left: paps1-1 mutant carrying only the CLV3>>Cre transgene. Note that no fasciated 
meristems were observed. Right, upper: paps1-1 mutant carrying both CLV3>>Cre and 
floxPAPS1 transgenes. Note some strongly fasciated meristems (arrows). Right, lower: 
another paps1-1 mutant carrying CLV3>>Cre and floxPAPS1 transgenes. Note the mildly 
fasciated meristems (arrows).   
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Figure 5.13 Internal chimerism causes inflorescences to split. 
A.  Magnified fluorescence micrographs of the same plant shown in Figure 5.12 right, upper 
panel. paps1-1 homozygous mutant carrying one copy each of the CLV3>>Cre and the 
floxPAPS1 transgenes were induced with ethanol vapour 7 days after germination.  
Image of a plant taken 13 days after induction.  
B.  The same plant in A imaged at 37 days after induction showing fasciated shoot.  
C. YFP micrograph and YFP/CFP/brightfield overlay of the enlarged section in B showing 
that the internally sectored side shoot was split into two side shoots, one of which is fully 
recombined in both layer.  
D. YFP micrograph and YFP/CFP/brightfield overlay of another section in B showing the 
internal chimerism inducing a split of the inflorescence.   
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Figure 5.14 Another plant with paps1-1 and wild-type sectors showed fasciated 
meristem. 
Magnified image of plant on the right, lower half of Figure 5.12. Arrow points at three 
positions where a meristem was split into two or three new meristems. The numbers 
indicates the splitting positions that are examined with fluorescence microscope as shown in 
Figure 5.15. 
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Figure 5.15 paps1-1 and wild-type chimerism in the internal layers causes meristems 
to split. 
Magnified fluorescence images of plant shown in Figure 5.14. Arrows point at positions 
where a meristem was split into two new meristems. Numbers on the left correspond to 
sections numbered in Figure 5.14.  
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Figure 5.16 An internally sectored inflorescence. 
paps1-1 homozygous mutant carrying one copy each of the CLV3>>Cre and the floxPAPS1 
transgenes were induced with ethanol vapour 7 days after germination and imaged 30 days 
later. YFP, CFP and overlay micrograph of inflorescence (A) and of the flowers (B) 
dissected from the inflorescence in (A). Note the terminated CFP sectors in (A)-arrow. Scale 
bar 1mm. 
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likely to be a general rule in plants because chimera layers with a different growth regulator 
such as BRI1 (BRassinosteroid Insensitive 1) (Savaldi-Goldstein et al., 2007) also follow this 
rule that the epidermis can drive the growth of the whole organ. 
Do the internal layers have any role? The answer is less straightforward. One result 
suggests no contribution of internal tissue. There was no difference inthe size of petals from 
two flowers that were taken from two different inflorescences, with one inflorescence being 
internally recombined, the other inflorescence wild-type (Figure 5.6-Level 1 and 2- whole 
flower-Int). On the other hand, another result suggests a contribution of the internal tissue. 
The internally recombined petals were 20% larger than fully wild-type petals derived from 
the same flowers (Figure 5.6 Level 3-split flower class C). These two results contradict each 
other on the role of paps1-1 mutant internal tissues in promoting petal growth. Supporting a 
role also for the internal tissue, at level of individual split petals (level 5), the data suggest a 
20% increase when the epidermis is mutant, and a 20% increase also when the internal 
tissue is mutant (Figure 5.6 Level 5). At present, the reason for this discrepancy is unclear; 
potentially the analysis of a larger number of chimeric inflorescences could indicate which of 
the two scenarios is supported by the majority of observations and whether there are 
different trends at different levels of analysis.  
The results here also suggest that the presence of paps1-1 mutant and wild-type tissues in 
the internal layer of a shoot/inflorescence meristem induces the meristem to split in to two or 
more meristems. It is important to point out that this effect is unlikely to be the effect of the 
CLV3>>Cre transgene or the effect of ethanol induction. This is because the paps1-1 
mutant plants containing CLV3>>Cre, which were induced together with these chimeric 
plants, did not show this fasciation and split phenotype (Figure 5.12). 
The evidence presented here support the hypothesis that internal chimerism in meristems 
can induce meristems to split. This is a novel finding. The stem cell population must be 
under tight control to maintain a certain size, despite the fact that stem cells do divide. A 
potential cause for this split is an asynchronised cell division between wild-type stem cells 
and paps1-1 mutant stem cells. This would also suggest that the difference in growth 
caused by the paps1-1 mutation acts at a single-cell level and also in stem cells, long before 
organ initiation. It remains an open question why only internal chimerism seems to induce a 
split, while epidermal chimeras form nicely sectored inflorescences without splitting. 
Additional explanation for the meristem splitting can be the conflict of the two parts of the 
chimera.  
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6 Chapter 6. Other genetic 
analysis of PAPS1 
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6.1 Ethanol inducible PAPS1: 
In order to answer when PAPS1 activity is required for organ size regulation, I generated 
plants carrying an ethanol inducible PAPS1 construct (pPAPS1::AlcR-
AlcA::genomicPAPS1) and the negative control (pPAPS1::AlcR-AlcA::YFP) in the paps1-1 
background.  
After a continous ethanol induction (by vapour or irrigation every other day) starting from 
bolting for 20 days, petals were measured on the 12th to 16th flowers (Figure 6.1). The 
experiment results proved that the ethanol inducible system worked and some line of 
pPAPS1::AlcR-AlcA::PAPS1 is able to fully rescue the petal size defect in the paps1-1 while 
none of the negative control is.  
A future experiment is to induce only once and then measure the petals of all the flowers 
which are made after the induction to see which flowers show the most rescued phenotype. 
From that, one can deduce which stage of the flower development is most sensitive to 
PAPS1 activity.  
6.2 cstF64 mutants do not have bigger flowers like paps1-1 
mutants: 
To ask whether the organ size phenotype is caused by a general reduction in 3’ end 
processing activity or by specific reduction of the enzyme poly(A) polymerase 1 activity only, 
the phenotype of cstf64-1 mutants (Liu et al., 2010) is examined. Arabidopsis has only one 
homolog of CstF64, which is a component in the 3’ end processing machinery of 
Arabidopsis. As shown in Figure 6.2, the cstf64-1 mutants have the same petal size as wild-
type. 
These results suggest the petal size phenotype is specific to the polyadenylation defect and 
it is not caused by a defect in cleavage of pre-mRNA or a general reduction in 3’ end 
processing. 
6.3 Genetic interactions between PAPS1 and other known size 
regulators. 
To test whether PAPS1 has genetic interactions with other size regulators, double mutants 
of paps1-1 with other size regulators which affect cell division and/or cell expansion were  
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Figure 6.1 Ethanol inducible PAPS1 constructs rescue paps1-1 phenotype. 
9dT2.X are the independent T2 families of paps1-1 mutants carrying the pSV9d 
(pPAPS1::AlcR-AlcA::genomicPAPS1), the ethanol inducible rescue construct; with X is the 
number of the family. 10bT2.X are the independent T2 families of paps1-1 mutants carrying 
the pSV10b (pPAPS1::AlcR-AlcA::YFPer), the negative control construct; with X is the 
number of the family. All plants were treated with ethanol once every other day (by watering 
plants with 2% Ethanol) immediately after bolting and flowers were taken for measure 20 
days after induction (Flower number 12th-16th).  
 
A.  Inflorescences after 20 days of ethanol induction. Note pSV9dT2.1 inflorescences have 
more flower buds than pSV10bT2.4.  
B.  Petal sizes measured from plants. For 9dT2.X and 10bT2.X, size was averaged amongst 
at least four T2 plants per family. All plants were treated with Ethanol.  
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Figure 6.2 cstf64-1 do not have bigger petals than WT 
Petals of Ler and cstf64 mutant plants were measured. s.e.m, n=20  
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analyzed. Because of the ecotype/background problem, the paps1-1 mutation in Ler were 
crossed directly to klu-2, bb-1, ant7F5 ; and the paps1-1 mutants that had been backcrossed 
to Col-0 three times were crossed to 35S::ARGOS, bpep, an3, jag. More crosses are 
ongoing but at the end of my PhD, the double mutant of paps1-1 and klu, bb, and ant7F5 
were ready for analyzed. As shown in Figure 6.3, paps1-1 is partially additive of klu-2, bb-1 
and ant7F5. The effects of paps1-1 in these double mutant backgrounds are not as strong as 
the effect in the paps1-1 single mutant background. Shown in Figure 6.3, a closer look at 
the petal lengths and petal widths revealed that the effects on petal width of paps1-1 are 
comparable in the double mutants paps1-1 bb-1 (+ 21%) and paps1-1 ant7F5 (+25%)  as to 
in single paps1-1 mutant (+19%). The effects of paps1-1 on petal length however, are much 
reduced in double mutants paps1-1 bb-1 (+ 14%) and paps1-1 ant7F5 (+17%) compared to 
single paps1-1 mutant (+32%). In paps1-1 klu-2 mutant background, the enlargement effect 
of paps1-1 on both petal length (ca. +25%) and petal width (ca. +12%) is reduced compared 
to that effect in single paps1-1 mutant (ca. +32% and +19% respectively). 
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Figure 6.3 Genetic interactions between PAPS1 and other size regulators that affects 
cell divisions: KLUH, BB, ANT. 
s.e.m, n >= 20. 
A.  % Petal area compared to WT ( Ler) , numbers and arrows indicate the increase causes 
by paps1-1 mutation in different background ( i.e. equal to the ratio of value from double 
mutant divided by the value from single mutant klu or bb or ant respectively). 
B.  % Petal length and width compared to WT. The % numbers (above the bars) in Bold  
(red  colour is for changes in petal width, blue colour is for changes in petal length) indicate 
the increase caused by paps1-1 in different background (i.e. equal to the ratio of value from 
double mutant divided by the value from single mutant klu or bb or ant respectively).The %  
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Figure 6.3. Genetic interactions between PAPS1 and other size regulators that affects 
cell divisions: KLUH, BB, ANT (continued). 
numbers (below /in) the bars and in black  colour indicate changes caused by single mutant 
klu or bb or ant respectively i.e. ratio of single mutant divided by WT.  
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7 Chapter 7. Whole genome 
microarray analysis 
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7.1 The design of the microarray: 
To understand the molecular defect in leaves and flowers, I performed whole-genome 
microarray analysis. There are three layers in the design of the microarray (Figure 7.1) 
The first layer is the genotype: wild-type (WT) (Ler) vs. mutant (paps1-1).  
The second is the tissue specificity: inflorescences (FL) or seedlings (LE). As paps1-1 
causes opposite effects on the growth of leaves and petals, we would like to indentify and 
then compare the lists of affected genes in leaves and floral organs. For this purpose, RNA 
was extracted from inflorescences of Ler (WT) and paps1-1 and from whole seedlings 
(including roots) of Ler (WT) at 9 day-old and paps1-1 at 11 day-old. The two different ages 
were chosen because paps1-1 mutant seedlings grow more slowly than Ler. At these ages, 
both seedlings were at a comparable early growth stage as judged by the size and cell 
division patterns of the first two leaves (Figure 7.2A and C). Also, at this age, the meristem 
is still vegetative as judged by the 1600X fold less expression of the APETALA1(AP1) gene, 
a marker for flower identity, in the seedlings compared to inflorescences (Figure 7.2B). 
Plants were grown at 21⁰C so that the phenotype is strong in both leaves and flowers.  
The third layer is the type of RNA used in hybridization: total RNA or RNA that was 
fractionated based on poly(A)-tail length. Total RNA is the standard microarray design using 
poly(A)+ RNA. Array hybridized with total RNA will give us information about the changes in 
the abundance (or steady-state level) of mRNAs. For the fractionated RNA, the idea is to 
identify the direct targets of PAPS1 based on the assumption that direct targets of PAPS1 
should have a shorter poly(A) tail in the paps1-1 mutant compared to WT. RNA was 
fractionated using an adapted protocol from mammalian system (Meijer et al., 2007) which 
results in the separation of total mRNA into two pools: the short poly(A)-tail pool which is 
enriched in mRNAs having a poly(A) tail of less than 50 nucleotides, and the long poly(A)-
tail pool which is enriched for mRNAs having poly(A) tail of longer than 50 nucleotides.  
Figure 7.3 showed that the fractionation was successful. After the fractionation, the long 
fraction and short fraction which comes from the same input RNA were differentially labeled 
(four biological replicates with dye swap) and hybridized to the same array (Figure 7.1). 
With this hybridization, each mRNA will have a ratio, referred to as the long/short ratio, 
which reflects how much of the mRNA is in the long poly(A)-tail form (over 50 A’s) and how 
much is in the short poly(A)-tail form (less than 50 A’s). If this long/short ratio changes 
between WT and mutant, the mRNA changes the poly(A)-tail length and therefore very likely 
to be the direct mRNA target of PAPS1.  
To sum up, the microarray were designed combining three factors: mutant vs. wt, 
inflorescences vs. seedlings and total mRNA vs. fractionated mRNAs in order to determine 
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Figure 7.1 The design of the microarray . 
WT: wild-type; MT: paps1-1 mutant. 
fl: inflorescences; le: 9-11 day-old seedlings. 
21: plant grown at 21⁰C; 16: plant grown at 16⁰C. 
t: total RNA; l: a long fraction (mRNAs with a poly(A) tail longer than 50 nucleotides; s: a 
short fraction ( mRNAs with poly(A) tail shorter than 50 nucleotides) 
The number of horizontal arrows indicates the number of biological replicates.  
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Figure 7.2 The seedlings used for microarray analysis. 
dag is days after germination.  
A.  Pictures of seedlings at the stages used for microarray analysis.  
B.  qPCR showing the expresssion of AP1, a floral-meristem marker, in WT seedlings at 8 
dag (WT8d) and mutant seedlings at 10,12 and 15 dag (mt10d, mt12d, mt15d) , i.e. before 
and after the stages where the samples were harvested for microarray. Expression was 
normalized to PDF2 gene. Inflorescence RNA was used as a positive control for AP1 
expression in the qPCR. 
C.  Cell division patterns revealed by pCycB1;1::CDBGUS reporter constructs at one  or two 
day before and one day after the stages of the seedlings used for microarray.  
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Figure 7.3 Poly(A)-tail length dependent fractionation of mRNA. 
A.  Radiograph showing the poly(A)-tail length patterns of different fractions. 
RNA fractions were end-labelled with 32P cordycepin then  treated with  RNaseT1 and 
RNaseA to degrade all RNAs but the poly(A) tails which are then resolved in 8M urea 10% 
polyacrylamide gel.  Amount used for labelling: I1: 1 μg total RNA; I2:  2 μg total RNA; I3: 
3μg total RNA; S and L: a fifth of the short and long fractions that were precipitated from the 
fractionation of 80μg of total RNA . U: one thirty fifth of the unbound from the fractionation of 
80μg of total RNA . The three biological replicates are:  Sample 1: paps1-1 inflorescences; 
sample 2: paps1-1 seedlings; sample 3: paps1-1 inflorescences. Plants were grown at 
21⁰C. 
B.  Quantitation of the graph in A.  
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 the changes in both steady-state abundance and poly(A)-tail length between WT and 
mutant, and to compare these changes between seedlings and inflorescences.  
At the first attempt for the microarray hybridization, I used inflorescence samples of plants 
grown at 16⁰C. At this temperature, the flowers were still 80% bigger in the mutant 
compared to wild-type plants but the reduction in leaf size is mild. So supposedly there are 
fewer targets affected at this temperature in flowers yet the size regulator ‘X’ is still strongly 
affected. Using 16⁰C therefore increase chances of identifying ‘X’ by reducing the other 
unrelated changes. Since initially we did not use dye swaps and the array results may 
contain many false positives, I do not present the analysis of this array here. Therefore all 
the analysis below is based on plants grown at 21⁰C.  
Regarding the idea to capture the direct PAPS1-sensitive targets that have altered 
polyadenylation by using RNA fractionation method, there are some false negatives that is 
noteworthy. These false negatives are mRNAs that do not change the steady state poly(A) 
tail length but can still be the direct PAPS1-sensitive target. If for these transcripts, the 
altered polyadenylation may result in immediate degradation of the pre-mRNA that have 
shorter poly(A) tails. In such case, although the transcript is a direct target but its steady 
state poly(A) tail length do not change but the abundance of the mRNA may change.  
7.2 Raw microarray results- the lists of genes that change 
abundance and/or tail length in seedlings and/or 
inflorescences:   
7.2.1 Total RNAs.  
Using the cut-off criteria of a corrected p-value <0.05 and a magnitude of the log2-fold 
change (mutant/WT)2 >= 1, 616 differentially expressed genes (413 up-regulated, 203 
down-regulated) between WT inflorescences and mutant inflorescences were identified. In 
seedling samples, more genes were differentially expressed (995 in total: 655 up-regulated 
and 340 down-regulated). After analyzing the overlap between differentially expressed 
genes in the two tissues, the genes similarly mis-regulated in both seedlings and 
inflorescences, the genes mis-regulated in seedlings only and in inflorescences only were 
summarized in Figure 7.4A and listed in supplemented excel files. 
7.2.2 Fractionated RNAs. 
As cut-off criteria, we used a corrected p-value<0.05 and a magnitude of ( log2(Mutant 
long/short ratio ) – log2(WT long/short ratio ) )2>=1, we identified in the seedling samples four genes   
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Figure 7.4 Overlap analysis between mis-regulated genes in seedlings (seedl.) vs. 
inflorescences (inflo.). 
A.  Tail-affected: transcripts that change poly(A)-tail length in paps1-1 compared to wild-
type. The number of genes whose mRNAs have a shorter poly(A) tail is shown in blue, a 
longer poly(A) tail length shown in red.  
B.  Abundance-affected: transcripts whose total abundance changes in paps1-1 compared 
to wild-type. The number of down-regulated genes is shown in blue, of up-regulated genes 
is shown in red.  
C. and D. inverse overlap analysis of A and B respectively, to reveal inversely regulated 
genes in inflorescences vs. seedlings. Note the colour code is reversed in seedling samples 
compared to inflorescence samples.  
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whose mRNAs have longer poly(A) tail and 701 genes whose mRNAs have a shorter 
poly(A)tail in mutant compared to WT tissue. The value for inflorescence samples were 12 
(longer tail) and 256 (shorter tail). After analyzing the overlap between the poly(A)-tail 
affected genes in the two tissues, the genes whose poly(A) tail was similarly changed in 
both seedlings and inflorescences, the genes whose poly(A) tail was changed in seedlings 
only and in inflorescences only were summarized in Figure 7.4B and listed supplemented 
excel files. The abbreviation and nomenclatures of different pools of mis-regulated 
transcripts are summarized in Box 7.1   
 
 
 
Box 7.1. Nomenclatures/Abbreviations for the mis-regulated transcript pools because 
of paps1-1 mutation. 
For simplicity, the mRNAs, identified by the total-RNA arrays, that change abundance 
between paps1-1 and WT, were referred to as abundance-affected mRNAs. The mRNAs, 
identified by fractionated-RNA arrays, that change poly(A)-tail length between paps1-1 
mutant and WT were referred to as tail-affected mRNAs. The seedling sample is 
abbreviated with LE and the inflorescences sample is abbreviated with FL. 
The affected genes that were only mis-regulated in one organ but were unchanged in the 
other organ will be referred to as organ-specific tail-affected gene (OSTAG) and organ-
specific abundance-affected gene (OSAAG). The affected transcript pool that was shared 
between both tissue types, i.e. inflorescences and seedlings, were abbreviated as BOTAG 
(both-organ tail-affected genes) and BOAAG (both-organ abundance-affected gene).  
To show the organ-specific information, the organ name (LE or FL) will be added as prefix of 
these abbreviations. To show the direction of regulation (Up or Down with OSAAG and 
BOAAG; Longer and Shorter with OSTAG and BOTAG), a corresponding suffix will be 
added.  
For example, a full name for a pool FL-OSTAG-shorter indicates the transcripts that have a 
shorter poly(A) tail in the paps1-1 mutant inflorescences compared to WT inflorescences, 
but are unaffected in paps1-1 mutant seedlings.  
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7.2.3 Verifications of the microarray by qPCR and LM-PAT: 
To verify the total RNA microarray, I performed quantitative PCR (qPCR) to check the 
expression of the abundance-affected genes identified by the array. The results are shown 
in Figure 7.5. Eight out of eight genes showed similar behavior in qPCR compared to array. 
For two of them (Figure 7.5B), the fold change determined by qPCR is quite different from 
the one determined by array, however the directions of regulation are similar between qPCR 
and array experiments. The result suggests that the total RNA microarray results are quite 
robust and accurate. 
To verify the fractionated microarray, LM-PAT (Ligation-Mediated Poly(A) tail Test) (Salles 
et al., 1999) should be used but I encountered problems with LM-PAT. Many of the tail-
affected genes that were chosen to be verified were too lowly expressed hence LM-PAT 
failed to amplify the ends of the mRNAs. In some other cases, the PCR gave many products 
with different sizes. The LM-PAT is now being optimized by another PhD student in the 
Lenhard’s lab. Therefore, it must be kept in mind that all the analysis on tail-affected 
transcripts needs further verification independently by PCR based poly(A) tail test.  
7.3  Detail-analysis of the gene lists and discussion 
We want to answer two main questions with these microarray experiments:  
1. How do the mis-regulated genes (with respect to both abundance and tail length 
changes) compare between seedlings and inflorescences taking into account the organ-
specific expression factor (i.e. whether the expression of a gene is organ-specific)? Can this 
explain the opposite phenotypes in leaves and flowers? 
2. Are there any prominent pathways that are changed by the paps1-1 mutation? Can these 
pathways explain the growth phenotypes in leaves and flowers? 
To answer question 1, overlap analysis and 2D-contour map analysis were performed.  
7.3.1 Inflorescences and seedlings have distinct PAPS1-dependent 
transcripts 
First to compare the affected genes in LE vs. FL, overlapping analysis was performed on 
affected genes (both tail and abundance-affected genes) between the two tissues. The 
results revealed that the mis-regulated genes were largely non-overlapping between the two 
tissues (Figure 7.4A and B). Moreover, despite the opposite growth effects on seedlings  
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Figure 7.5 qPCR validations of several abundance-affected genes identified from total 
RNA microarray. 
A.  qPCR were performed using RNA from inflorescences of plants grown at 16⁰C. 
Expression levels are normalized to PDF2 gene.  
B.  Table comparing the qPCR results and the microarray results. * qPCR/array difference is 
calculated by log2(the value in column 2 divided by the value in column 3). Genes for which 
this difference is more than one is bold.  
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and flowers, there were only five abundance-affected mRNAs and no tail-affected mRNAs 
were regulated in opposite directions between seedlings and inflorescences (e.g. lower 
abundance in seedlings but higher abundance in inflorescences due to paps1-1 mutation) 
(Figure 7.4C and D). This suggests that the opposite phenotypes are caused by different 
genetic pathways and not by the inverse regulation of one genetic pathway.  
This overlapping analysis defined the pools of transcripts based on firstly the kind of mis-
regulated (abundance/tail), secondly the tissues affected (LE, FL or both tissues) and thirdly 
direction of regulation (up/down and shorter/longer). For nomenclatures of transcript pools, 
see explanations in Box 7.1 
7.3.2 Distinct PAPS1-dependent transcripts in inflorescences and 
seedlings are not due to the issue of organ specific expression. 
I asked whether a gene only being affected in one organ was due to that gene only being 
expressed in this organ but not the other one. To answer this question, I employed a 2D-
contour map with the total mRNA abundance, i.e. expression level, in FL (horizontal axis) 
and the total mRNA abundance in LE (vertical axis) as the two dimensions (Figure 7.6). The 
map has the resolution of 22x22=484 squares, each of which represents a specific 
combination of the two values in two dimensions. The number of genes falling into each 
square was calculated and then plotted (spectrum heat map) to produce what is called a 
2D-contour map shown in Figure 7.6. If genes are expressed comparably in LE and FL, 
they will lie around the diagonal line of the 2D-contour map, while organ-specific genes will 
lie on either sides of the diagonal line. I use this 2D-contour map to analyze distribution in 
different transcript pools: the entire trancriptome (Bulk); OSAAG and BOAAG (Figure 7.6), 
OSTAG and BOTAG (Figure 7.7). There were some spots that were shifted away from the 
diagonal line (Marked with red arrow in Figure 7.6 and Figure 7.7). Nevertheless, for most 
of transcript pools, the overall distribution of the spots was more or less centered along the 
diagonal line, arguing against organ-specific expression as the main reason for OSAAG and 
OSTAG.  
7.3.3 The reason behind OSTAG?  
The existence of distinct sets of OSTAG in LE and FL attracted my attention, because if one 
assumes that OSTAG are direct targets of PAPS1, this result suggests that organ identity 
changes the specificity PAPS1 to its mRNA substrates. I was therefore interested in what 
makes the LE-OSTAG and FL-OSTAG different from each other in terms of the mRNAs 
properties: tail length and abundance in FL and LE. 
One pattern concerning the mRNA abundance stands out from the 2D-contour analysis. In 
the FL-OSTAG-shorter pools and BOTAG-shorter pools (refer to box 6.1 for nomenclature),   
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Figure 7.6 2D-contour: WT total mRNA abundance in inflorescences (inflo.) vs total 
mRNA abundance in seedlings (seedl.) analyzing abundance-affected transcripts. 
See Box 7.1 for explanation of the different transcript pools used in the analysis. In brief, 
different pools of transcripts (bulk: all mRNAs, abundance-affected transcripts (up/down in 
both tissues, in seedlings only and in inflorescences only) were separated in two 
dimensions: WT total mRNA abundance in inflorescences vs WT total mRNA abundance in 
seedlings. 
WT total mRNA abundance is log2 of WT expression value extracted from microarray data. 
The number of genes that occupy an area in the 2D-map  were spectrum-colour coded. The 
number on the right of each colour in the spectrum indicates a threshold, e.g. (black circle in 
the top left panel: if the area is occupied by more than 12 genes (the threshold), it will be  
  
(FL-OSAAG-up) (BOAAG-up)
(BOAAG-down)(FL-OSAAG-down) (LE-OSAAG-down)
(LE-OSAAG-up)
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Figure 7.6 2D-contour: WT total mRNA abundance in inflorescences (inflo.) vs total 
mRNA abundance in seedlings (seedl.) analyzing abundance-affected transcripts 
(continued). 
shown in red. The red arrow highlight gene clusters that is potentially interesting (see text 
for details) 
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Figure 7.7 2D-contour: WT total mRNA abundance in inflorescences (inflo.) vs. 
seedlings (seedl.) analysing tail-affected transcripts 
See Box 7.1 for detailed explanation of the different transcript pools used in the analysis. In 
brief, different pools of transcripts ( bulk: all mRNAs and tail-affected transcripts (shorter in 
both tissues, in seedlings only and in inflorescences only) were separated in two 
dimensions: WT total mRNA abundance in inflorescences  vs WT total mRNA abundance 
seedlings. 
 
WT total mRNA abundance is log2 of WT expression values extracted from microarray data. 
The number of genes that occupy an area in the 2D-map  were spectrum-colour coded. The 
number on the right of each colour in the spectrum indicate a threshold, e.g. if the area is 
occupied by more than 12 genes (the threshold), it will be shown in red. The red arrows 
highlight a gene cluster that is potentially interesting (see text for details) 
  
  
FL-OSTAG-shorter BOTAG-shorter LE-OSTAG-shorter
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there were very few genes which are highly expressed (Figure 7.7) but in the LE-OSTAG-
shorter, there seemed to be an enrichment of genes that are highly expressed in both 
organs. Therefore, it seems that the FL-OSTAG-shorter and the BOTAG-shorter tend to be 
lowly expressed but many of the LE-OSTAG-shorter do not. Therefore, I speculate that in 
the inflorescences, PAPS1 function is more important for the proper polyadenylation of lowly 
abundant transcripts than the highly abundant transcripts.  
Additionally, I employed more 2D-contour mapping to compare the patterns in the OSTAG 
set of FL and LE in different two-dimension spaces: tail-length in FL vs. tail length in LE and 
tail-length vs. abundance in FL or LE. Firstly, comparing the poly(A)-tail length in FL vs. tail 
length in LE, Figure 7.8 showed that there is a subpopulation of FL-OSTAG-shorter that 
have longer poly(A) tails in FL than in LE. This pattern is not observed for LE-OSTAG-
shorter of BOTAG-shorter, yet it is observed, though to a lesser degree, in bulk RNA (arrow 
Figure 7.8-bulk RNA) suggesting the property of having longer poly(A) tail in FL than in LE 
is specific to FL-OSTAG.  
Finally, 2D-separation by tail length vs. abundance in one tissue type probably discriminate 
FL-OSTAG and LE-OSTAG the best (Figure 7.9 Figure 7.10 Figure 7.11). FL-OSTAG-
shorter set are enriched with lowly-expressed and long tail transcripts, which were also 
enriched in the bulk transcript pools but not in LE-OSTAG. By contrast, the LE-OSTAG set 
is enriched in both lowly-expressed, long-tail transcripts and highly-expressed normal-tail 
transcripts, with the later being more enriched.  
To sum up, tail-affected and abundance-affected transcripts in inflorescences and seedlings 
do not overlap; suggesting that PAPS1-dependent regulation is modified in an organ-
specific manner, despite the organ-nonspecific expression of the affected genes. FL-
OSTAG-shorter tends to have a long tail and be lowly expressed while the LE-OSTAG-
shorten pool is more enriched with mRNAs that are highly expressed and have a medium 
tail length.  
7.3.4 Gene categories analysis linking differential expressed genes 
to cellular pathways:  
Are there any prominent pathways changed by the paps1-1 mutation? Can these pathways 
explain the growth phenotype in leaves and flowers?  This analysis is not completed. But 
here I present the ideas and some preliminary results.  
To find biological pathways that may be enriched in the misregulated genes, I employed 
MASTA (Reina-Pinto et al., 2010), and MAPMAN (Thimm et al., 2004). MASTA is a 
bioinformatic tool to compare a differential-expressed gene (DEG) list of interest with 600 
other DEG lists that are identified from published microarray experiments analyzing various 
conditions/mutants. MAPMAN is another bioinformatic program, where genes that are   
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Figure 7.8 2D-contour: WT poly(A)-tail length in inflorescences (inflo.) vs WT poly(A)-
tail length in seedlings (seedl.) analysing tail-affected transcripts.   
See Box 7.1 for detailed explanation of the different transcript pools used in the analysis. In 
brief, different pools of transcripts ( bulk: all mRNAs and tail-affected transcripts (shorter in 
both tissues, in seedlings only and in inflorescences only) were separated in two 
dimensions: the WT poly(A)-tail length in inflo. and seedl.  
 
WT poly(A)-tail length is log2 of the WT long tail/short tail ratio as determined from the 
fractionated microarray. Positive value indicate relatively long poly(A) tails.The number of 
genes that occupy an area in the 2D-map  were spectrum-colour coded. The number on the 
right of each colour in the spectrum indicate a threshold, e.g. if the area is occupied by more 
than 6 genes (the threshold), it will be shown in red. 
The red arrow highlights gene clusters that are potentially interesting (see text for details) 
 
FL-OSTAG-shorter BOTAG-shorter LE-OSTAG-shorter
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Figure 7.9 2D-contour: WT tail length in inflorescences (inflo.) vs WT total mRNA 
abundance in inflo. analysing tail-affected transcripts.   
See Box 7.1 for detailed explanation of the different transcript pools used in the analysis. In 
brief, different pools of transcripts ( bulk: all mRNAs and tail-affected transcripts (shorter in 
inflorescences only and in both tissues) were separated in two dimensions: the WT poly(A)-
tail length in inflo. and the WT total mRNA abundance in inflorescences.  
 
WT poly(A)-tail length is log2 of the WT long tail/short tail ratio as determined from the 
fractionated microarray. Positive value indicate relatively long poly(A) tails. WT total mRNA 
abundance is log2 of WT expression values extracted from microarray data. The number of 
genes that occupy an area in the 2D-map was spectrum-colour coded. The number on the 
right of each colour in the spectrum indicate a threshold, e.g. if the area is occupied by more 
than 4 genes (the threshold), it will be shown in red. 
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Figure 7.10 2D-contour: WT tail length in seedlings (seedl.) vs WT total mRNA 
abundance in seedlings analysing tail-affected transcripts.   
See Box 7.1for detailed explanation of the different transcript pools used in the analysis. In 
brief, different pools of transcripts ( bulk: all mRNAs and tail-affected transcripts (shorter in 
seedlings only and in both tissues) were separated in two dimensions: the WT poly(A)-tail 
length in seedlings and the WT total mRNA abundance in seedlings. 
 
WT poly(A)-tail length is log2 of the WT long tail/short tail ratio as determined from the 
fractionated microarray. Positive value indicate relatively long poly(A) tails. WT total mRNA 
abundance is log2 of WT expression values extracted from microarray data. The number of 
genes that occupy an area in the 2D-map was spectrum-colour coded. The number on the 
right of each colour in the spectrum indicate a threshold, e.g. if the area is occupied by more 
than 4 genes (the threshold), it will be shown in red. 
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183 
 
 
Figure 7.11 2D-map non-contour : separation of genes with tail length vs abundance 
in seedlings and inflorescences.  
Similar to Figure 7.9 and Figure 7.10 but here the density in each area is not considered, 
and the different pools of transcripts were overlappingly drawn on top of each other. Red 
crosses represent bulk mRNA. Black crosses represent tail-affected transcripts in 
inflorescences (left) or seedlings (right). See Box 7.1 for detailed explanation about pools of 
transcripts.  
WT poly(A)-tail length is log2 of the WT long tail/short tail ratio as determined from the 
fractionated microarray. Positive value indicate relatively long poly(A) tails. WT total mRNA 
abundance is log2 of WT expression values extracted from microarray data.  
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known/predicted to be involved in one biological pathway are grouped together, which helps 
answer whether a DEG is enriched for a particular biological pathway.  
Combining both of these programs, we found that the LE-OAASG is enriched with pathogen 
related genes while FL-OAASG is not (genes lists attached as an electronic 
supplementation file). In paps1-1 seedlings, a pathogen response seemed to be ectopically 
elicited. By contrast, in paps1-1 inflorescences, this is not the case. This suggests PAPS1 in 
seedlings resembles a negative regulator of pathogen response. 
7.3.5 Other interesting observations from microarray analysis 
There was strikingly not much correlation between tail length changes and 
abundance changes. 
Overlap analysis between tail-affected transcripts and abundance-affected transcripts 
showed that poly(A)-tail length changes seldom correlate with mRNA abundance changes 
(Figure 7.12) This is striking, because it was well believed that poly(A) tail length is 
important for mRNA stability. The result also suggests that the changes in poly(A)-tail length 
by paps1-1 mutants could leads to the instability of some mRNAs but not the others. 
Furthermore, looking at the extent of tail changes revealed that the distributions of the LFC 
tail changes (Figure 7.13) are similar between the two pools: (the tail-affected but 
abundance-unaffected mRNAs) vs. (the tail-affected but abundance-downregulated 
mRNAs). This suggests the degree of tail change cannot be the reason for whether a tail-
affected mRNAs is unstable or not. It remains to be answered how the poly(A)-tail length 
changes in paps1-1 plants result in different effects on the mRNA stability.  
It is also an open question what the consequences of the tail-affected, but abundance-
unaffected type of misregulation are for the target mRNAs? Does this type of mis-regulation 
affect translational effiency or whether does it not have any consequences to the regulation 
of the mRNAs? 
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Figure 7.12 Overlap analysis between tail-affected and abundance-affected gene lists 
in each tissue type. 
A and C: inflorescences; B and D: seedlings. A and B normal overlap analysis; C and D 
inverse overlap-analysis (note that the colour label is reversed compared to A and B for the 
tail-affected genes).   
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Figure 7.13 The degree of poly(A)-tail shortening in shorter-tail transcripts that were 
down regulated and transcripts that were unchanged in expression level because of 
the paps1-1 mutation. 
The degree of poly(A)-tail shortening is represented by ( log2(Mutant long/short ratio ) – log2(WT 
long/short ratio ) ).  Left: transcripts that have shortened poly(A) tails and are down regulated in 
mutant seedlings (LE.) compared to WT seedlings (correspond to the 53 genes in Figure 
7.12.) Right: transcripts that have shortened poly(A) tails but have the expression level 
unchanged in the mutant seedlings compared to WT seedlings (correspond to 648 genes in 
Figure 7.12B excluding the 85 genes in Figure 7.12D )  .  
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8 Chapter 8. General discussion 
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8.1 Summary 
Here I have characterized a mutant that affects sizes of flowers and leaves in opposite 
directions: i.e., smaller leaves but bigger flowers than wild-type. 
Phenotypically, I showed that the opposite phenotypes are dependent on organ identity 
rather than organ position. I measured and compared the growth parameters of leaves and 
petals between mutants and wild-type showing that: i) Mutant leaves are smaller mainly due 
to reduced cell expansion ii) Mutant petals are larger due to both increased cell proliferation, 
whose spatial patterns remain unchanged, and increased cell expansion. iii) Mutant petals 
are larger because the growth period is prolonged while the growth rate is unchanged.   
Molecularly, I identified the causal gene that is At1g17980, a gene encodes for PAPS1 
protein , one of the four canonical poly(A) polymerases (PAPSs) in Arabidopsis thaliana. I 
isolated and characterized the mutants in the other three PAPS1-orthologs in Arabidopsis 
showing that i) The single null mutants of the other PAPS orthologs: PAPS2 and PAPS4 do 
not have a phenotype. ii) The paps2 paps4 double mutants are late flowering, but otherwise 
morphologically normal; especially, the sizes of paps2 paps4 petals and leaves are 
comparable to wild-type (WT). ii) Mutants in the third ortholog of PAPS1, i.e., paps3 
mutants,  displayed a pleiotropic phenotype, i.e paps3 plants are very small and sterile. 
Different paps1 alleles, which differ in the abundance and integrity of the PAPS1 transcripts 
have different phenotypes: paps1-1 and paps1-4 similarly have smaller leaves and bigger 
flowers than WT, whereas paps1-2 have smaller leaves, but deformed and smaller petals 
than WT. One other allele, paps1-3, is most likely gametophytic lethal.  
By transgenic experiments, I showed that a chimeric PAPS created by replacing the N-
terminal domain of PAPS1 with the N-terminal domain of PAPS4 (the 
pPAPS1::gNPAPS4::gCPAPS1) can fully rescue the size phenotypes in both leaves and 
flowers of the paps1-1 mutant. By contrast, promoter swapping alone (pPAPS1::gPAPS4) 
does not rescue paps1-1 mutant, suggesting that the differences in the C-terminal domain 
makes different PAPSs functional non-redundant. 
In vitro, the mutated protein PAPS1P313S (encoded by the paps1-1 allele) has almost no 
activity while the wild-type protein has polyadenylation activity. In vivo, however, the bulk 
poly(A) tail change is very subtle between paps1-1 mutant and WT.  
Using an mRNA fractionation coupled with microarray, I have defined a set of mRNAs 
whose poly(A)‐tails and stability are changed in the mutant compared to wild type. 
Independently by qPCR analysis, I could verified the abundance-affected transcripts 
identified in microarray experiments. Subsequent bioinformatic analysis suggests compared 
to WT,  in paps1-1 mutant seedlings but not paps1-1 mutant inflorescences, ectopic 
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pathogen responses are elicited. The tail-affected transcripts identified by fractionation 
microarray, however, remains to be verified by LM-PAT test.  
Based on the results suggested by the microarray, it seems that the affected transcripts 
composed of only small proportions of the transcriptome; and there is probably not much 
correlation between tail-length changes and abundance changes. Furthermore, seedlings 
and inflorescences seemed to have distinct pools of abundance-affected transcripts and 
perhaps also of tail-affected transcripts.  
By genetic analysis, I showed that mutants in the CstF64, a component of the 3’ end 
processing complex, do not share phenotype with paps1-1. PAPS1 seems to be additive, 
albeit not completely, to other size regulators bb, klu and ant mutants.   
Using a system to generate predictable paps1-1 chimerism, I showed that the effect of 
paps1-1 in petal growth is cell-autonomous within individual petals, but non cell-autonomous 
across the epidermis and internal (L2) layer in petals. Additionally, I showed that the paps1-
1 chimerism in the internal layer of a meristem caused the meristem to split.  
Taken together, this study uncover an potentially additional layer of gene regulation: a 
transcript-specific synthesis-dependent regulation of poly(A) tail length by different canonical 
PAP isoforms. Some transcripts that are more sensitive to the defect in this regulation can 
serve as size regulators.  
8.2 Opposite size regulations in leaves and flowers are caused 
by different, potentially novel pathways. 
The opposite phenotypes in leaves and flowers of paps1-1 mutants can be caused by the 
opposite regulation of the same size regulator or by affecting two independent size 
regulators. The results here support the later scenario. The results of microarray analysis, 
performed using total RNA, revealed that very few genes were oppositely regulated in the 
two organs  (i.e. upregulated in seedlings but downregulated in inflorescences and vice 
versa). Moreover, microarray analysis also showed that all the known size regulators are not 
misregulated in the paps1-1 mutant. Genetic interactions showed that the petal enlargement 
is largely additive to BB, KLUH and ANT. Therefore, the affected size regulating pathways in 
leaves and flowers are probably distinct and potentially novel.  
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8.3 What could be the reason for the identity dependent effect of 
paps1-1 mutation?  
Organ identity (leaf vs. flowers) influence the the effects of paps1-1 mutation and causes 
several differences found in these two organs: i) phenotypically: size; ii) molecularly: 
mRNAs that are sensitive to polyadenylation defects.  
8.3.1 Organ identity dependent size regulation in paps1-1 mutants:  
paps1-1 mutation promotes petal growth but suppresses leaf growth. Upregulated genes in 
the mutant seedlings are enriched for defense-related genes, whose abundance remains 
largely unchanged in the mutant inflorescences. It is well known that when a pathogen 
response is elicited, growth is inhibited (Chinchilla et al., 2007).  
Therefore, the data suggest that paps1-1 leaves are smaller because of the upregulation of 
pathogen-defense related genes. By contrast, in petals, the defense pathway is not 
upregulated, probably allowing petals to respond to some yet unknown hypothetical size 
regulator  ‘X’, which might be misregulated in petals due to the paps1-1 mutation.  
A remaining question is whether wild-type inflorescences also innately do not response to 
pathogen attack or only paps1-1 inflorescences do not mount an ectopic pathogen attack 
like the leaves. The future experiments are : i) to suppress pathogen response in paps1-1 
seedlings by combining paps1-1 with some main pathogen-reponse mutants (e.g., pr1, 
npr1, sid2-1, 35S::NahG etc. ) and see whether this rescues the leaf-size defect;  ii) to 
clarify how well the WT inflorescences and mutant inflorescences respond to pathogen 
attack.  
Recently, (Winter et al., 2011) showed that when the plants enter reproductive phase, 
LEAFY is expressed and down-regulate genes that are involved in pathogen-reponse. 
Hence it seems likely that inflorescences of WT innately have a low response to pathogen 
attack. 
8.3.2 Organ identity dependent regulation of the sensitivity of pre-
mRNAs to the paps1-1 defect: 
Microarray analysis clearly showed that the pools of abundance-affected (and potentially 
also tail-affected ) transcripts are largely non-overlapped between the two organs. More 
importantly this specificity is not the results of these genes being expressed in only one 
organ but not the other. It is also because PAPS1 is expressed restrictly in one organ, 
either. Hence, organ identity must influence the sensitivity of some transcripts to paps1-1 
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defect. One potential explanation is that organ identity determines the preference of some 
mRNAs to be processed by one PAPS complex or the other complexes, hence making 
some mRNAs more sensitive to PAPS1 defects than the other mRNAs. See further 
discussion on section 8.4 
8.4 Why are some transcripts more sensitive to paps1-1 defect  
than others?  
Microarray analysis on mRNAs fractionated according to their poly(A)-tail length suggested 
that there is a subclass of mRNAs (ca. 1000 transcripts) that are more sensitive to 
polyadenylation defect.  
 A plausible explanation for this sensitivity is that the different PAPSs that exist in plants 
may have different substrate specificity or different kinetics. In the first scenario, PAPS1-
sensitive transcripts would be preferentially polyadenylated by PAPS1. This is surprising 
because PAPS has no substrate specificity in vitro on its own. Additionally, polyadenylation 
happens after the cleavage of pre-mRNA so CPSF should be the one which interacts with 
pre-mRNA first and therefore is more likely to determine the substract specificity of the 
3’end formation reaction. So probably PAPS1 has substrate specificity by inheriting the 
substrate specificity of the protein complex it is in.  
By contrast, in the second scenario there need not be substrate specificity; instead, all 
mRNAs are processed by all PAPS complexes, yet sensitivity would apply only to a 
subclass of transcripts that somehow require a particularly high polyadenylation activity. 
Results in chapter 7 showed that tail-affected mRNAs in inflorescences are enriched for 
ones with long poly(A) tails but low expression levels. So, one possibility is that these 
mRNAs are unstable, they undergo rapid transcription and degradation, hence they requires 
more polyadenylation than the others; at the same time PAPS1 is perhaps the most active 
PAPS. This possibility is consistent with the result that paps2 and paps4 single and even 
paps2 paps4 double mutants showed only a very mild phenotype.  
The two scenarios have a fundamental difference: one strongly implies there is a substrate 
preference, the other does not. Experiments to distinguish these two hypotheses require 
changing PAPS enzyme kinetics without affecting substrate specificity. One experiment 
could be to overexpress PAPS1 in paps2 paps4 double mutants, and vice versa, to 
overexpress PAPS2 or PAPS4 in paps1-1 mutants to see if there is any rescue 
phenotypically (organ size in case of paps1-1 and flowering time in case of paps2 paps4) 
and molecularly (A-tail change). Other experiments to prove substrate preference can be to 
show that PAPS1-sensitive mRNAs associated more strongly with PAPS1 complexes than 
other PAPS complexes by RNA immunoprecipitation using PAPS antibody. A third 
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experiment is to identify transcripts that are PAPS2 and PAPS4 sensitive and check 
whether they overlap with PAPS1 sensitive transcripts. For example, if the most highly 
PAPS1-sensitive transcripts are also affected in paps2 paps4 double mutant, albeit to a 
lesser degree, this would suggest that the sensitivity depends on how high the overall 
requirement for polyadenylation (by all PAPS) is for that transcript rather than the substrate 
specificity.  
Future experiments to futher characterise PAPS1-sensitive transcripts are, for example,  to 
determine if there are any cis-elements, likely in the  3’ UTR of the tail-affected transcripts, 
that encodes for the sensitivity to PAPS1 using ethanol an inducible GUS/YFP-3’UTR  
reporter gene system.  
8.5 The functional specialization amongst PAPSs  
The fact that mutations in different PAPS genes have different phenotypes suggests that 
they have specific functions. At the protein level, I showed that the C-terminal domain is the 
specificity determinant between PAPS1 and PAPS4 proteins. A  possible explanation is that 
by modifications/protein interaction at the CTD, plants can change the activity of PAPS or 
the recruiment of PAPS to hypothetical different PAPS complexes in plants thereby making 
PAPSs functionally different.  
Literature have evidence to support this hypothesis. Manzano et al., 2009 pulled down FY, a 
componenent of the 3’end complex, complexes (using FY-C terminal TAP tag construct) 
and reported two distinct complexes at different sizes (Manzano et al., 2009).C-terminal 
domain of mammalian PAPOLA can be sumoylated or acetylated (Vethantham et al., 2008) 
(Shimazu et al., 2007). (see also section1.3.2.4)  
The next experiments are to find the interactors of the C-terminal domain by yeast two 
hybrid or in planta pull-down using antibody against C-terminal domain. 
8.6 An additional layer of gene regulations: PAPS-dependent 
transcript-specific de novo regulation of poly(A) tail length. 
It is a widely accepted view that canonical PAPs are non-specific and add a poly(A) tail of 
the same length to every pre-mRNA (see section 1.4.1.1). The results here suggest that 
different plant canonical PAPSs are functionally distinct and perhaps by using different 
PAPSs,  the de novo poly(A) tail synthesis are different for each transcript. 
Moreover, in silico results suggest that PAPS1 expression is specifically induced by 
pathogen attack; loss of PAPS1 function causes upregulation of pathogen-related genes in 
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seedlings. Together, these results strongly suggest that plants actively use PAPS1 as a 
break to prevent plants from overreacting to a pathogen, as an unchecked defense 
response  will result in serve growth retardation. The expression of PAPS2 and PAPS4, by 
contrast, are up-regulated during anoxia treatment. It is therefore tempting to hypothesize 
that for a certain stimulus, plants can respond not only by transcriptional changes, but also 
by altering the poly(A)-tail length patterns of specific transcripts, which consequently 
changes the post-transcriptional regulation of the mRNA. Given that different PAPSs are 
known to be also regulated post post-transcriptionally by alternative splicing and protein 
modifications at the C-terminal domain, the potential to modify PAPS activity in response to 
stimuli will be diverse.  
The findings here that different mRNAs respond differently to polyadenylation defects opens 
up  questions about how poly(A)-tail length patterns can be used for the regulation of genes, 
and why for some stimuli/some genes, the regulation at the poly(A)-tail level seems to  
employed. One scenario I imagine is that by choosing different poly(A) sites, plants can 
employ different PAPS complex which will give the pre-mRNA a different poly(A)-tail length. 
More than half of plant genes have more than one poly(A) sites, whose biological functions 
are largely unknown. Especially for those alternative poly(A) sites that are only 15-30 base 
pairs apart and do not have any binding sites for miRNAs in between, it is difficult to imagine 
what their functions could be. Much research on alternative polyadenylation (APA) using 
next-generation sequencing only focuses on the sequence of the APA, but none of the 
studies checked the poly(A)-tail length of these spliced forms. It is possible that in some 
cases, the sequences of the 3’ UTR are not important;  the important point may be that by 
choosing a different poly(A) site, the mRNA will have a different poly(A)-tail length pattern. 
Because the APA can be as small as 10 nucleotides apart, which can be very difficult to 
detect, this kind of regulation will be very likely missed out in conventional poly(A) tail tests, 
unless the 3’ ends are subcloned and sequenced. Finally, one question that  will be 
interesting to address is that how does this potential novel mode of gene regulation via 
poly(A)-tail intergrated with the promoter-driven transcriptional regulation. For example, for 
the PAPS1-dependent transcripts that change both their tail length and abundance, can we 
find any biological conditions where the abundance change is not coupled with the poly(A)-
tail change ?  
In sum, the most interesting questions to address in the future is why some transcripts are 
sensitive to polyadenylation defects and others not, and how different patterns of poly(A)-tail 
lengths can contribute to gene regulation.  
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8.7 Relationship between Poly(A) polymerases and Deadenylase 
CCR4. 
There are three enzyme complexes that specifically degrade/shortens poly(A) tails: PAN, 
CCR4 and PARN. Interestingly, the ccr4 mutant in Arabidopsis is also more sensitive to 
pathogen. PR1 expression is downregulated and its mRNA has a shorten poly(A) tail in ccr4 
compared to WT(Liang et al., 2009). PR1 is upregulated in paps1-1 mutant. These two 
results suggests that the PR1 pre-mRNA may have their poly(A) tail length tightly regulated 
by PAPS1 and CCR4.  
8.8 The cell-autonomous effect of paps1-1 mutation in petal 
enlargement 
So far the autonomy/non-autonomy has been studied with several size regulators: KLUH 
(non cell-autonomous)(Eriksson et al., 2010); AN3 (cell non-autonomous)(Kawade et al., 
2010); BRI1 (non cell-autonomous) (Savaldi-Goldstein et al., 2007);. The autonomous 
activity of PAPS1 suggests that the synchronised growth of different parts within an organ 
can be overridden. 
8.9 paps1-1 chimerism in the internal layer of a meristem 
induces the meristem to split.  
The results in chapter 5 suggest that the presence of paps1-1 mutant and wild-type tissues 
in the internal layer of a shoot/inflorescence meristem induces the meristem to split into two 
or more meristems. Two questions arise from these results. 
Firstly, why do only the meristems that are chimeric for the paps1-1 mutant, but not the fully 
paps1-1 mutant meristems, split? One potential cause is that the paps1-1 stem cells divide 
asynchronously compared with the neighbouring wild-type stem cells; this might cause the 
meristem to split.  
The stem cell population must be under tight control to maintain a certain size, despite the 
fact that stem cells do divide. To maintain a constant number of stem cells, when the stem 
cells divide in wild-type plants, on average one of the daughters of stem cells must lose its 
fate, supposedly because it is displaced out of the location where stem cells can receive the 
WUS-mediated stem-cell inducing signal. In the paps1-1 chimeric meristem, either both of 
the stem-cell daughters may maintain their stem-cell identity thus leading to fasciation,  or 
somehow the stem-cell neighbouring cells ectopically acquire a stem cell fate. This 
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possibility would also suggest that the difference in growth caused by the paps1-1 mutation 
acts at a single-cell level and also in stem cells, that is long before organ initiation. It is not 
yet known whether in WT all stem cells divide synchronously or not (live image can only 
track the stem cells in the epidermis (Reddy et al., 2004) but the study did not investigate 
this question). One other potential cause for the meristem split is that the paps1-1 mutation 
may cause a reduction CLV signalling (in fact, total RNA microarray indicates that CLV2 
expression is reduced mildly (1.5 fold) in paps1-1 mutant compared to wild-type). If all the 
stem cells have reduced activity of CLV, there may be no problem, but if stem cells have 
unequal CLV signaling amongst their population, the meristem might split. To test these two 
hypotheses, plants with chimeric meristem for CLV3/CLV2 and also chimeric for different 
size regulators like DA1 or ANT should be tested to see whether this can also cause 
meristem spliting. It will also be useful to do in situ hybridization with probes against CLV3 
and WUS in the split meristems.  
Secondly, why do only the internal paps1-1 chimeras but not the external paps1-1 chimera 
induce the meristem splitting? Does this internal-layer-chimerism inducing split suggest a 
more important/direct role of the internal tissue in stem cell homeostasis?  
8.10 Using the meristem splitting to increase crop yield 
This way of using chimerism in the meristem to induce a meristem to split may have a 
potential to change the architecture of the plant for agriculture purposes. Inflorescence 
meristem splitting increases the number of inflorescences without the need of making new 
axillary leaves.  Hence, one can increase the harvest index (ratio of harvestable material 
over total mass).  
8.11 The modifier screen on mutagenized paps1-4 mutant and the 
quest for the novel size regulator in flowers. 
The trans-heterozygous paps1-4/paps1-2 has bigger flowers than paps1-4 mutants 
suggesting that the misregulation of the flower size can be enhanced beyond the level seen 
in paps1-4. One hypothesis is that in paps1-4 flowers, there are size repressor(s) ‘X’ that 
are downregulated partially; if so ‘X’ null mutants would make even bigger flowers in a 
paps1-4 background. Therefore, I mutagenized paps1-4 by EMS and screen the M2 
population for modifiers of petal size. At the same time, this screen can also identify 
modifiers that act together with PAPS1 to regulate the polyadenylation of pre-mRNAs. We 
identified a number of mutants that have bigger flowers than paps1-4 and one mutant with 
deformed flowers, which resembles paps1-2. Future experiments involve crossing these 
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mutant out to WT to test whether the mutated genes have a genetic interaction with PAPS1, 
in which case they will be studied further. This will be recognized by comparing the novel 
single mutant to the double mutant with paps1-4 and looking for more or less than additive 
effects in the double mutant. 
8.12 Hypothesis to explain the opposite size-regulation in petals 
of different paps1 alleles and opposite phenotype between 
leaves and flowers: 
The hypothesis is based on four observations stemmed from the analysis of different paps1 
alleles and of paps1-1 at increasing temperature: i) paps1-1 phenotype changes from bigger 
flowers at 23⁰C to smaller/deformed petals at 28⁰C. ii) paps1-2, homozygous of which gives 
small/deformed petals but trans-heterozyogus of which with paps1-4 gives bigger petals 
(even bigger than paps1-4 homozygous mutant). iii) Leaves of paps1-1, in contrast to WT 
leaves’ behavior at high temperature, showed a dramatic reduction in size in response to 
high temperature. iv) paps1-3, the most likely null paps1 allele, is probably gametophytic 
lethal.  
These four observations allow us to make three assumptions: i) The remaining PAPS 
activity in different mutant alleles is ranked in this descending order: (Figure 8.1): WT 
(100%), paps1-4, paps1-1 at 23⁰C, paps1-1 at 28⁰C or paps1-2, paps1-3 (0%); ii) There are 
two classes of mRNAs with different sensitivities to PAPS1 defect. One class is highly 
sensitive to PAPS1 defect. A reduction in PAPS1 at paps1-1 level is able to cause them to 
be mis-polyadenylated or mis-regulated. The other class is less sensitive such that at the 
PAPS1 reduction level in paps1-1 mutants, they are not affected; they are only mis-
regulated after PAPS1 activity is further reduced. This assumption is supported by the 
microarray data showing that there are 1% of the transcriptome are highly sensitive to 
paps1-1 defect; iii) There are  negative size regulator(s) X, which belongs to the highly 
sensitive class, and gets down-regulated by the paps1-1 defect. There are positive 
regulator(s) Y (or genes that are essential for growth) which belongs to the less sensitive 
class and are not affected/or only mildly affected by paps1-1 defect.  
With these three assumptions, we can explain why some paps1 alleles cause big flowers 
and some cause small flowers. For example, in paps1-2, the remaining PAPS1 activity is 
below the limit for the less sensitive classes, hence many genes that are essential for 
growth (genes Y) are affected. This in turns causes growth depression and smaller/deforms 
petals. Although in paps1-2, target X is also mis-regulated but its growth-promoting effect is 
masked by the mis-regulations of Ys. This epitasis effect is lifted in the trans-heterozygous 
of paps1-2/paps1-4. In this genetic background, or in the paps1-1 mutants, the remaining 
PAPS1 activity is at the level such that Y mRNAs become un-affected while X mRNAs are 
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more mis-regulated than in paps1-4 mutants. The final out come is that paps1-2/paps1-4 
trans-heterozygous plants form normally-shaped petals which are larger than paps1-4 
homozygous petals.  
This hypothesis could also be used to explain why leaves are smaller in all paps1 alleles as 
a second hypothesis in parallele with, and not mutually exclusive with the hypothesis in 
section 8.3.1. Perhaps, the sensitivity of both classes of transcript increases in leaves 
compared to petals because somehow in leaves PAPS1 is the more important PAPS. This 
results in the growth depression in leaves of all paps1 alleles.  
The hypothesis predicts for many of the PAPS1-dependent transcripts, the degree of mis-
regulation is ranked such as the strongest mis-regulation is with paps1-2 and mildest effect 
is with paps1-4.  We have some preliminary qPCR data on expression level of several 
PAPS1-dependent transcripts in WT and different paps1 mutant alleles that supports this 
hypothesis. 
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Figure 8.1 Hypothesis to explain for the differences in flower phenotypes of paps1 alleles   
Poly A polymerase 1  activity remaining 100% 0%
Highly sensitive mRNA (including growth repressors) 
Less-sensitive mRNA (including factors essential for growth) 
WT paps1-4 paps1-1 (23⁰C) paps1-2 paps1-3
Highly sensitive mRNA (including growth repressors) 
Less-sensitive mRNA (including factors essential for growth) 
FLOWERS
LEAVES: 
PAPS1 is the 
main PAPS
Bigger leaves  and flowers are either: bigger if repressor X is still sensitive  or normal if X is not that sensitive 
paps1-4 paps1-1 (23⁰C) paps1-1 (28⁰C)
PAPS1 Other PAPS 
PAPS1 Other PAPS 
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9 Chapter 9. Materials and 
methods 
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9.1 Materials 
9.1.1 Plant materials 
The Landsberg erecta (Ler) background was used as wild-type background for experiments 
involving mutants that are also in Ler background including paps1-1, paps3-1 (T-DNA line 
GT_5_7040), klu-2, bb-1, ant7F5, cstF64-1. Ler is a derivative of the Landsberg (La-0) 
accession that is mutated at the ERECTA locus (Redei, 1962).  The bb-1 (bb) and klu-2 
background alleles used in this study are described in Disch et al. (2006) and Anastasiou et 
al. (2007). The ant72F5 mutant was kindly provided by Kai Schneitz (University of Zürich, 
Switzerland). This allele displays a very strong ovule phenotype similar to the putative null 
allele ant-1 (Klucher et al., 1996). 
T-DNA insertion lines or T-DNA lines were obtained from NASC. Other mutants including 
paps1-2 (T-DNA line SAIL_172_F11), paps1-3 (T-DNA insertion line WiscDsLox413-
416L14), paps1-4 (T-DNA line WiscDsLox441G5), paps2-3 (T-DNA line SALK_126395), 
paps4-3 (T-DNA line SALK_007979), paps3-3 (T-DNA line SALK_133557), paps3-4 (T-DNA 
line SALK_133558), are in the Columbia-0 (Col-0) background and therefore Col-0 was 
used as wild-type control for these plants. 35S::NahG (Col-0 background) is obtained from 
Cyril Zipfel lab. For other plants, the background is specified in the text or in the seed stock 
lists (attached as electronic version). 
cstf64-1 is kindly provided by Caroline Dean (Liu et al., 2010). 
9.1.2 Bacterial and yeast strains 
E. coli strain XL1-Blue (Stratagene, La Jolla, USA) was used for the cloning and 
propagation of plasmids. Agrobacterium tumefaciens (Agrobacterium) strain GV3101 ((Van 
Larebeke et al., 1974) was used for plant transformations.  
9.1.3 Growth media  
Compositions of bacteria, yeast and plant tissue culture media are described in Table 9.1. 
9.1.4 Selective antibiotics and herbicides 
The final concentrations of antibiotics and herbicides used in this study are listed in Table 
9.2 
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Media  Composition  
Bacterial growth media  
Lysogeny broth (LB) 
medium  
10 g/l Bacto-tryptone, 5 g/l bacto-yeast extract, 10 g/l NaCl, pH 
was adjusted to 7.0, for solid medium 1.5% (w/v) Bacto agar 
(Difco) was added.  
Super Optimal broth 
with Catabolite 
repression (SOC)  
20 g/l Bacto-tryptone, 5 g/l bacto-yeast extract, 0.5 g/l NaCl, 2.5 
mM KCl, pH was adjusted to 7.0, medium was autoclaved prior to 
addition of glucose to a final concentration of 20 mM and MgCl2 to 
a final concentration of 2 mM. This media is used for incubation of 
bacterial after transformation by electroporation. 
Plant growth medium  
½ MS medium 
2.15 g/l Murashige and Skoog (MS) plant salt mixture (ForMedium, 
Hunstanton, UK), for solid medium 0.8% (w/v) Bacto agar (Difco) 
was added. 
Table 9.1  Media used for bacteria and plant tissue cultures 
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Antibiotic/herbicide Dissolved in Final concentration  
Selection of Bacteria 
Carbenicillin (Carb) ddH2O 50 µg/ml 
Chloramphenicol (Cam) ethanol 30 µg/ml 
Gentamycin (Gent) ddH2O 25 µg/ml 
Kanamycin (Kan) ddH2O 50 µg/ml 
Spectinomycin (Spec) ddH2O 40 µg/ml 
Tetracycline (Tet) ethanol 10 µg/ml 
Selection of Arabidopsis thaliana  
Basta H2O 0.1% (v/v) 
Kanamycin (Kan) ddH2O 50 µg/ml 
Phosphinothricin (PPT) ddH2O 10 µg/ml 
 
Table 9.2 Concentrations of antibiotics and herbicides for selection of bacteria and 
Arabidopsis. 
Antibiotic were made as 1000x concentration then aliquots were stored at -20°C. 
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9.1.5 Chemicals 
Unless stated otherwise, chemicals were purchased from Sigma-Aldrich Ltd (Haverhill, UK), 
Melford Laboratories Ltd (Ipswich, UK) or Fisher Scientific (Loughborough, UK). 
9.1.6 Enzymes 
Restriction endonucleases were purchased from New England Biolabs Ltd (NEB, Ipswich, 
UK), Invitrogen Ltd (Paisley, UK) or Roche (Burgess Hill, UK). Modifying enzymes were 
purchased from Roche or NEB. Taq polymerase was purchased from Roche or Promega 
Ltd (Southampton, UK). 
9.1.7 Oligonucleotides  
Oligonucleotides used as primers for standard polymerase chain reaction (PCR) and 
sequencing reactions were ordered from Sigma-Aldrich Ltd (Haverhill, UK) and 
resuspended in sterile ddH2O to obtain a 100 µM stock solution which is then stored at -
20°C. Oligonucleotides used in this study are listed in APPENDIX A.  
For RT-PCR primers in Figure 3.8: qPCR primers for PAPS1 are oSV187 + oSV188. 
Primers upstream paps1-2 are oSV304 + oSV305, primers flanking paps1-2 are oSV304 + 
oSV100, primers downstream paps1-2 are oSV76 + oSV100. Primers upstream paps1-4 
are oSV187 + oSV188, primers flanking paps1-4 are oSV186 +oSV188, primers 
downstream paps1-4 are oSV186 + oSV197. Primers for RT-PCR PDF2 are ML 179 + 
ML180. Primers for qPCR of UBC are oSV167 + oSV168. Primers for qPCR of PDF2 are 
oHB86+oHB87. 
For RT-PCR primers in Figure 4.4A: Primers flanking paps2-3 are oSV198 + oSV121. 
Primers flanking paps4-3 are oSV110 + oSV112. Primers for RT-PCR of PDF2 are ML179 + 
ML180.  
Primers for qPCR validation in Figure 7.5: At1g54020 (oSV205 and oSV206); At4g03156 
(oSV242 and oSV243); At2g35640 (oSV232 and 233); At4g04580 (oSV211 and oSV212); 
At4g23160 (oSV213 and oSV214); At5g59680 (oSV215 and oSV216); At4g11890 (oSV234 
and oSV235); At4g25100 (oSV236 and oSV237). 
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9.1.8 Plasmids 
All plasmids used and generated in this study are listed in APPENDIX B. Detailed 
procedures on constructing these plasmids are listed in APPENDIX C. 
9.1.9 Stock solutions 
General stock solutions are lists below 
TE   10 mM Tris-HCl pH 8.0, 1 mM EDTA 
50x TAE  40 mM Tris base, 40 mM acetic acid, 1 mM EDTA 
1x PBS   137 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4, 2 mM KH2PO4 
10% (w/v) SDS  100 g sodium dodecyl sulphate per litre dH2O 
Other specific solutions for each protocol are listed within the protocol. 
9.2 Methods 
9.2.1 Molecular biology - DNA-related methods 
9.2.1.1 Preparation of electro-competent E. coli and Agrobacterium cells 
The protocol below is for E.coli. For Agrobacterium, the volumes and growing temperature 
are given in parentheses. 50 ml LB-broth containing the appropriated antibiotic were 
inoculated with a single colony of E. coli strain XL1-Blue (Agrobacterium strain GV1301) and 
incubated overnight at 37 (28)°C with shaking at 200 rpm. 4 ml of this overnight culture were 
used to inoculate 400 ml of prewarm LB-broth (the OD at this stage of the whole culture was 
about 0.1). The culture was then grown to an OD600 of 0.4-0.5 (about 2 h for E. coli and 3-4 
h for Agrobacterium) at 37 (28)°C with shaking and then placed on ice for 15 min. The 
following steps were carried out on ice or in the cold room and all centrifugation is at 4oC. 
The cells were harvested by centrifuging at 4.600 x g for 10 min The supernatant was 
discarded and the cells were gently resuspended in 200 ml of sterile ddH2O (prechilled to 
4oC) . The cells were centrifuged again at 4.600 x g for 10 min. The supernatant was 
discarded and the pellet was resuspended gently 200 ml of chilled sterile ddH2O. After 
centrifugation at 4.600 x g for 10 min, the supernatant was discarded and the cells were 
gently resuspended in 10 ml chilled sterile 10% (v/v) glycerol. The cell suspension was 
transferred to a sterile 50 ml tube and centrifuged at 4.000 rpm for 10 min. The supernatant 
was removed and the cells were resuspended in 1 ml chilled sterile 10% (v/v) glycerol. Cells 
were aliquots in 40 (20) µl, frozen immediately in liquid nitrogen and stored at -80°C. 
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9.2.1.2 Transformation of E. coli and Agrobacterium cells  
Growing temperature and times for Agrobacterium are given in parentheses. 
Aliquots of electro-competent cells were thawed on ice for about 5 min, 1-4 µl ligation or 0.5 
μl plasmid DNA were added and the cell suspension was transferred to a Bio-Rad 2 mm 
cuvette (prechilled on ice). The electroporation was carried out at 2.5 kV, 200 Ω resistance 
and 25 μF capacitance. Then 1 ml SOC medium was added to the cuvette and the cell 
suspension was transferred to a 1.5 ml tube. For transforming with a AmpR plasmid, 0.2ml 
SOC medium was used. The cells were incubated at 37 (28)ºC with shaking at 200 rpm for 
1 (2) h. This step is ommited if an AmpR plasmid was used for transformtion. The cells were 
centrifuged in a microcentrifuge briefly and most of the supernatant was discarded. The 
remaining supernatant (200µl) was used to resuspend the cells and then spread on LB-agar 
plates containing the appropriate antibiotics. The plates were incubated at 37 (28)ºC 
overnight (48h). 
9.2.1.3 Frozen bacterial stocks 
600 µl  of overnight culture was mixed with 400 µl of sterile 60% (v/v in water) Glycerol. The 
mixture was frozen immediately with liquid Nitrogen and stored at -80 ºC 
9.2.1.4 Alkaline lysis miniprep of plasmid DNA from E. coli 
Extraction buffer I  50 mM Tris-HCl pH 8.0, 10 mM EDTA 
Extraction buffer II  1% (w/v) SDS, 0.2 M NaOH 
Extraction buffer III  3.1 M KOAc pH 5.5  
A single colony of E. coli was used to inoculate 5 ml LB-broth containing the appropriate 
antibiotic overnight at 37oC with shaking (200 rpm). The following procedure was carried out 
at room temperature. 2 ml of the overnight culture were transferred to a 2 ml tube and 
centrifuged at 13.000 rpm for 1 min. The supernatant was discarded, 150 µl extraction 
buffer I were added and vortexed to resuspend the cells completely. After adding 150 µl 
extraction buffer II, the tube was gently mixed by inverting. 200 µl extraction buffer III was 
added and the tube was again gently inverted 2-4 times. The sample was centrifuged at 
13.000 rpm for 10 min. The supernatant was transferred to a fresh tube containing 500 μl 
isopropanol and mixed by inverting, then centrifuged at 13.000 rpm for 15 min. The pellet 
was washed with 70% (v/v) ethanol, air-dried and resuspended in 50 μl TE containing 0.1 
mg/ml RNase A. For sequencing, the plasmids were resuspended in ddH2O. 
For low-copy number plasmid (the pBarMAP derivatives), a modification of this miniprep 
was used. 6 ml overnight culture was used with twice the amount of the solutions and the 
plasmid was finally elute with 20 μl TE. 
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9.2.1.5 Alkaline lysis midiprep of plasmid DNA from E. coli 
Extraction buffer I  50 mM Tris-HCl pH 8.0, 10 mM EDTA 
Extraction buffer II  1% (w/v) SDS, 0.2 M NaOH 
Extraction buffer III 3.1 M KOAc pH 5.5  
50 ml LB-broth containing the appropriate antibiotic were inoculated with a single colony of 
E. coli and incubated overnight at 37oC with shaking (200 rpm). The next day the overnight 
culture was transferred to a sterile 50 ml tube and centrifuged at 7500 rpm for 3 min (Sigma 
4-15C, rotor: 12196-H). The supernatant was discarded, 5 ml extraction buffer I were added 
and vortexed thoroughly. After adding 5 ml extraction buffer II, the tube was gently mixed by 
inverting. 7 ml extraction buffer III were added and the tube was gently inverted 2-4 times. 
The sample was centrifuged at 10.000 rpm for 10 min. The supernatant was transferred to a 
fresh tube containing 17 ml isopropanol and inverted. The sample was centrifuged at 10.000 
rpm for 15 min. The pellet was washed with 70% (v/v) ethanol, centrifuged for 5 min at 
10.000 rpm and air-dried. The pellet was resuspended in 200 μl TE containing 0.1 mg/ml 
RNase A. 
9.2.1.6 QIAprep Spin Miniprep Kit 
For highquality DNA, plasmid DNA from bacterial cultures grown overnight was isolated 
using QIAprep Spin Miniprep Kit (QIAGEN Ltd #27104, Surrey, UK) according to the 
manufacturer’s instructions. 
9.2.1.7 Preparation of plasmid DNA from Agrobacterium 
10 ml LB-broth containing the appropriate antibiotics were inoculated with a single colony 
and the culture was grown for 16-24 h at 28°C. 2 ml culture were transferred to a 1.5 ml 
tube and centrifuged in a microcentrifuge for 1 min at 13.000 rpm. The following steps were 
performed according to the manufacturer’s instructions for the QIAprep Spin Miniprep Kit 
(QIAGEN) using 2x the volumes of buffer P1, P2 and N3. The plasmid DNA was eluted with 
20 μl EB. 17.5 μl eluate were used in a restriction digest and the restriction pattern was 
compared to respective E. coli plasmid DNA. 
For low copy number plasmid (pBarMAP derivatives) 10ml of overnight culture was used or 
the midiprep was used with a modification: A pinch lysozyme was added to the extraction 
buffer I, the mixture was incubated 5 min room temperature before extraction buffer II was 
added.  
9.2.1.8 High-throughput plant DNA preparation method, to use in PCR applications 
for fragments up to 1 kb 
Sucrose solution 50 mM Tris-HCl, pH 7.5, 300 mM NaCl, 300 mM sucrose 
The solution was newly prepared and used immediately for every experiment. 
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A piece of leaf (ca.0.5cm x 0.5cm) was collected into one of the collection microtubes 
(QIAGEN #19560) and one 3 mm tungsten carbide bead (QIAGEN #69997) was added to 
each tube. 300 µl sucrose solution were added to each tube and the tubes were sealed with 
collection microtube caps (QIAGEN #19566). The tissue was ground with 1200 strokes/min 
for 2 min using the SPEX SamplePrep Model 2000 Geno/Grinder (SPEX CertiPrep, 
Metuchen, USA). The samples were centrifuged briefly for 30s. The metal beads were 
removed using a magnet. The samples were incubated at 55°C to 60°C for 1h and 600 µl 
ddH2O were added. 1 µl sample was used per 20 µl PCR reaction. These DNA preparations 
can be stored in -20°C and used within two weeks with less than 2 thawn-freeze cycles. 
The metal beads were reused in the next experiments by cleaning with 1 M HCl for 
approximately 30 min then rinsing with water and 70% (v/v) EtOH and air-dried. 
9.2.1.9 Plant DNA miniprep 
Miniprep buffer 200 mM Tris-HCl, pH 7.5, 250 mM NaCl, 25 mM EDTA, 0.5% (w/v) SDS 
All steps were at room temperature. Up to 1cm x 0.5 cm leaf material was collected into 1.5 
ml tube and ground with a plastic pestle. 400 µl Miniprep buffer were added and grinding 
was continued. The samples can be stored on ice at these step until all the samples were 
ground. The samples were then centrifuged for 10 min at 13.000 rpm. The supernatant was 
transferred to a new tube containing 400 µl isopropanol. The samples were mixed by 
inverting and centrifuged for 15 min at 13.000 rpm. The supernatant was pour off and the 
pellet was washed with 500 µl 70% (v/v) EtOH. The pellet was air-dried for 20 min and 
dissolved in 150 µl ddH2O. 1 to 3 µl  of the sample were used in a PCR reaction. 
9.2.1.10 Restriction digestion of plasmid DNA 
To prepare restriction fragments for cloning, the restriction digests were performed in the 
buffer and at the temperature recommended by the manufacturer for 2h to overnight. To 
avoid star activity, the final volume of enzyme/glycerol was kept below 10% (v/v) of the final 
reaction volume (usually 20-50 μl). For preparing recipient vector in cloning, 2U of restriction 
endonuclease was added to 3 μg of plasmid (ca. 1μl to 2μl of the miniprep if the plasmid is 
high copy number e.g., ML939 derivatives), samples were incubated for one hour then 
another 2U of restriction endonuclease was added and incubated for another two hours.  
9.2.1.11 Agarose gel electrophoresis of DNA 
DNA loading dye 30% (w/v) sucrose, 0.2% (w/v) cresol red, 0.3% (w/v) tartrazine  
DNA fragments were separated by electrophoresis in horizontal agarose gels. Gels were 
prepared with 1x TAE buffer and 0.7-3% (w/v) agarose. 0.01% (v/v) ethidium bromide (EtBr) 
was added to the molten agarose before the gels were casted. Gels were run in 1x TAE at 
80C-110V. The DNA was visualised using a short-wavelength ultraviolet light 
transilluminator (610 nm) (UVP Inc., Cambridge, UK). For the isolation of DNA fragments 
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from gels, the DNA was visualised using long-wave ultraviolet light transilluminator to 
minimise DNA damage. 
9.2.1.12 Isolation of DNA fragments from agarose gel 
DNA fragments were isolated from agarose gel using the QIAquick Gel Extraction Kit 
(QIAGEN #28704) according to the manufacturer’s instructions. 
 
9.2.1.13 DNA dephosphorylation 
If the vectors can be self-ligated (e.g., by cloning using one restriction enzyme), the 5′ 
phosphates of the vector were removed with rAPid Alkaline Phosphatase (rAP) (Roche #04-
898-133-001). Up to 1 μg of the 5' ends of vector DNA were dephosphorylated using 1x rAP 
buffer and 1 μl of rAP in a total reaction volume of 20 μl. The sample was incubated for 30 
min at 37°C and the enzyme was heat-inactivated for 2 min at 75°C. 
9.2.1.14 DNA ligation 
Both the insert and vector DNA were run on a agarose gel to check their concentration 
before using in ligation. 10 μl ligations were performed using 1x ligation buffer and 0.5 μl-1μl 
T4 DNA ligase (NEB, M0202L). Insert and linearised vector DNA were added to give a 
molar ratio of DNA ends of 1:3 vector:insert. Ligations were incubated at room temperature 
for 2 h or at 16ºC overnight. Up to 4 μl of this ligation were used to transform E.coli 
electrocompetent cells.  
9.2.1.15 Quantification of nucleic acid concentration 
The optical density (OD260) of a nucleic acid sample was measured in an Ultrospec 1000E 
UV/visible light spectrophotometer (Pharmacia, Kent, UK) and the concentration of the 
nucleic acid was calculated by assuming that: 1 OD260 unit equals 50 μg/ml double-stranded 
DNA and 40 μg/ml single-stranded DNA or RNA. The NanoDrop ND-1000 
spectrophotometer (NanoDrop Technologies, Thermo Fisher Scientific Inc.) was used for 
accurate quantifications of very small sample volumes. For approximate estimates the DNA 
sample was run in an agarose gel supplemented with 0.01% (v/v) EtBr with DNA standards 
of a range of known concentrations. The DNA was visualised on a UV transilluminator and 
the DNA concentration of sample was estimated by comparing the intensity of the band with 
those of the known standards. 
9.2.1.16 Polymerase chain reaction (PCR)  
The GoTaq Flexi DNA Polymerase (Promega #M8301) was used for amplification of DNA 
fragments from DNA plasmids, colony-PCR and genotyping. The Phusion Taq from NEB 
(M0530S/L) was in PCR for cloning to reduce PCR errors. For amplifications of DNA 
fragments using primers that introduce mutations, the PCR was run at an annealing 
temperature 5oC below the actual annealing temperature for the first five cycles. To ensure 
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correct handling and mixing of the components, a negative and a positive control sample 
were run together with the samples.  
Final concentration Component  
1 pg-40 ng 
50-500 ng 
plasmid DNA or  
genomic DNA  
1x 
Or 5x 
GoTaq Flexi Buffer  
Or HF Phusion PCR buffer 
200 μM deoxyribonucleotides (dNTPs)  
0.25-0.5 μM oligonucleotide A  
0.25-0.5 μM oligonucleotide B  
0.5 U 
0.4 U 
GoTaq Flexi polymerase  
Phusion Taq polymerase 
20 μl Total volume 
PCR amplifications were performed in either a Tetrade Thermal Cycler PTC-225 (MJ 
Research, Waltham, USA) or in a G-Storm GS1 thermal cycler (Gene Technologies Ltd, 
Essex, UK) using the following program.  
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Step  Temperature  Time  
                  GoTaq PhusionTaq GoTaq Phusion Taq 
1  (Denaturation) 95°C  98°C  2 min  30 s  
2  (Denaturation) 95°C  98°C  30 s  10 s  
3  (Annealing) Tm-3°C  
Tm°C ( must be 
>60°C) 
30 s  30 s  
4  (Elongation) 72°C  1 min/1 kb  30 s/1 kb  
5  Repeat steps 2 to 4 for 24 to 39 times  
6  (Final elongation) 72°C  3 to 5 min  
7  25°C  1 min 
For overlap-PCR for cloning, Phusion Taq was used. In the first round of PCR, I used 25 
cycles using conditions above. The PCR products from the first round were electrophoresis 
and bands of expected size were gel-purified and used as template for the second round of 
PCR (also 25 cycles).  
9.2.1.17 Bacteria colony-PCR 
A single colony was picked and transferred to a 1.5 ml tube containing 50 µl ddH2O. As a 
negative control, an empty space in the petri agar plate was touched by the pipet tip and the 
tip was washed (by pipetting up and down) in 50 µl ddH2O. The tube was vortexed, kept on 
ice and 5 µl of the suspension was used as template in a 20 µl PCR reaction using GoTaq. 
The initial denaturation was increased to 5 minutes. 40 cycles of PCR was used.  
9.2.1.18 DNA sequencing 
Cycle sequencing reactions were performed using the Big Dye Terminator v3.1 Cycle 
Sequencing Kit (Applied Biosystems Inc., Foster City, USA) according to the manufacturer’s 
instructions. 100-200 ng template DNA were used in a 10 μl reaction containing 3.5 μl of 1 
μM sequencing primer, 1.5 μl Big Dye sequencing buffer and 1 μl ABI BigDye version 3.1 
sequencing mix. Analysis of the reaction products was performed on AbiPrism 3730XL and 
3730 capillary sequencers (Perkin and Elmer, Connecticut, USA) by the DNA Sequencing 
Service at the JIC. The data were downloaded and analysed using the Vector NTI Advance 
11 software package (Invitrogen). The cycle sequencing reactions were performed using the 
following program.   
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Step  Temperature  Time  
1  96°C  10 s  
2  55°C  5 s  
3  60°C  4 min  
4  Repeat steps 1 to 3 25 times  
5  Cool down to 10°C  
Some of the sequencing were carried out using a service provided by LGC Genomics 
GmbH, Germany according to the company protocols.  
9.2.1.19 DNA concentration 
Plasmid/genomic DNA was diluted to the total volume of larger than 50 µl with ddH2O. 0.1 
volume of 3M NaOAc pH 5.2, two volumes of ethanol (96-100%) were added. The tube was 
mix and incubated at -20oC for 30 min, then spun at 13.000 rpm for for 20 min at room 
temperature. The pellet was then washed with 70% ice cold ethanol, spun again for 5 min. 
The pellet was allowed to dry completely then elute in ddH2O. 
9.2.2 Molecular biology – RNA-related methods 
9.2.2.1 Mini Hot Phenol Arabidopsis RNA extraction procedure 
Homogenisation buffer  100 mM Tris pH 8.5, 5 mM EDTA pH 8.0, 100 mM NaCl, 0.5% 
(w/v) SDS 
Unless otherwise stated, the steps were carried out at room temperature. 
Hot phenol tubes were prepared by adding 250 µl phenol, 500 µl homogenisation buffer and 
5 µl β-mercaptoethanol to a 1.5 ml tube and heated in a 60oC water bath. Approximately 
300 mg frozen Arabidopsis tissue (maximum half the volume of a 1.5 ml tube) were ground 
to fine powder in liquid nitrogen with a pestle. A pinch of glass sand was added to aid the 
grinding process. After the liquid nitrogen was completely evaporated but the sample was 
not thawn, the hot phenol mixture was added. The tube was shaken for 15 min, 250 µl 
chloroform were added and the tube was shaken for additional 15 min. The sample was 
centrifuged in a microcentrifuge at 13.000 rpm for 10 min and 550 µl aqueous layer were 
transferred to new tube. After adding 550 µl phenol:chloroform:isoamylalcohol (25:24:1), the 
mixture was shaken for 10 min. The sample was centrifuged at 13.000 rpm for 10 min and 
500 µl aqueous layer were transferred to new tube. 50 µl 3 M sodium acetate and 400 µl 
isopropanol were added and the tube was incubated at -80oC for 15 min. After centrifugation 
at 13.000 rpm for 30 min (4oC), the supernatant was removed and the pellet was air-dried 
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for 10 minutes*. The pellet was then resuspended in 500 µl ddH2O**. After adding 4 M LiCl, 
the sample was mixed and incubated overnight at 4oC. The next day the sample was 
centrifuged at 13.000 rpm for 30 min (4oC), the pellet was washed in 1 ml 80% (v/v) ethanol 
and centrifuged at 13.000 rpm for 5 min. The supernatant was removed carefully to not 
disturb the delicate pellet and the pellet was air-dried. The pellet was resuspended in 20 µl 
ddH2O and the RNA was quantified using a spectrophotometer. 
* It is important not to dry the phellet for too long or it will be very difficult to dissolve in the 
next step. 
** It is important to dissolve the phellet fully to prevent carry over of genomic DNA. 
9.2.2.2 DNase digestion of RNA samples 
Traces of DNA that may be present following RNA isolation protocols were removed by 
digestion with Turbo-DNAse (Ambion Inc. #AM1907, Warrington, UK). A maximum of 10μg 
of RNA was used with 10U Turbo DNase in a 50 μl total reaction volume. 5 volume 10x 
Turbo DNase buffer and 1 μl Turbo DNase (10 U/μl) were added to the RNA and mixed 
gently. After incubation at 37oC for 30 min, 0.1 volume of DNase Inactivation Reagent was 
added, mixed and incubated for 5 min at room temperature. The sample was centrifuged for 
1.5 min at 10.000 x g and the supernatant was transferred to a fresh tube. 
For higher amount of RNA to be digested, it is important to adjust the reaction volume so 
that the concentration of RNA does not exceed 0.1 μg/μl.  
9.2.2.3 cDNA synthesis of polyadenylated transcripts 
For the synthesis of cDNA, the SuperScript III Reverse Transcriptase (RTase) kit (Invitrogen 
#18080-051) was used according to manufacturer’s instructions.  
2 μg of total plant RNA ( up to 12.2μl) was mixed with 0.8 μl of 100μM oligo(dT)17 primer, 1 
μl of 10mM dNTPs and water up to 14 μl. The tube was incubated for 5 min at 65oC and 
then briefly chilled on ice. The following reaction mixture was prepared and added to each 
sample.  
Volume (μl) Component 
4 5x First Strand Buffer 
1 DTT (100mM) 
1 SuperScript III RTase  
The samples were mixed by pipetting up and down, then incubated at 50oC for 60 min 
followed by heat inactivation of the RTase enzyme at 75oC for 10 min. The cDNA was 
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stored at -20oC. For qPCR and standard RT-PCR the cDNA was diluted one in 10 and 4 μl 
was used for a 20 μl PCR reaction. 
9.2.2.4 RNA concentration: 
For crude estimating the integrity and concentration of the extracted total RNA, RNA was 
electrophoresis in 1% Agarose gel in 1xTBE. To minizmize RNAse contamination, the gel 
apparatus was cleaned twice with soap and rise with ddH2O before electrophoresis, TBE 
was autoclaved and agarose was used from freshly open bottle, which is designated to use 
only for RNA.   
RNA was precipitated using 0.1 volume of 3M Sodium Acetate pH 5.2 and 1 volume of 
isopropanol. The mixture was incubated at -20⁰C for at least 30 minutes or overnight, then 
centrifuged at 13,000 rpm at 4⁰C for 45 minutes. The supernatant was removed and the 
pellet was washed with 200 µl of 80% ice-cold ethanol. The pellet was air dried and 
dissolved in 11 µl water, stored at -20⁰C.  
9.2.2.5 Poly(A) tail removal by RNase H/oligo dT treatment of total 
RNA:   
Chemical/reagents Amount added 
Total RNA (DNase treated) 20 µg 
10x RNase H buffer              10 µl 
RNase H (5U/µl) (NEB) 0.4 µl 
100 µM oligo dT* 3.2 µl 
Water  Adjust to total volume reaction 
volume of 100 µl 
* if poly(A) tail persists, can increase oligo dT amount up to 2 times.  
The above mixture was prepared, in the sample without oligo dT, water was added in 
replacement of oligo dT. The reaction was incubated at 37⁰C for one hour. Then 100µl 
phenol/chloroform/isoamyl alcohol (25:24:1) was added to inactivate the enzyme. The tube 
is mixed by inversing and then spin at 13,000rpm for 10 minutes at room temperature. The 
aqueous phase was transferred to a fresh tube and RNA was precipitated using 0.1 volume 
of 3M Sodium Acetate pH 5.2 and 1 volume of isopropanol. The mixture was incubated at -
20⁰C for at least 30 minutes or overnight, then centrifuged at 13,000 rpm at 4⁰C for 45 
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minutes. The supernatant was removed and the pellet was washed with 200 µl of 80% ice-
cold ethanol. The pellet was air dried and dissolved in 11 µl water, stored at -20⁰C.  
9.2.2.6 RNA Ligation Mediated Poly(A) test (LM-PAT).  
The protocol was done according to (Meijer et al., 2007).  
RNA ligation 
4 µg of total RNA was mixed with with 50 picomoles of the RL-PAT-anchor DNA primer 
(oSV220), water added to 8 µl. The mixture was incubated at 65⁰C for 5 minutes then place 
immediately on ice. 1 µl of RNA ligation buffer and 1 µl of RNA ligase (Promega M1051) 
were added and incubate at 37⁰C for 30 minutes, then inactivated at 65⁰C for 15 minutes 
then put on ice.  
cDNA synthesis 
50 picomoles of the RL-PAT-Rev primer (oSV219), 1 µl of 10 mM dNTPs was then added to 
the tube from the ligation step, water was then added to adjust the total volume to 25 µl.  
The tube was incubated at 65⁰C for 5 minutes then placed immediately on ice. The following 
master mix was then added to the tube: 10 µl of first strand buffer 5X, 2.5 µl of 0.1 M DTT, 
11.5 µl of water and 1 µl of the Superscript III reverse transcriptase (Invitrogen). The tube 
was then incubated at 55⁰C for one hour, heat inactivate at 70⁰C for 15 minutes. The 
resulting cDNA was stored at -20⁰C. 
PCR  
PCR was done using GoTaq (Promega) with the following mix:  
Chemical/reagents Amount added 
Water 33.75 µl 
5x GoTaq Flexi buffer 10 µl 
25 mM MgCl2 3 µl 
10 mM dNTPs 1 µl 
20 µM RL-PAT-Rev primer (oSV219) 1 µl 
20 µM Gene specific forward primer 1 µl 
GoTaq 0.25 µl 
cDNA template from the above step 1 µl 
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Cycle conditions 
The following condition was used: initial denaturation: 5 minutes at 95⁰C; 40 cycles of: 1 
minutes at 95⁰C, 1 minute at 58 ⁰C, 2 minutes at 72⁰C;  final extension: 10 minutes at 72⁰C.  
Nested PCR  
For transcripts that have low abundance, nested PCR was carried out using the same PCR 
conditions as above with modifications. In the first PCR: the first gene specific primer and 
oSV219 were used at half the concentration listed above (i.e. final concentration was 0.2 
µM). In the second round of PCR: a second gene specific primer (the nested primer) and 
oSV219 was used at full concentration (i.e. 0.4µM); the template was 2 µl of the 20x dilution 
of the first PCR product.   
9.2.2.7 Bulk poly(A) tail-length analysis: 
The protocol is modified from (Preker et al., 1995). In summary, RNA samples (2 ug) were 
3'- end labelled with 32P cordycepin and subjected to RNase A and RNase T1 digestion. The 
Rnase treatment was stopped and poly(A) tails were precipitated and separated by 
ectrophoresis on a gel of 10% polyacrylamide and 8.3 M urea. 
3’end label with cordycepin  
Chemicals/Reagents Concentration of 
stock 
Amount 
added 
Final 
concenctration
/amount 
PAP Buffer 5x 2µl 1x 
Rnase-free water  5 µl  
Yeast PAP enzyme 5U/ µl 1 µl 5U 
32P cordycepin 10 µCi/µl, 
5000Ci/mmol 
1 µl 10 µCi 
Total RNA 2 µg/ µl 1 µl 2 µg 
 
Total RNA was extracted using hot phenol method and dilute in water to 2µg/µl. 2µg of total 
RNA were 3'- end labelled with 32P cordycepin (From PerkinElmer, Product No. 
NEG026250UC) using yeast poly(A) polymerase (USB Affymetrix Product No. 74225Y). The 
reaction was incubated at 37⁰C for 20 minutes followed by heat inactivation at 70⁰C for 10 
minutes.  
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Rnase treatment 
Chemicals/Reagents Concentration of 
stock 
Amount added Final 
concenctration/a
mount 
Tris-HCl (pH 8) 100mM 8 µl 10mM 
NaCl   3M         8 µl 300mM 
Rnase T1 * 125U/ µl 1 µl 125U 
Rnase A* 10mg/ml 0.5 µl 5 µg 
Rnase-free water  51.5 µl  
* Rnase T1 was purchased from Ambion 1000U/µl then diluted in 10mM Tris-HCl (pH 8)-
300mM NaCl to make 125U/ µl. Rnase A was purchased from Sigma.  
The above master mix (70 µl) was added to the tube (10 µl) in the previous step and was 
incubated at 37⁰C for 60 minutes.  
Stopping RNase reaction 
Chemicals/Reagents Concentration of 
stock 
Amount added Final 
concenctration/a
mount 
proteinase K 20 mg/ml 5 µl 1 mg/ml 
SDS 10 %    10 µl 0.5 % 
EDTA   500 mM 2 µl 10 mM 
Water  3 µl  
The above master mix (20 µl) was added to the tube in the previous step (80 µl) and was 
incubated at 37⁰C for 30 minutes. 
Precipitation of poly(A) tails 
Chemicals/Reagents Concentration of 
stock 
Amount added Final 
concenctration/a
mount 
tRNA  10 mg/ml 5.2 µl 52 µg 
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Glycogen 23 mg/ml 5.4 µl 125 µg 
Ammonium acetate* 6M 83 µl 2.5 M 
MgCl2 1M 3 µl 15 mM 
Rnase-free water  3.4 µl  
Ammonium acetate* make fresh with autoclaved water, can store in the fridge for several 
weeks.  
The above master mix (100 µl) was added to the tube in the previous step (100 µl) and then 
500 µl absolute Ethanol was added. The tube was mixed by inversing several times then 
centrifuge for 1 hour at 13,000 x g at 4⁰C to 10⁰C. The pellet was washed with ice-cold 80% 
Ethanol and allowed to dry at room temperature.  
Resuspend in loading buffer 
Chemicals/Reagents Concentration of 
stock 
Amount added Final 
concentration 
Formamide 98% 960 µl 94% 
EDTA 0.5M 40 µl 20 mM 
Bromphenol blue  2 mg 0.2% 
Xylene cyanol  2 mg 0.2% 
Loading dye was prepared and stored in small aliquots in -20⁰C. 
The dried pellet in the previous step was resuspended in the 10 µl of the loading buffer 
(formula above). The RNA can be stored in - 20⁰C or immediately used for electrophoresis.  
Gel preparation and electrophoresis 
Sequencing gel apparatus were used. The glass plates were cleaned thoroughly with a final 
rinse with ethanol. The glass plates then siliconized with dimethyl dichlorosilane (Sigma) on 
one side. 0.4 mm comb were used. The gel mixture were prepared with the following recipe. 
Chemicals/Reagents Concentration of 
stock 
Amount added Final 
concentration/ 
amount 
TBE 5x 18 ml 1x 
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Water   10 ml  
Urea  45 g 8.3M 
Acrylamide 30% 33 ml 10% 
TMED 100% 60 µl  
APS 10% 330 µl  
This is the formula for a final volume of 90ml, enough for one gel.  APS 10% was made 
fresh or can be stored in -20⁰C for 2 months. TBE was autoclaved and keep free of Rnase.  
TBE, water and urea were mixed and heat until fully dissolved then acrylamide was added. 
The mixture was cooled with icy water to slow down polymerization. APS and TMED was 
added last and quickly pour in to the gel apparatus. The polymerized gel together with glass 
plates were then stored in the cold room overnight and used next morning. RNA samples (3-
5 µl) were heated at 70⁰C for 2 minutes then load on the gel together with RNA ladder (3 µl) 
which was heated at 95 C for 5 minutes. The gel was run at 1.5kV 43mA  at 55⁰C for about 
3 hours until the faster running dye (bromephenol blue, which co-migrates with 10bp RNA) 
is 7 cm above the bottom of the gene.  The gel was carefully peeled off from the glass 
plates on to blotting paper then exposed to the phosphoimage screen overnight.  
RNA ladder preparation  
The RNA ladder was the Decade Marker system (Ambion AM7778), it was prepared 
according to the manufacture protocol. 32P Gama ATP was ordered from PerkinElmer. Once 
produce the ladder can be stored in -20⁰C in small aliquots and used within 4 weeks.  
9.2.2.8 Poly(A) tail-length dependent RNA fractionation. 
The protocol is based on (Meijer and de Moor, 2011) with modifications: Total RNA was 
fractionated without the spiked in radioactive synthetic poly(A) probes. Instead, the poly(A) 
tail length of the final fractions were analyzed using the bulk poly(A) tail length analysis 
protocol (section 1.2.2.7). Below is the protocol for fractionation.  
Materials 
80 µg total RNA in RNase free water 
PolyA Tract System 1000, containing paramagnetic streptavidin beads, GTC extraction 
buffer, dilution buffer, biotinylated oligo (dT), β-mercaptoethanol (BME), 0.5x SSC and 
magnetic separation stand, Promega cat. no. Z5400 
Extra 50 pmole/µl biotinylated oligo(dT), Promega cat. no. Z5261 
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RNase free water 
3M Sodium acetate  pH 5.2 
100% isopropanol 
10 µg/µl yeast tRNA 
70% ethanol 
Important: non-stick tubes (2ml) (Ambion AM12475) were used in all steps to prevent 
sticking of RNA to the tubes which results in significant loss of RNA from the short fractions.  
Methods 
The GTC, BME, biotinylated oligo(dT), 0.5xSSC and H2O were allowed to reach room 
temperature. 41 µl BME was added to each 1 ml of GTC (GTC/BME). 20.5 µl BME was 
added to each 1 ml dilution buffer (DIL/BME). The DIL/BME was preheated to 70°C. The 
0.085x SSC was prepared from DEPC-treated water and 0.5x SSC provided in the poly(A) 
Tract kit. Note that this concentration was critical in order to obtain the 50 nucleotide 
threshold of separation i.e. the short fraction was depleted of of RNA having a longer tail 
than 50 nucleotides. The paramagnetic streptavidin beads were prepared as follow: The 
beads were completely resuspened by gently rocking the bottle. The resuspended beads 
(600 µl) were transferred to a 2 ml tube for each sample. The tube was placed on the 
magnetic stand and the stand was slowly moved to a horizontal position until the beads 
were collected at the tube side (takes 30 seconds to 1 minute). The storage buffer was 
carefully poured off by tilting the tube so that the solution run over the captured beads. The 
beads were resuspended in 600 µl 0.5xSSC and captured again using the stand. This wash 
step was repeated twice. The beads were resuspended in 600 µl 0.5xSSC. 80µg of total 
RNA (2 µg/µl) was mixed with 400 µl GTC/BME in a 2 ml non-stick tube. 15 µl biotinylated 
oligo(dT) and 816 µl DIL/BME were added and incubated at 70°C for 5 minutes. The tube 
was spun at 12,000 g for 10 minutes at room temperature. Note that the cooling centrifuge 
was used otherwise the temperature will go to 40⁰C. After the spin the supernatant was 
added to the beads. The biotinylated oligo(dT) was allowed to bind to the beads by rotation 
at room temperature for 15 min. The beads were then captured using the magnetic stand. 
The supernatant was transferred to a new tube and kept on ice (400 µl unbound fraction). 
The beads were washed three times with 0.5x SSC, supernatant was discarded. The tube 
was rotated for 5-15 minutes between each wash. The beads were resuspended in 400 µl 
0.085x SSC, then rotate for 15 minutes at room temperature. The beads were captured 
using the magnetic stand. The eluate (400 µl) was transferred to a new non-sticky tube. This 
eluation step using 0.085x SSC was repeated one more time in ordered to fully elute the 
short fractions. The resulting pooled 800 µl eluate (the short fraction) was kept in a tube ice. 
Note care was taken not to disturb the beads and also to remove the last drops of eluate 
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from the beads. After the short fraction was eluted, the beads was resuspended in 400 µl 
water and rotated for 15 minutes at room temperature.  The eluation with water was 
repeated one more time resulting in a combined 800 µl eluate (the long fraction). The short 
fraction, long fraction and unbound fraction were spun at 13,000 rpm for 5 minutes at 4⁰C to 
remove any transferred beads. To the supernatant from the unbound fraction (400 µl), 400 
µl of isopropanol was added, mixed and precipitated overnight. To the supernatants from 
the long (800 µl) and short fraction (800 µl), 20 µg of tRNA, 72 µl of Sodium acetate, and 
720 µl of isopropanol were added, mixed and precipitated overnight.  
Next day, all the samples were spun at 13,000 rpm for 30 minutes at 4⁰C to precipitate the 
RNA. The supernatant was removed carefully, and washed with 800 µl of 80% ethanol. The 
samples were spun again at 13,000 rpm for 20 minutes at 4⁰C and supernatant was 
carefully removed leaving 20 µl. Samples were spun again at 13,000 rpm for 5 minutes at 
4⁰C. Note that it is important that this extra spin was carried out to make sure that the pellet 
sticks to the tube wall. The pellet was allowed to dry and finally resuspended in 12 µl water. 
RNA concentration was measured and samples were stored in -20⁰C for no longer than 2 
weeks.  
All the fractions were analyzed by bulk poly(A) tail analysis as described in section 215, in 
which 2 µl (approximately 2 µg) of each fractions were used.  
9.2.2.9 Non-specific polyadenylation assay:  
(Adopted from ((Vethantham et al., 2008)), performed by Nishta Rao.  
32P-labeled SVL precleaved substrate (pre-SVL) was prepared as described (Ryner et al., 
1989). A nonspecific polyadenylation assay reaction mixture consisted of 2.5% PVA, 1 mM 
MnCl2, 100–125 ng of BSA, 1 mM ATP, 0.5 U of RNasin, 10 mM HEPES (pH 7.9), 25 mM 
NH4(SO4)2, 0.2 mM PMSF, 0.2 mMDTT, and the indicated amounts of PAP from both 
reaction mixtures. The nonspecific assays were incubated for 30 min at 30°C, and RNAs 
were resolved by denaturing PAGE and subjected to autoradiography. 
9.2.2.10 Quantitative PCR (qPCR): 
qPCR was carried out using SensiMix SYBR Low-ROX Kit (Bioline Cat No. QT625-05) and 
AB7500 Fast Real time PCR machine according to the standard manufacturer's instructions. 
The master mix is modified as follow: 
SensiMix SYBR Low-ROX 2x                 5 µl 
Primer forward (10 µM)                            0.25 µl 
Primer reverse (10 µM)   0.25ul 
Water                                    0.5 µl 
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cDNA (1 in 20 dilution*)    4 µl 
*cDNA was synthesized as in 9.2.2.3 and diluted 1 in 20 and store in small aliquots in -20°C 
C. 
The data is analyzed using LinRegPCR program (Ramakers et al., 2003). 
9.2.3 Molecular biology – protein-related work 
9.2.3.1 Expresssion and purification of recombinant Arabidopsis PAPS1 from 
E.coli: 
This procedure was provided and performed by Nishta Rao.   
 pET-PAPS1wt or pET-PAPS1P313S was transformed to Rosetta 3 cells. A single colony was 
picked and inoculated in 50 ml LB with 200µg/ml Kanamycin. Cells were grown for 4-5 hours 
at 37°C. 20 ml of this culture was added into 400 ml of LB+antibiotic and grown at 37°C for 
1-2 hours. The cultures were shifted to 16°C and let to cool for 15-20 min before IPTG to a 
final concentration of 1mM was added and these cultures were grown overnight in the 
shaker (16 hours). After 16 hours, the cultures were cool briefly on ice and harvested by 
centrifugation at 4°C at 5000 rpm for 10 min. The pellets from 1x400 ml flask were 
resuspended in 12 ml of cold  binding buffer (PMSF at final concentration of 0.5mM). Pellet 
can be frozen at this stage if needed at -80C. The frozen pellets were thawn in a 37°C water 
bath and placed on ice. 50µl of protease inhibitor cocktail was added. The mixtures were 
sonicated at an output between 2-4 , 20 times while on ice and made sure that there were 
no bubbles. The mixtures were transferred to clean tubes, spun at 9000 rpm in cold for 20 
min. While the spin was going, 1mL of Ni agarose per tube of lysate was spun down at 5000 
rpm. Supernatant was removed. This agarose beads were washed 2-3 times with binding 
buffer, then resuspended with 0.5 ml of binding buffer. The supernatants of cell lysates were 
transfered to new falcon tubes. 12ml of binding buffer was added and then the mixtures 
were filtered using 0.8µM filter. Ni-agarose slurry was added to these mixtures and the 
tubes were placed on rotator in a cold room for 2 hours. The tubes were spun 6 min in a 
cold room.  
The  protein column (BioRad) was set up in the cold room. The supernatant was decanted 
and the slurry was mixed with some binding buffer and poured into column It was made sure 
that there were no bubbles.  The column was washed with wash buffers 1, 2 (increasing 
Imidazole concentration). Upon finishing the second wash, an elution buffer (high Imidazole 
concentration) was added to the column and eluates was collected. 
222 
 
9.2.4 Plant-related methods 
9.2.4.1 Plant growth conditions on soil 
All plants were grown either in glasshouses, in controlled environment rooms (CER) or in 
Sanyo growth cabinet. All plants were grown under long day conditions consisting of a 
photoperiod of 10 hours lit with 400 W metal halide power star lamps supplemented with 
100 W tungsten halide lamps, providing a level of photosynthetically active radiation (PAR) 
of 113.7 μmol photons m-2s-1 and a red:far red (R:FR) ratio of 2.41 and a 6 hour extension 
of tungsten halide lamps alone giving PAR 14.27 μmol photons m-2s-1 and R:FR 0.66.  
Humidity was around 50-70%. The standard temperature is from 22°C to 25° C. For paps1-1 
mutant, various growth temperatures were used ranging from 16°C to 28°C. The exact 
temperature is mentioned in each specific experiment. Control plants were grown side by side with 
the plants to be tested.  
Plants were grown on a loam-based soil consisting of John Innes Potting Compost Number 
1, vermiculite and grit in the ratio 1.5:1:1 by volume or a mixture of Levingtons Potting 
Compost Number 3 and grit in the ratio 6:1 by volume. The seeds were sown on water-
saturated soil, and covered with transparent lids. To break seed dormancy, the trays were 
stratified in at 4°C for 2 to 3 days before transferring them to a glasshouse or CER. After 10-
14 days, the lids were removed. The plants were watered once or twice daily. To harvest 
seeds, the inflorescences were bagged when the mature siliques turn yellow. After the 
siliques had dried up, the seeds were harvested and dried at RT or in a closed nylon bag 
with silica gel for at least 2 weeks before sowing. 
9.2.4.2 Growing conditions on MS plates 
All sterile procedures involving plant material were performed in laminar flow hoods in a 
tissue culture room. Autoclaved media were cooled to ~50°C and the appropriate antibiotic 
or PPT was added prior to pouring the medium into 90 mm or 140 mm Petri dishes (Sterilin, 
Caerphilly, UK). After sowing the sterilised seeds onto the medium, the plates were sealed 
with micropore surgical tape (3M). The seeds were stratified at 4°C for 2 to 3 days and then 
transferred to a CER.  
For transferring of seedlings from MS plates to soil: Seedlings were normally tranfered to 
soil 10-14 days after germination. The seedlings were covered with a propagator lid for 
about 5 days only after transferering. 
9.2.4.3 Seed sterilisation 
Wet sterilization 
Sterilisation solution: 5% (v/v) sodium hypochlorite solution, 0.1% (v/v) Tween-20 
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Seeds were transferred to 1.5 ml tube and 1 ml 70% (v/v) EtOH was added. After the seeds 
had settled, the EtOH was decanted and 1 ml sterilisation solution was added. An 
incubation step for not more than 4 min followed. Brief centrifugation were occationally 
required to bring the seeds to the bottom of the tube in the following washing procedures. 
The sterilisation solution was removed and the seeds were washed five times with sterile 
ddH2O and rinsed with 1 ml 100% (v/v) EtOH. The seeds were then air-dried in a laminar 
flow hood. 
Gas sterilization 
Tubes or bags containing a small amount of seeds (less than 50μl) were fumed with chlorine 
gas. The tubes/bags of seeds were put in a rack next to an open container which contains 
3ml concentrated HCl mixed with 100ml bleach. The open container and tubes/bags of 
seeds were put into a bigger container and sealed for four hours. The tubes/bags containing 
seeds were then left under a sterile flow hood overnight to make sure all the chlorine gas 
has evaporated. 
9.2.4.4 Mapping of the ds39 (i.e. paps1-1) mutation 
ds39 homozygous mutants after being backcrossed to Ler twice were crossed to Col-0. The 
F1 plants were allowed to self and seeds were collected in pools. In the F2 population, the 
mutants were identified as seedlings which small and pointed leaves, which were later 
checked for the bigger-flower phenotype. Initially, bulk segregation analysis was carried out 
using a pool of 20 mutant plants using markers across the genome of Arabidopsis. This 
identified a location between marker nga64 and nga392 which is tightly linked to the 
mutation. Another 140 mutant plants identified in this F2 population were genotyped for left 
inner markers: CER474022, CER481865 and right inner markers: F19G10, CER470358. 
Fine mapping was carried out using about 1000 F2 mutant-looking individuals in pools of 
three. These approximately 335 pools of DNA were PCR-screened with the two flanking 
markers CER481865 and CER470358 to identify recombinants. New markers were 
designed to finally narrow down the mapping interval to 80kb between 2 markers: 
CER475120 (2 recombinants found) and CER475042 (1 recombinant found). There were 19 
genes in this inteval. T-DNA insertion lines that have T-DNAs predicted to have inserted in 
each of these 19 genes were looked up and ordered. At the same time, the cDNA of these 
19 genes from the mutant were sequenced. A T-DNA insertion lines (SAIL_172_F11) i.e., 
the later called paps1-2 allele, segregated for the pointed leaves and small leaves 
phenotype. Sequencing of cDNA for At1g17980 found a mutation C to A.  
9.2.4.5 Agrobacterium floral dip transformation of Arabidopsis 
Infiltration medium 5% (w/v) sucrose, 0.05% (v/v) Silwet L-77 (De Sangosse Ltd 
#45290, Cambridge, UK) 
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The floral dip transformation protocol was carried out (Clough and Bent, 1998). Arabidopsis 
plants were grown in the glasshouse until they have produced three inflorescences with 
young buds. To prepare the Agrobacterium, 10 ml LB-broth containing the appropriate 
antibiotic were inoculated with a single colony of Agrobacterium strain GV1301 transformed 
with the desired plasmid and grown to stationary phase at 28°C with shaking at 200 rpm. 
400 ml LB-broth were inoculated with 2 ml overnight culture and the culture was grown 
overnight at 28°C. The next day, the cells were harvested at 4.600 x g for 15 min at room 
temperature and the cell pellet was then resuspended in 10 ml infiltration medium. The cell 
suspension was transferred to beakers containing 1 l infiltration medium. The plants were 
inverted into the suspension (all aboveground tissues submerged) and left submerged for 
20 seconds, during which the pots were pulling up and down gently, still keeping the 
inflorescences in the suspension. Infiltrated plants were placed horizontally in trays, covered 
with propagator lids and left in low light or dark overnight. The following day the plants were 
placed into the glasshouse and left to set T1 seeds. 
9.2.4.6 Cross-pollination of Arabidopsis plants 
Young flower buds whose stigmas were still fully enclosed within the sepals were 
emasculated (removing all floral organs but the gynoecium). The emasculated bud was then 
left untouched for one day then pollinated with pollen from the respective donor plant. The 
pollinated buds were then allowed to set siliques and the matured siliques were harvested 
shortly before dehiscence.  
9.2.4.7 Measurement of organ size using ImageJ 
Petals were dissected from the 6th to 15th flowers and used for measurements. For leaves, 
the 4th and 5th leaf of plants at the bolting stage were taken for measurements. To measure 
organ size, the organs were placed with forceps onto Sellotape. Once all organs were 
collected, the tape was stuck onto a black Perspex sheet. The organs were scanned with a 
resolution of 3600 dpi in greyscale (8-bit) using the HP Scanjet 4370. The organ size was 
then measured using the Image Processing and Analysis in Java (ImageJ) software 
(http://rsbweb.nih.gov/ij/).  
9.2.4.8 Measurement of cell size: 
Two methods were used: For petals, low-melt agarose was used to analyse epidermal cells; 
for leaves Chloral hydrate method was used to analyse palisade cells in the subepidermal 
layer.  
a. Low-melt agarose method to analyze size of petal epidermal cell: 
The protocol is adapted from (Horiguchi et al., 2006). A drop of 2% low-melt agarose 
containing 0.01% bromophenol blue pre-warmed at 50°C was placed on a pre-warmed 
glass slide. The droplet was smeared by a pipet tip to get a thin layer of melting agarose. A 
petal was immediately gently placed on it. Once the gel solidified, the petal was carefully 
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peeled off, and the remaining gel cast was left to dry for about 10 min. The gel cast was 
then observed without a cover glass under a differential phase contrast microscope.  
b. Chloral hydrate method: 
FAA solution: Ethanol, 50ml; Glacial acetic acid, 5ml; Formaldehyde (37-40%), 10ml; 
distilled water, 35ml.  
Chloral hydrate solution: chloral hydrate, 200 g; glycerol 20 g; distilled water, 50 ml.  
Leaves are fixed in FAA solution (by immersing in FAA solution and vaccum infiltration). 
Then FAA solution was replaced with Chloral hydrate solution and the tube was incubated 
overnight. Samples were mount on a glass slide and observe under a differential phase 
contrast microscope.  
9.2.4.9 Ethanol induction of plants 
Induction by vapour 
Ten to twelve pots, each of which is 10 cm in diameter, 10cm high and contains 4-8 plants, 
were put into a tray and covered in a nylon bag. Ten to twelve 1.5 ml tubes, each of which 
contains 1ml of absolute ethanol, were open and distributed evenly in the nylon bag 
containing the pots and plants. The nylon bag was sealed during incubation time, which 
varies depending on the experiments. This is the standard for plants grown on soil. For 
seedlings that were grown on 10cm-diameter petri dishes, 5-10 μl of absolute ethanol was 
pipetted on to the cap of a PCR tube and put on to the agar surface, the dish was closed 
with a lid and sealed with parafilm. Two days after induction, plants can be pricked out on to 
soil. 
For induction of Cre, the incubation time was 20-30 minutes. This created chimeric 
meristems. An incubation of up to four hour has been tried, at which both fully recombined 
and chimeric meristems were obtained. Plants were induced at 7 days after germination 
(resulting in only a few leaves in the rosette were mutant, and most of the rosette are wild-
type). 
For induction of PAPS1 in  pPAPs1::AlcR-AlcA::genomicPAPS1, I used an incubation time 
of two hours in each time, and once every other day.  
Induction by irrigation 
This induction method was used for the induction of PAPS1 in pPAPs1::AlcR-
AlcA::genomicPAPS1 only. 15ml of 2% ethanol was used to irrigate a pot containing 
approximately 300ml of soil. 8 plants were grown per such pot. Induction was carried out 
once every other day. 
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9.2.4.10 GUS staining: 
Staining buffer (100ml) : 2 ml 10% Triton X-100; 10 ml 0.5 M NaPO4 pH 7.0; 500 µl 100 mM 
Potassium ferrocyanide; 500 µl 100 mM Potassium ferricyanide; 87 ml dH2O.  
Staining buffer was prepared and can be stored at 4°C for 2 weeks. Just before the 
experiment, 40 µl of X-Gluc Stock 50 mM ( store at -20°C) was added to 1ml staining buffer 
to make the GUS staining solution (1X). Tissues were immersed in this GUS staining 
solution and vaccum infiltrated 5 times until all tissues sunk to the bottom of the tube. The 
tube was incubated at 37°C for either 2 hours, 4 hours or overnight depending on the 
strength of the GUS expression in the plants. The reaction was stopped by exchanging the 
solution with 70% Ethanol. Several rinses with 70% Ethanol (20 minute incubation then 
exchanged with new 70% Ethanol solution) were carried out until the tissue was cleared of 
chlorophyll.  
9.2.4.11 Developmental series of petal growth:  
Petals were dissected from the flowers/buds in the inflorescences and areas were 
measured then plotted against their growth periods. The growth period of the youngest bud, 
which contained the smallest dissectible petals was set to be 0. The growth period of the 
next bud was calculated by adding the plastochron to the growth period of the previous bud.  
The plastochron (the time difference between two sequential buds) was estimated by 
counting how many flowers that were made in six days.  
9.2.5 Microscopy 
9.2.5.1 Clonal analysis using fluorescence microscopy 
The fluorescence expression in transgenic plants was analysed using a Zeiss SteREO 
Lumar stereomicroscope fitted with a Zeiss AxioCam MRm digital camera. Images taken 
were analysed using the Zeiss Axiovision Software 4.6. For fluorescence analysis the 
following filter sets for the respective chromophores were used. 
Chromophore Zeiss Filter set Excitation (nm) Emission (nm) 
CFP 47 HE BP 436/20 BP 480/40 
YFP 46 HE BP 500/20 BP 535/30 
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9.2.6 Microarray analysis: 
9.2.6.1 Plant materials for microarray:  
For inflorescences collection, main inflorescences excluding the open flowers/buds were 
collected from 30 day-old plants grown on soil. Plants at the stage of harvest, have around 
7-12 siliques (WT) or 2-5 siliques (mutant). Plants were grown in long day condition and 
materials were collected at 5 or 7 hours after the light period starts.  
For seedlings collection, the whole seedlings including roots were harvested from 11 days 
old (mutant) or 9 day old (WT) grown on MS plates. The mutants were sown out 2 days 
before so that they can be harvested at the same time as WT. Plants were grown in long 
day condition and materials were collected at 5 or 7 hours after the light period starts.  
9.2.6.2 RNA hybridization: 
Total RNA was prepared by hot phenol method and cleaned up with QIAGEN RNAeasy Kit, 
digested with TURBO Dnase (Ambion).  
Fractionated RNA was prepared as in section 9.2.2.8. From 80 μg of total RNA input for 
each RNA sample, 10 μl of short fraction and 10 μl of long fraction were obtained 
(concentration is around 1μg/μl). 
RNA were shipped on dryice to CRX Biosciences Ltd (James Lindsay Place DUNDEE DD1 
5JJ, UK) for subsequent labelling and array hybridization.  
Two colour array platform was used: Agilent Arabidopsis 4x44K oligo microarray (G2519F, 
AMADID 15059), and Agilent 4x44K gasket slides (G2534-60011). 1 µg of total RNA 
samples, and 2 µl the short fraction and 8 µl the long fraction were used for labelling with 
the Quick Amp Labelling Kit – Two Colour (Agilent# 5190-0444).  
9.2.6.3 Bioinformatic analysis: 
For array using total RNA: 
Analyses were done using the R/Bioconductor (Gentleman et al., 2004) package Limma 
Background corrections were done using the backgroundCorrect function with the minimum 
method : background intensities were subtracted from foreground intensities, resulting 
values of zero or below were replaced by half the minimum foreground intensity. 
Normalization was done using quantile normalization method. 
Differential gene expression were identified using ttest with Benjamini and Hochberg (BH) 
corrected p-value (Benjamini et al., 2001). The thresold was absolute log2-fold change 
(mutant/WT) of 1 and pBH <0.05.  
For array using fractionated RNA: 
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Analyses were done using the R/Bioconductor (Gentleman et al., 2004) package Limma. 
Background corrections were done using the backgroundCorrect function with the minimum 
method: background intensities were subtracted from foreground intensities, resulting 
values of zero or below were replaced by half the minimum foreground intensity.  
Normalization was done for each microarray using negative and positive control spots with 
known quantities of RNA. This was done using the normalizeWithinArrays function with the 
control method : a loess curve is fitted through a set of control spots and then applied to all 
other spots (Oshlack et al., 2007). 
A quantile normalization using the normalizeBetweenArrays function with the tquantile 
method was done for the following groups of all different samples:  MT long, MT short, WT 
long, WT short. Expression ratios between long- and short-tail RNA fractions (long/short 
ratio) were calculated using the Limma method. ttest with with Benjamini and Hochberg 
(BH) corrected p-value was used to identify genes that change the ratio long/short between 
mutant and wild-type. Genes with absolute log2 expression ratios (log2(Mutant long/short ratio ) – 
log2(WT long/short ratio ) ) above 1 and BH-corrected p-values below 0.05 were considered 
significant.  
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APPENDIX A: Oligonucleotide lists 
1. For genotyping of PAPS alleles: For TDNA specific amplification, use RP and BP primers 
(of the respective T-DNA) combinations. For locus specific amplification, use LP and RP 
primers combinations.  
Oligonucleotide 
name Sequence Description 
oSV166 
TAATGCCCATCATTACTCCTGCGA
AT  genotype paps1-1 
oSV126 GCTTTGTTTGATTCCATAGC genotype paps1-1 
oSV100 TCTCGTACAATCCAACATCTTG genotype paps1-2  LP primer 
oSV91 AGTGTCCAACTCTCCAAGTTTC genotype paps1-2  RP primer 
oSV126 GCTTTGTTTGATTCCATAGC genotype paps1-3  LP primer 
oSV78 TGGGACCTAGACATGCAACTAG genotype paps1-3 RP primer 
oSV77 TGTGAAGTAAACTCAACCCAGAC genotype paps1-4 LP primer 
oSV79 GGTCTTCTATCAATGGAATTG genotype paps1-4 RP primer 
oSV120 ACATGGAGATGTTGAACTGCC genotype paps2-3 LP primer 
oSV121 CCACTGTTCCACGTATATCAAAC genotype paps2-3 RP primer 
oSV110 TGCATCTGCTGCCACTATATC genotype paps4-3  LP primer 
oSV111 TTGCTGAAGCTGTAGGGTCTG genotype paps4-3  RP primer 
oSV116 TGGATACCAACCGAATGCAAC genotype paps3-4  LP primer 
oSV117 CTGCAAACAAACATCTCACAG genotype paps3-4  RP primer 
ML437 TGGTTCACGTAGTGGGCCATCG BP primer for SALK-TDNA 
oSV139 
AACGTCCGCAATGTGTTATTAAGT
TGTC BP primer for Ws-TDNA  
ML438 TTCATAACCAATCTCGATACAC BP primer for SAIL-TDNA 
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2. For RT-PCR  
Oligonucleotide 
name Sequence Description 
oSV187 GTTGCAGACCCATGAAGTAAGAG qPCR primer for PAPS1 
oSV188 GCTCACACTGAAGATCGAGAGAC qPCR primer for PAPS1 
oSV76 AACAAGCACGCGGCTGATTC RT-PCR PAPS1 
oSV100 TCTCGTACAATCCAACATCTTG RT-PCR PAPS1 
oSV186 GTGGGAAGAACCTCAAGTTC RT-PCR PAPS1 
oSV197 GGAAACCAAGTGATTGAGCAG RT-PCR PAPS1 
oSV304 CCAACATTCGTTGAGAATCTTAC RT-PCR PAPS1 
oSV305 ATCTCATTCTTTGCGACGGTG RT-PCR PAPS1 
ML179 CGTTACTGCCAGCCATTGTAGAA RT-PCR and qPCR for PDF2  
ML180 CCGCAGGTAAGAGTTTGGAACAT RT-PCR and qPCR for  PDF2 
oSV167 CTGCGACTCAGGGAATCTTCTAA qPCR primer for UBC 
oSV168 TTGTGCCATTGAATTGAACCC qPCR primer for UBC 
oSV198 CCTAGTATGTTGGTTTCTCGA RT-PCR PAPS2 
oSV121 CCACTGTTCCACGTATATCAAAC RT-PCR PAPS2 
oSV110 TGCATCTGCTGCCACTATATC RT-PCR PAPS4 
oSV112 
CAATCGTGCCATGGTGGTGGGTAC
TCAAAATTTAGG RT-PCR PAPS4 
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3. For qPCR validation: 
Oligonucleotide 
name Sequence Description 
oSV205  CGAAATGGCGGAAACTAAAC At1g54020 qPCR 
oSV206 CTTTGTGTCCTGCGAAGAATAAC At1g54020 qPCR 
oSV242  
CAAGCATCTGTGGTAGTAGTGAAG
AC At4g03156 qPCR 
oSV243 
GCTATCGTTCTTATTCTCTGTGTTG
TTC At4g03156 qPCR 
oSV232  GGACAAGAGAGGAGGCATAAG At2g35640 qPCR 
oSV233 CGTCTACCAAACCATTCATACC At2g35640 qPCR 
oSV211 
CAACAAAGGCTACAACTGGATAATA
C At4g04580 qPCR 
oSV212 GGACAATTCTTCTTCACCAGTTG At4g04580 qPCR 
oSV213  GCAAAGCGTCCGACAATATC At4g23160 qPCR 
oSV214 CGGGTCCTTTACGGGACTAC At4g23160 qPCR 
oSV215  AGACCACTTGGCCCTTATCTAC At5g59680 qPCR 
oSV216 GGTGTGCATCCAATGTGTAAG At5g59680 qPCR 
oSV234 TGGAACAGAGGAGAAGCCATAG At4g11890 qPCR 
oSV235 TCAGCATTCTCATCCACACATAG At4g11890 qPCR 
oSV236  CCAGAACCGAAGACCAGATTAC At4g25100 qPCR 
oSV237 GCCTCAAGTCTGGCACTTACAG At4g25100 qPCR 
oSV167 CTGCGACTCAGGGAATCTTCTAA UBC qPCR 
oSV168 TTGTGCCATTGAATTGAACCC UBC qPCR 
oHB86 TGGCTCCAGTCTTGGGTAAG PDF2 qPCR 
oHB87 GCCTGTCTTCAGCAAGTTCTAC PDF2 qPCR 
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2. For other genotyping: 
Oligonucleotide 
name Sequence Description 
ML822 
GGTGAAGTTGAAGTGAAAAAGATC
GTTC genotyping klu-2 
ML823 
CTTGGAAGTCAAACCAACGAAGGA
A genotping klu-2 
cstf64.f7 ATTCAGATTAGTTACGGATAGAGA genotyping of cstf64-1 
cstf64.R2 ACGGGTTTTGTCAGTGC genotyping of cstf64-1 
ML5 AACCCACTGCTAGATTCTCCT genotyping of bb-1 
ML6 TAAAGTATAGAAGTCCACCCAAG genotyping of bb-1 
ML7 GAGAAGGCTCTGAAGGCTT genotyping of bb-1 
 
Other oligos ( for cloning, sequencing) can be found in the oligo list (electronic excel file).  
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APPENDIX B. Plasmids 
pSV1 (ML939_XbaI_rescue_gPAPS1) 
pSV1b  (pSV1XbaI gPAPS1 inserted in  rev direction) 
pSV1c  (pSV1b_SDM_SalI_UTR5') 
pSV2 (ML1297_AscI_gPAPS1_AscI 
pSV3  (ML996_AscI_gPAPS1) 
pSV4a  (ML939_PstI_cPAPS1_KpnI) 
pSV4b (ML939_PstI-cPAPS1_KpnI_35SUTR3'_EcoRI) 
pSV4c (ML939_pPAPS1_cDNA_PAPS1) 
pSV4d (pBarMAP AscI/pPAPS1UTR5-PAPS1cDNA-UTR3-35Sterm) 
pSV5a (ML939-NcoI_gPAPS4_NcoI) 
pSV5a rev  (ML939-NcoI_gPAPS4_NcoI) gPAPS4 inverse 
pSV5b  (ML939_SDM_NcoIatATG_gPAPS4_NcoI) 
pSV5c (pSV1_SDM_NcoI at ATG_gPAPS1) 
pSV5d (ML939-pPAPS1::ATGgPAPS4-PAPS4UTR3') 
pSV5e (pBarMAP/AscI/pPAPS1UTR5::ATGgPAPS4-PAPS4UTR3') 
pSV6a (ML939-SEP3cDNA) 
pSV6b ( Op::SEP3 in PPpzp222)  
pSV7a (Op::PI-Op::AP3) 
pSV7b (Op::SEP3-Op::PI-Op::AP3) 
pSV9a (AlcA::UTR5’gPAPS1UTR3’::35Sterm in ML1004) 
pSV9b (pPAPS1::UTR5::EcoRI::AlcR) 
pSV9c (pBarMAP_AscI_AlcA::UTR5gPAPS1::UTR3-35Sterm) 
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pSV9d.1  (pBarMAP:pPAPS1::AlcR-AlcA-genomic rescue PAPS1) 
pSV9d.2 (pBarMAP:pPAPS1::AlcR-AlcA-genomic rescue PAPS1) 
pSV9x ( pPAPS1::UTR5 in ML939) 
pSV10a (pBarMAP AlcA::YFP) 
pSV10b.1  (pBarMAP:pPAPS1::AlcR-AlcA::YFP) 
pSV10b.2 (pBarMAP:pPAPS1::AlcR-AlcA::YFP) 
pSV11a  (ML939-SDM cDNA NdeI PAPS1) 
pSV11b (pET28a-PAPS1cDNAwt) 
pSV11c  (ML939-SDM cDNA NdeI PAPS1 SDM P313S - the ds39 mutated) 
pSV11d (pET28a_cDNAPAPS1-P313S-the ds39 mutated version) 
pSV12 (pSV5c SDM to have StuI site at Cterm ML939 genomic PAPS1 ) 
pSV14(pPAPS1::UTR5PAPS1::NPAPS4::CtermPAPS1 (genomic) 
pSV15 (pBarMAP/AscI/pPAPS1::UTR5PAPS1::ATGNPAPS4-CtermPAPS1 
(genomic)) 
pSV16 (pPAPS1::GUS) 
pSV17 (pPAPS2::NLSGUS) 
pSV18a (pPAPS3::NLSGUS) 
pSV18b (pPAPS3::NLSGUS) 
pSV19a (pPAPS4::NLSGUS) 
pSV19b (pPAPS4::NLSGUS) 
pSV20 (pBarMAP-pPAPS2::GUS) 
pSV21 (pBarMAP-pPAPS1::GUS) 
pSV22a (pBarMAP-pPAPS3::GUS) 
pSV22b (pBarMAP-pPAPS3::GUS) 
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pSV23a (pBarMAP-pPAPS4::GUS) 
pSV23b (pBarMAP-pPAPS4::GUS) 
pSV24(p35S::UTR5PAPS1-cDNAPAPS1-UTR3PAPS1::35Sterm in pML595) 
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APPENDIX C. Cloning procedures: 
Unless otherwise stated, most of  the plasmids are stored as vector NTI file. The Database 
of vector NTI is attached as an electronic folder.  
1. pSV1 (pSV1 (ML939_XbaI_rescue_gPAPS1).  
Genomic fragment of PAPS1 (5877bp)  was isolated from from a BAC clone JAtY72B09 by 
digesting the BAC with XbaI and gel purify the fragment around 5.8 kb. The fragment was 
cloned into ML939 using XbaI site.  
2. pSV1b  (pSV1 XbaI gPAPS1 inserted in  reverse direction)  
pSV1b is similar to pSV1 but the XbaI-genomic PAPS1-XbaI fragment was inserted in the 
reverse direction in ML939 digested XbaI vector. 
3. pSV1c  (pSV1b_SDM_SalI_UTR5') 
Introduce SalI site in front of the 5’ UTR of genomic PAPS1 (in pSV1b) by overlap PCR 
using primer oSV114 and oSV115. Introduce the modified fragment back in to pSV1 by 
BstEII and KpnI site.  
4. pSV2 (ML1297_AscI_gPAPS1_AscI) 
pSV1 digested AscI insert + ML1297 digested with AscI vector. 
5. pSV3  (ML996_AscI_gPAPS1) 
pSV1 digested AscI insert + ML996 digested with AscI vector.  
6. pSV4a  (ML939_PstI_cPAPS1_KpnI) 
cDNA of PAPS1 was amplified using primer oSV89 and oSV97 (introduce PstI site and KpnI 
sites to the PCR product). Clone this KpnI/PstI digested PCR product in ML939 digested 
KpnI/PstI vector.  
7. pSV4b (ML939_PstI-cPAPS1_KpnI_35SUTR3'_EcoRI)  
Insert the the 35S-3’UTR from ML1297 to pSV4a vector by EcoRI/KpnI site.  
8. pSV4c (ML939_pPAPS1_cDNA_PAPS1)  
Insert the promoter pPAPS1 from pSV1 (ScaI-BstEII) to vector pSV4b (ScaI-BstEII). 
9. pSV4d (pBarMAP AscI/pPAPS1UTR5-PAPS1cDNA-UTR3-35Sterm) 
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Combine the PAPS1 insert from pSV4c to pBarMAP by AscI site . 
10. pSV5a (ML939-NcoI_gPAPS4_NcoI) 
Isolate the genomic PAPS4 fragment from BAC clone: JAt49G10 and JAt59J22 by NcoI 
digestion and gel purifying the 9906bp NcoI-genomicPAPS4-NcoI fragment. Clone the 
fragment into ML939 using NcoI site. 
11. pSV5a rev (ML939-NcoI_gPAPS4_NcoI) gPAPS4 inverse 
pSV5a rev has the NcoI-genomicPAPS4-NcoI inserted in to ML939/NcoI in the reverse 
direction compared to pSV5a.  
12. pSV5b  (ML939_SDM_NcoIatATG_gPAPS4_NcoI) 
Introduce NcoI site at ATG of gPAPS4 by overlap PCR using primer  oSV112 and oSV113. 
Clone back in to pSV5a using PmeI/XhoI  site.  
13. pSV5c (pSV1_SDM_NcoI at ATG_gPAPS1) 
Introduce NcoI site at ATG of gPAPS1 in pSV1 by overlap PCR using primer oSV104 and 
oSV105. Clone back in to pSV1 using ClaI/BstEII sites. 
14. pSV5d (ML939-pPAPS1::ATGgPAPS4-PAPS4UTR3') 
Combine the insert genomic PAPS4 from pSV5b/NcoI and vector pSV5c/NcoI using NcoI 
site.  
15. pSV5e (pBarMAP/AscI/pPAPS1UTR5::ATGgPAPS4-PAPS4UTR3') 
Introduce the fragment in pSV5d in to pBarMAP by AscI site. 
16. pSV6a (ML939-SEP3cDNA) 
PCR amplify SEP3 cDNA using primer oSV122 and oSV123 introducing BamHI site at one 
end, the other end is blune. Clone in to ML939 using BamHI/SmaI site. 
17. pSV6b ( Op::SEP3 in PPpzp222) 
The vector PPpzp222 do not have a full sequence map. The putative map of OP::PI and 
Op::AP3 are obtained from Robert Sablowski’s lab:  
Op::PI vector : LB-ECORI-SACI-SACII-NOTI-XBAI-OPERATOR-SPACER-OPERATOR-
XBAI-SPEI CAMV TATA-NHEI-CLAI-SACI-XHOI-APOI-KPNI-NHEI-PI-NHEI-BAMHI-SPEI-
XBAI-NOS-PSTI-HINDIII-RB 
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The SEP3 cDNA was digested with BamHI and then partially with KpnI ( SEP3 has an 
internal KpnI site). Ligate this fragment in to Op::PI vector using KpnI and BamHI site.  
18. pSV7a (Op::PI-Op::AP3) 
Op::PI vector: LB-ECORI-SACI-SACII-NOTI-XBAI-OPERATOR-SPACER-OPERATOR-
XBAI-SPEI CAMV TATA-NHEI-CLAI-SACI-XHOI-APOI-KPNI-NHEI-PI-NHEI-BAMHI-SPEI-
XBAI-NOS-PSTI-HINDIII-RB 
Op::AP3 vector: LB-ECORI-SACI-SACII-NOTI-XBAI-OPERATOR-SPACER-OPERATOR-
XBAI-SPEI CAMV TATA-NHEI-CLAI-SACI-XHOI-APOI-KPNI-KPNI-AP3 MINIGENE-
BAMHI-BAMHI-SPEI-XBAI-NOS-PSTI-HINDIII-RB 
Cut Op:AP3 with NotI , blunt end, then cut with EcoRI, purify the backbone plasmid. Cut 
Op::PI with PstI, blunt the end, cut with EcoRI, purify fragment. Ligate.  
19. pSV7b (Op::SEP3-Op::PI-Op::AP3) 
Cut pSV7a with NotI, blunt end, then cut with EcoRI, purify the backbone plasmid. Cut 
pSV6b with PstI, blunt the end, cut with EcoRI, purify fragment. Ligate to give pSV7b.  
Putative map of pSV7b  
LB- ECORI SACI-SACII-NOTI-XBAI-OPERATOR-SPACER-OPERATOR-XBAI-SPEI CAMV 
TATA-NHEI-CLAI-SACI-XHOI-APOI- SEP3-BAMHI-SPEI-XBAI-NOS-PSTI blunt-bluntNOTI-
XBAI-OPERATOR-SPACER-OPERATOR-XBAI-SPEI CAMV TATA-NHEI-CLAI-SACI-
XHOI-APOI-KPNI-NHEI-PI-NHEI-BAMHI-SPEI-XBAI-NOS-PSTI-blunt-blunt-NOTI-XBAI-
OPERATOR-SPACER-OPERATOR-XBAI-SPEI CAMV TATA-NHEI-CLAI-SACI-XHOI-
APOI-KPNI-KPNI-AP3 MINIGENE-BAMHI-BAMHI-SPEI-XBAI-NOS-PSTI-HINDIII-RB 
20. pSV9a (AlcA::UTR5’gPAPS1UTR3’::35Sterm in ML1004) 
ML1004 digested with SalI/SmaI (vector) ligate to pSV1c digested with BsaAI/SalI (insert).  
21. pSV9x ( pPAPS1::UTR5 in ML939) 
PCR amplify the promoter PAPS1 from pSV1 using primer T7 and oSV141 , digest PCR 
product with NcoI. Clone this insert into ML939 (NcoI/EcoRIblunt)vector.  
22. pSV9b (pPAPS1::UTR5::EcoRI::AlcR) 
pSV9x digested with EcoRI (insert) + EA6 digested with EcoRI (vector) 
22. pSV9c (pBarMAP_AscI_AlcA::UTR5gPAPS1::UTR3-35Sterm) 
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pSV9a digested with AscI insert + pBarMAP digested with AscI vector. Remembered to 
select for reverse direction . 
23. pSV9d.1  (pBarMAP:pPAPS1::AlcR-AlcA-genomic rescue PAPS1) 
       pSV9d.2 (pBarMAP:pPAPS1::AlcR-AlcA-genomic rescue PAPS1) 
pSV9b digested with PacI insert + pSV9c digested with PacI vector. There are two 
directions of the pPAPS1::AlcR and AlcA::Genomic rescue PAPS1 (number 9d.1 and 9d.2) 
24. pSV10a (pBarMAP AlcA::YFP) 
ML1043 digested PacI/AscI insert + pBarMAP digested with PacI/AscI vector. 
25. pSV10b.1  (pBarMAP:pPAPS1::AlcR-AlcA::YFP) 
       pSV10b.2 (pBarMAP:pPAPS1::AlcR-AlcA::YFP) 
pSV9b digested with PacI insert + pSV10a digested with PacI vector; 10b.1 and 10b.2 refer 
to two directions of pPAPS1::AlcR and AlcA::YFP. 
26. pSV11a  (ML939-SDM cDNA NdeI PAPS1) 
Introduce NdeI site in front of the ATG site in PAPS1 by PCR using oSV128 and oSV101. 
Digest PCR product with EcoO109I then purify 333bp fragment (insert). Digest pSV4a with  
PstI, blunt then digest with EcoO109I (vector). Ligate. 
27. pSV11b (pET28a-PAPS1cDNAwt)  
pSV11a  digested with NdeI/EcoRI  insert  +  pET28a NdeI/EcoRI vector. 
28. pSV11c  (ML939-SDM cDNA NdeI PAPS1 SDM P313S - the ds39 mutated) 
Digest pSV11a with BglII/PmeI (vector). PCR using oSV78 and oSV80 using cDNA from 
PAPS1-1 mutant. Digest PCR product with BglII/PmeI, isolate the 875bp-fragment (insert). 
Ligate.  
29. pSV11d (pET28a_cDNAPAPS1-P313S-the ds39 mutated version) 
pET28a (EcoRI/NdeI) vector + pSV11c (EcoRI/NdeI) insert. 
30. pSV12 (pSV5c SDM to have StuI site at Cterm ML939 genomic PAPS1 ) 
Introduce StuI site by overlap PCR using primer oSV202 and oSV203. Clone the insert into 
pSV5c by PmeI/Bsp1407I sites. 
31. pSV14(pPAPS1::UTR5PAPS1::NPAPS4::CtermPAPS1 (genomic) 
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pV5d  digested with StuI/PstI vector 7380 bp + pSV12 StuI/PstI insert (1950bp fragment ). 
32. pSV15 (pBarMAP/AscI/pPAPS1::UTR5PAPS1::ATGNPAPS4-CtermPAPS1 (genomic)) 
 pSV14 digested with AscI insert + pBarMAP digested with AscI vector  
33. pSV16 (pPAPS1::GUS) 
pSV9x digested with  KpnI + pKJ1 digested with KpnI vector. 
34. pSV17 (pPAPS2::NLSGUS) 
PCR amplify promoter PAPS2 by primer oSV189 and oSV190; digest with KpnI (insert) + 
pKJ1 digested with KpnI vector. 
35. pSV18a (pPAPS3::NLSGUS); pSV18b (pPAPS3::NLSGUS) 
PCR amplify promoter pPAPS3 by primer oSV246 and oSV247; digest with KpnI (insert) + 
pKJ1 digested with KpnI vector. a and b are clones derived from the pPAPS3 from two 
independent PCR reactions. 
36. pSV19a (pPAPS4::NLSGUS) ; pSV19b (pPAPS4::NLSGUS) 
PCR amplify promoter pPAPS4 by primer oSV244 and oSV245,  digest with KpnI (insert) + 
pKJ1 digested with KpnI (vector). a and b are clones derived from the pPAPS3 from two 
independent PCR reactions. 
37. pSV20 (pBarMAP-pPAPS2::GUS) 
pSV17 digested with AscI insert + pBarMAP digested with AscI vector.   
38. pSV21 (pBarMAP-pPAPS1::GUS) 
pSV16 digested with AscI insert + pBarMAP digested with AscI vector. 
39. pSV22a (pBarMAP-pPAPS3::GUS) 
pSV18a digested with AscI insert + pBarMAP digested with AscI vector. 
40. pSV22b (pBarMAP-pPAPS3::GUS) 
pSV18b digested with AscI insert + pBarMAP digested with AscI vector. 
41. pSV23 (pBarMAP-pPAPS4::GUS) 
pSV19a digested with AscI insert + pBarMAP digested with AscI vector. 
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42. pSV23b (pBarMAP-pPAPS4::GUS) 
pSV19b digested with AscI insert + pBarMAP digested with AscI vector. 
43. pSV24(p35S::UTR5PAPS1-cDNAPAPS1-UTR3PAPS1::35Sterm in pML595) 
pSV4a digested with PacI insert + pML595 digested with Pac I vector.  
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Abbreviations 
35S  Promoter of the 35S gene from CaMV 
aa  Amino acid(s)  
ABA  Abscisic acid 
ABI ABSCISIC ACID-INSENSITIVE 
ADP Adenosine 5’ diphosphate 
Agrobacterium Agrobacterium tumefaciens  
AIL AINTEGUMENTA-LIKE 
Ala Alanine 
AMP Adenosine monophosphate 
Amp  Ampicillin 
AN3  ANGUSTIFOLIA3 
ANT  AINTEGUMENTA 
AP3 APETALA3 
APE  APETALA 
APS  Ammonium peroxide sulfate 
Arabidopsis Arabidopsis thaliana  
ARF  AUXIN RESPONSE FACTOR 
ARGOS  
AUXIN-REGULATED GENE INVOLVED IN 
ORGAN SIZE 
ARL ARGOS-LIKE 
At Arabidopsis thaliana 
ATP Adenosine 5’ triphosphate 
BB  BIG BROTHER 
BOAAG 
both organs (seedlings and inflorescences) 
abundance-affected genes 
BOP BLADE-ON-PETIOLE 
BOTAG 
both organs (seedlings and inflorescences) 
tail-affected genes 
bp  Base pairs 
BPE BIGPETAL 
BR  Brassinosteroid 
BSA  Bovine serum albumin 
Ca Calcium 
Cam  Chloramphenicol  
CaMV  Cauliflower Mosaic Virus 
Carb  Carbenicillin 
CDB Cyclin-destruction box 
CDK Cyclin-dependent kinase 
cDNA  Complementary deoxyribonucleic acid  
CDS  Coding sequence  
CER Controlled environment room 
CFP  Cyan fluorescent protein  
CIN CINCINNATA 
CLV  CLAVATA 
cm  Centimetre 
Col  Columbia, Arabidopsis thaliana accession 
cPAP canonical Poly(A) Polymerase 
CTD C-terminal domain 
CYC  CYCLIN 
CYP  Cytochrome P450 
CZ central zone 
d Deionised 
dCTP  2’-deoxycytosine 5’-triphosphate 
DELLAs DELLA proteins 
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DEG Differential expressed gene list 
DMCs Dispersed meristematic cells 
DMSO  Dimethylsulfoxide 
DNA  Deoxyribonucleic acid 
DNase  Deoxyribonuclease 
dNTPs  Deoxynucleoside triphosphates 
down downregulated 
ds Double-stranded 
DTT  Dithiothreitol 
E. coli  Escherichia coli 
e.g. Exempli gratia 
EDTA  Ethylendiaminetetraacetic acetate 
EIL1 EIN3-Like 
EIN ETHYLENE INSENSITIVE 
ER ERECTA 
er  Endoplasmatic reticulum 
ERL ERECTA-LIKE 
EtBr Ethidium bromide 
EtOH  Ethanol 
EYFP Enhanced yellow fluorescent protein 
F Faraday 
FAE FASCIATE 
FL flowers/inflorescence tissue 
FZR Fizzy-related 
g  Gramme  
GA Gibberellin 
Gent  Gentamycin 
GFP  Green fluorescent protein 
GIF GRF-INTERACTING FACTOR 
GRF GROWTH REGULATING FACTOR 
GUS  ß-glucuronidase 
h Hour(s) 
H2O Water 
HCl Hydrochloric acid 
His Histidine 
i.e. Id est 
IAA  Indole-3-acetic acid, auxin 
ICK 
Inhibitor/interactor with cyclin-dependent 
kinase 
IPTG Isopropyl β-D-1-thiogalactopyranoside 
JA Jasmonic acid 
JAG  JAGGED 
Kan  Kanamycin 
kb  Kilo base pairs 
kDa  Kilodalton 
KLU  KLUH / CYP78A5 
kV Kilo-volt 
l Liter 
L1 Layer 1 (epidermal layer)  
L2  Layer 2 (subepidermal layer)  
L3 
Layer 3 (layer forming vasculature and pith 
of plants)  
LB  Lysogeny broth or Left border of the T-DNA 
LE leaves/seedling tissue 
Ler  
Landsberg errecta, Arabidopsis thaliana 
accession 
LFY LEAFY 
M Molar 
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m Milli 
min  Minute(s) 
mm Millimeter 
mRNA  Messenger RNA 
MS-salts  Murashige and Skoog basal salt mixture 
N  Amino  
NaCl Sodium chloride 
NaOH Sodium hydroxide 
NASC Nottingham Arabidopsis stock centre 
NLS  Nuclear localisation sequence 
NUB NUBBIN 
OD  Optical density 
ORF  Open reading frame 
OSAAG organ specific abundance-affected genes 
OSTAG organ specific tail-affected genes 
PAP Poly(A) Polymerase 
PAPS 
canonical Poly(A) Polymerase like protein in 
Arabiodopsis 
PBS  Phosphate-buffered Saline 
PCR  Polymerase chain reaction 
PI PISTILLATA 
PMSF  Phenylmethylsufonyl fluoride 
PPD PEAPOD 
PPT  Phosphinothricin (BASTA) 
Pro Proline 
PZ  Peripheral zone 
RNA  Ribonucleic acid 
RNase  RNA nuclease 
rpm  Revolutions per minute 
rRNA Ribosomal RNA 
RT  Reverse transcriptase 
RT-PCR  Reverse transcriptase PCR 
s  Seconds 
S. cerevisiae Saccharomyces cerevisiae 
SAM  Shoot apical meristem 
SDS  Sodium dodecyl sulfate 
SDS-PAGE  SDS polyacrylamide gel electrophoresis 
SEM  Standard error of the mean 
SEP SEPALLATA 
Ser Serine 
SLY SLEEPY 
SOC 
Super optimal broth with catabolite 
repression 
Spec  Spectinomycin 
ss Single-stranded 
SSC  Standard saline citrate 
Str  Streptinomycin  
SV40 Simian virus 40 
TAE  Tris-acetate EDTA 
TAP Tandem affinity purification 
Taq  DNA polymerase from Thermus aquaticus 
TCP 
TEOSINTE BRANCHED1, CYCLOIDEA, 
PCF 
T-DNA  transferred DNA 
TE  Tris/EDTA 
TEMED  N,N,N’,N’-tetramethylethylenediamine 
Tet  Tetracycline  
Tm Melting temperature of primers 
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TOR TARGET OF RAPAMYCIN 
Tris  Tris(hydroxymethyl)aminomethane 
tRNA Transfer RNA 
Trp Tryptophan 
Tx  Generation x after transformation 
U  Unit(s) 
up upregulated 
UTR  Untranslated region 
UV  Ultraviolet  
V  Volt 
v/v  Volume by volume  
vol  Volume 
w/v Weight by volume  
wt  Wild-type  
WUS  WUSCHEL 
X-Gal  Bromo-chloro-indolyl-galactopyranoside 
YFP  Yellow fluorescent protein 
μ Micro 
Ω  Ohm 
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